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SUMMARY
The availability of the complete sequence of HSV-1 has 
permitted interpretation of HSV-1 gene function. As a result 
of database searches, US3 and UL13, the two HSV-1 genes 
studied during the course of this research, were found to 
possess amino acid sequence motifs characteristic of the 
protein kinase family. The US3 gene has indeed been shown to 
encode a protein kinase present in the cytoplasm of infected 
cells, however, protein kinase activity has not yet been 
assigned to the UL13 gene product, although the protein does 
correlate with a novel protein kinase activity in the nuclei 
of HSV-1 infected cells. Protein kinases constitute a very 
important class of enzymes which are responsible for the 
regulation of many cellular processes, thus, it is considered 
likely that these two genes play a significant role in the 
life cycle of HSV-1. This was investigated by constructing 
HSV-1 viruses which contain the US3 or UL13 genes disrupted 
by the insertion of the Escherichia coli lacZ gene. This 
insertional mutagenesis technique has been used successfully 
to investigate the functions of several other HSV-1 genes. 
During the course of this research three lacZ insertion 
mutants were constructed, a US3-JacZ insertion mutant, a 
UL13-IacZ insertion mutant and a UL13-US3 double insertion 
mutant. The effects of these mutations on the growth 
properties of HSV-1 and on the phosphoprotein profiles of 
infected cell extracts and virion preparations were then 
investigated.
The US3-lacZ insertion mutant used in the experiments 
described in this thesis was found, at a late stage of the 
work, to be contaminated with a low level of wt virus, 
despite 5/6 rounds of plaque purification. Nevertheless, the 
titres of the US3-lacZ virus were significantly reduced 
compared to wt, indicating that, although the gene is not 
essential for virus growth, its disruption does impair virus 
growth. This reduction in growth does not appear to be due 
to a decrease in the amount of DNA synthesised by the US3- 
lacZ virus but to a decrease in the infectivity of the virus 
particles (as indicated by the significantly higher 
particlerpfu ratio for the US3-lacZ virus). Examination of 
the phosphoprotein profiles of US3-lacZ infected cells, 
following in vitro phosphorylation, showed a reduction in the 
degree of phosphorylation of several proteins with estimated 
MWs of 200K, 80K and 30K. These proteins, which represent 
potential substrates of the US3 protein kinase, have not yet 
been identified, although the 30K protein may correspond to 
the UL34 gene product, which has recently been reported to be 
a substrate of the US3 protein kinase.
The growth of the UL13-lacZ insertion mutant, both in vitro 
and in vivo, does not differ significantly from that of wt, 
indicating that UL13 is not essential for virus growth, 
despite its conservation throughout the three herpesvirus 
families. Comparison of silver-stained gels of wt and UL13- 
lacZ virion preparations identified the 57K UL13 gene product 
as a relatively abundant component of the tegument, probably 
corresponding to VP18.8 - a phosphoprotein previously mapped
to this region of the genome. The phosphoprotein profiles of 
both UL13-IacZ-infected cells (nuclear extracts) and UL13- 
lacZ virions showed a reduction in the phosphorylation of 
several proteins, of MW 160K, 106K, 60K, 45K and 38K, 
indicating that the UL13 gene product does possess protein 
kinase activity. One of these potential substrates of UL13, 
the 38K phosphoprotein, has been mapped, using intertypic 
recombinants, to gene UL49, the product of which is known to 
be the virion tegument protein VP22. UL13-IacZ infected cell 
nuclear extracts were also found to contain two hyper- 
phosphorylated proteins with estimated MWs of 45K and 70K.
The origins of these proteins are not known.
Preliminary experiments with the UL13-US3 double insertion 
mutant have indicated that the growth of the virus is 
impaired to a much greater extent than expected from the 
growth properties of the two single lacZ mutants. One 
possible explanation for this is that the two kinases have 
common substrates and can therefore substitute for each 
others absence in the two single mutants, however this is 
considered unlikely as the phosphoprotein profiles of the two 
single mutants have not revealed any common substrates. 
Alternatively, the possibility exists that the two kinases 
may carry out similar functions in the virus life cycle.
Thus, the research presented in this thesis provides evidence 
that the UL13 gene product, a relatively abundant virion 
protein, possesses protein kinase activity, and identifies 
the UL49 gene product as a major substrate for this activity.
The research has also indicated several potential substrates 
for the US3 protein kinase, although these have not yet been 
identified. Finally, preliminary experiments with the 
UL13-US3 double insertion mutant have revealed a considerabl 
reduction in virus growth compared to the two single mutants
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CHAPTER 1: INTRODUCTION
Herpes simplex virus type 1 (HSV-1) encodes at least 70 
proteins, of which, approximately one-third have no known 
function. The elucidation of these functions was 
revolutionised by the availability of the HSV-1 genomic 
sequence (McGeoch et al., 1988a) which enabled the use of 
many techniques including computer based analyses, the 
expression of isolated genes, the construction of viruses 
with precise mutations and, the use of oligopeptide antisera. 
Indeed, it was as a result of database searches that the two 
HSV-1 genes studied during the course of this research, US3 
and UL13, and their homologues in other herpesviruses, were 
found to contain short amino acid motifs characteristic of 
the protein kinase family (McGeoch & Davison, 1986; Smith & 
Smith 1989; Chee et al., 1989). The presence of similar 
motifs within the N terminal domain of the large subunit of 
HSV ribonucleotide reductase (encoded by gene UL39) has led 
to the suggestion that this protein may also possess protein 
kinase activity (Chung et al., 1989; Paradis et al., 1991). 
Subsequent experiments with the US3 gene have identified the 
gene product as a novel protein kinase (Purves et al., 1986a, 
1987; Frame et a l ., 1987) which phosphorylates the product of 
gene UL34 (Purves et al., 1991, 1992), although the 
physiological significance of this phosphorylation is 
unknown. Less is known about the UL13 gene. The gene 
product is known to be a constituent of the virion and has 
been associated with a novel protein kinase activity present 
in the nuclei of infected cells (Cunningham et al., 1992).
As protein kinases are known to be of great importance in the
regulation of normal cellular metabolism it is anticipated 
that the HSV-1 encoded protein kinases play significant roles 
in some aspect of the virus life cycle. Thus, the objective 
of the research presented in this thesis was to investigate 
the role of the HSV-1 US3 and UL13 gene products during the 
lytic infection of cells, specifically, to determine if the 
UL13 gene product possesses protein kinase activity and to 
identify the substrates of the US3 and UL13 gene products.
The approach chosen for this research was the construction of 
HSV-1 mutants with insertions in the US3 gene, the UL13 gene 
or both the US3 and UL13 genes.
The aims of the following introduction are; (1) to give an 
overview of the biology of HSV-1, concentrating on the lytic 
infection, to describe the structure of the HSV-1 virion, as 
both US3 and UL13 have been reported to be constituents of 
the virion, and to give brief descriptions of the 
pathogenicity of the virus, latency, and the role of HSV-1 in 
transformation and oncogenesis; (2) to summarise the use of 
HSV-1 mutants to elucidate HSV-1 gene function, as this was 
the approach taken in this research; (3) to review current 
knowledge on the protein kinase family, focusing on protein 
kinases associated with or encoded by viruses; and (4) to 
describe in detail both the organisation of the US3 and UL13 
genes and the structure and properties of the proteins they 
encode.
1.1. CLASSIFICATION OF THE HERPESVIRUSES
4
The herpesviruses have been classified on the basis of 
characteristics such as the G+C content of their DNAs, genome 
arrangement and biological properties. According to the 
genome arrangement scheme the herpesviruses can be divided 
into six groups (A-F) depending upon the number, size and 
location of major repeat regions. Herpes simplex virus (HSV) 
falls into group E, together with human cytomegalovirus 
(HCMV; see Roizman, 1990). The most widely used 
classification, however, is based on the biological 
properties of the viruses and comprises three subfamilies, 
designated Alphaherpesvirinae, Betaherpesvirinae and 
Gammaherpesvirinae (reviewed in Roizman, 1990). HSV-1 and 
HSV-2 are members of the Alphaherpesvirinae. These viruses 
are characterised by their variable host range, relatively 
short reproductive cycle (usually less than 24 h ) , cytolytic 
infection and the ability to establish latent infection 
primarily in ganglia. Other examples of this subfamily 
include varicella-zoster virus (VZV), equine herpesvirus 
(EHV) and pseudorabies virus (PRV). The betaherpesviruses, 
such as HCMV and human herpesvirus-6 (HHV-6), have a 
restricted host range and a relatively long reproductive 
cycle. Infection often results in the formation of enlarged 
cells and latent infections can be established in various 
tissues such as secretory glands and lymphoreticular cells. 
Members of the Gammaherpesvirinae, such as Epstein-Barr virus 
(EBV), have a very limited host range with a tropism for
lymphocytes. The length of the reproductive cycle is 
variable and latent infections are frequently established in 
lymphoid tissue. Increasingly, comparison of genome 
sequences is being used to determine the evolutionary 
relationships between members of the Herpesviridae. The 
genomes of the alphaherpesviruses HSV-1, HSV-2, VZV, PRV and 
EHV-1 correspond quite closely in their content and the 
arrangement of homologous genes, especially in U l (Davison & 
Wilkie, 1983c), while comparison of VZV and the gamma- 
herpesvirus EBV reveals regions of rearrangements and 
divergence (Davison & Taylor, 1987). In 1988 Buckmaster et 
al. used this technique to show that Marek's disease virus 
(MDV), previously classified as a gammaherpesvirus, 
is more closely related to the Alphaherpesvirinae subfamily.
1.2. PATHOGENICITY OF HSV
HSV is transmitted by direct physical contact and causes 
characteristic vesicular lesions on the skin and mucosal 
surfaces. The mouth and lips are the most common sites of 
HSV-1 infections (herpes labialis, "cold sores"), while HSV- 
is largely associated with genital lesions (herpes 
genitalis). Following a primary HSV infection, which is 
usually asymptomatic, a latent infection is frequently 
established in the neuronal cells of the sensory ganglia.
The virus is periodically reactivated from the latent state 
by diverse stimuli such as UV light, menstruation and stress 
giving rise to localised disease. Although HSV infections
are usually mild, more severe conditions can occur, such as 
keratoconjunctivitis and acute necrotising encephalitis.
HSV-2 has also been implicated in cervical cancer, although 
this remains controversial. In addition, even mild HSV 
infections can be life-threatening in neonates and people who 
are immunocompromised (reviewed in Whitley, 1990).
1.3. LATENCY
A characteristic of HSV is its ability to establish latent 
infections in neuronal tissue (reviewed in Hill, 1985; 
Stevens, 1989; Feldman, 1991). Latency can be viewed in 
three stages: establishment, maintenance, and reactivation.
1.3.1. Establishment and Maintenance of Latency
The preferred site of HSV latency is nervous tissue although 
non-neuronal sites, such as the mouse footpad (Clements & 
Subak-Sharpe, 1988) and human corneas (Shimeld et al., 1982) 
have also been reported. HSV enters the nervous tissue 
through the nerve endings that innervate the site of primary 
infection and is transported up the axon, by retrograde 
axonal transport, to the cell body where it enters the 
nucleus. Here, the viral DNA becomes "endless" (Rock & 
Fraser, 1983; Efstathiou et al., 1986), implying that the DNA 
has integrated into the host DNA,has circularised or has 
concatemerised. Current evidence suggests that the latter is 
more likely (Mellerick & Fraser, 1987). The establishment of
latency does not require the products of the lytic genes 
(Russell et al. , 1987b; Steiner et al., 1990a) and the 
latency associated transcripts or LATs (see section 1.3.3.) 
are also dispensable (Javier et al., 1988; Clements & Stow, 
1989; Steiner et al., 1989).
It has been suggested that the host's immune response is 
involved in maintaining HSV in its latent state (Stevens & 
Cook, 1974), however, this has been disputed (Sekizawa et 
al., 1980).
1.3.2. Reactivation from Latency
HSV can be reactivated from the latent state by a variety of 
stimuli including UV light, trauma, hormonal changes, stress 
and immunosuppression (Hill, 1985). The precise mechanism by 
which reactivation occurs is not known although it is likely 
to involve triggers to both the ganglion and the skin (Hill, 
1985). Recent evidence suggests that HSV gene expression may 
be necessary for efficient reactivation. The immediate-early 
protein VmwllO is required for reactivation in an in vitro 
latency system (Russell et al., 1987b; Harris et al., 1989) 
and the LATs have been shown to augment the reactivation 
process (Leib et al., 1989; Steiner et al., 1989; Hill et 
al., 1990).
81.3.3. Latency Associated Transcripts (LATs)
The LATs are the only gene products detectable during HSV 
latency (Deatly et al., 1987; Stevens et al., 1987; Rock et 
al., 1987; Wagner et al., 1988a; Wechsler et al., 1988;
Gordon et al., 1988). They are transcribed from a region 
within the long repeats which is known to extend 750 bp into 
the 3' end of VmwllO, on the opposite strands and may extend 
into R s . The predominant transcripts are approximately 1.8 
to 2.2 kb and 1.2 to 1.5 kb in size. These transcripts are 
related by splicing and are poly(A)-. The 1.8 to 2.2 kb LAT 
has been detected during HSV-1 replication in tissue culture 
cells while the smaller LATs have only been detected during 
latent infection (Spivack & Fraser, 1988a, 1988b).
A low abundance poly(A)+ transcript has also been detected in 
latently infected cells. This transcript extends from 650 bp 
upstream to at least 5 kb downstream of the abundant poly(A)- 
LATs (Stevens et al., 1987; Wagner et al., 1988a, 1988b; 
Dobson et al. , 1989). It has been suggested that these 
abundant poly(A)- LATs represent introns spliced from the 
larger poly(A)+ transcript. This suggestion is supported by 
the fact that the 5' end of the abundant poly(A)- LAT is a 
canonical 5' splice donor site (Wagner et al., 1988a) and 
that the LAT promoter is situated approximately 700 bp 
upstream of the abundant LATs (Dobson et al., 1989).
The function of LATs is not known. It was proposed that LATs
prevented a lytic infection by inhibiting VmwllO expression 
through an antisense mechanism. However, it is now known 
that LATs are not required for the establishment of latency 
(Javier et al., 1988; Clements & Stow, 1989; Steiner et al., 
1989). Another proposal is that LATs exert their effects by 
encoding a polypeptide. Two open reading frames have been 
identified in this region of the genome, the larger of which 
potentially encodes a 305-amino acid polypeptide (Wagner et 
al., 1988a; Wechsler et al., 1989). An antibody raised 
against a LAT fusion protein has identified a latency- 
associated antigen (LAA) of 80 KDa in latently infected 
neurons (Doerig et al., 1991).
1.3.4. Models Used to Study Latency
The most useful animal models for studying latency are mice, 
guinea pigs and rabbits. In mice, latent infections are 
established readily following eye, footpad or ear 
inoculation. Reactivation does not occur spontaneously but 
can be induced in vivo by a variety of physical and chemical 
stimuli or in vitro by explantation of latently infected 
ganglionic tissue (Stevens & Cook, 1971).
Tissue culture latency systems have been developed in an 
attempt to reduce the complexities inherent in the animal 
models. In most of these systems latency is established by 
treatment of cultured cells with inhibitors of HSV 
replication, and reactivation is induced by chemical
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manipulation, temperature change or superinfection (O'Neill 
et al., 1972; O'Neill, 1977; Wigdahl et al., 1981, 1982; 
Youssoufian et al., 1982; Rapp, 1984; Wilcox & Johnson, 1987,
1988). Russell & Preston (1986) described a system in which 
HSV-2 established a latent infection in human foetal lung 
(HFL) fibroblasts when incubated at the supraoptimal 
temperature of 42°C for 6 days and subsequently downshifted 
to 37°C. Reactivation was achieved by superinfection with 
HSV or HCMV. The efficiency of this system has since been 
increased by using an HSV-1 Vmw65 mutant as the latent virus 
(Harris & Preston, 1991).
1.4. ONCOGENESIS AND TRANSFORMATION
HSV-2 has been implicated in the aetiology of human cervical 
cancer on the basis of seroepidemiological studies (Nahmias 
et al., 1974) and the detection of HSV-2 DNA in cervical 
cancer specimens (Galloway & McDougall, 1983; Park et al., 
1983; Macnab et al., 1985). However, a direct link between 
HSV-2 and cervical cancer remains controversial. It is more 
likely that HSV-2 contributes to the development of malignant 
disease by acting in synergy with another factor such as 
human papillomavirus (zur Hausen, 1982).
It is well established that HSV can transform cultured cells 
(Duff & Rapp, 1971; Galloway & McDougall, 1983; Cameron et 
al., 1985; Jariwalla et al., 1986). Three morphological 
transformation regions (MTRs) have been identified in the HSV
genome; one in HSV-1, designated MTRI (0.311 to 0.45 m.u., 
Reyes et al., 1979); and two in HSV-2 designated MTRII (0.58 
to 0.62 m.u., Reyes et al., 1979; Galloway & McDougall, 1981
Cameron et al., 1985), and MTRIII (0.54 to 0.58 m.u.,
Jariwalla et al., 1983). In contrast to other DNA tumour 
viruses, such as SV40 or adenovirus, where viral DNA becomes 
integrated into the cellular DNA and encodes a transforming 
protein, the HSV MTRs do not contain a complete ORF and are 
not necessarily retained in the transformed cell, thus, a 
"hit and run" mechanism has been proposed for HSV 
transformation (Galloway & McDougall, 1983; reviewed in 
Macnab, 1987) . This mechanism may involve the activation of
cellular genes, either by trans-activation or by promoter or
enhancer insertion. Indeed, a set of cellular polypeptides 
are induced in both transformed cells and HSV-2 infected 
cells (Macnab et al., 1985; Hewitt et al., 1991). 
Alternatively, the virus may introduce mutations into 
cellular genes; HSV infection has been shown to increase the 
mutation frequency of the HGPRT and supF genes (Pilon et al. 
1985, 1986; Clarke & Clements, 1991) and both HSV-1 and HSV- 
have been implicated in gene amplification (Lavi, 1981; 
Schlehofer et al., 1983). Another mechanism used by many 
viruses to induce transformation is the expression of 
oncogenes. As many oncogenes encode protein kinases the 
products of the protein kinase genes of HSV (US3, UL13) and 
the N terminal domain of the UL39 product are potential 
candidates for a transforming protein. The regions of the 
genome which encode US3 and UL13 protein kinases do not
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correlate with the MTRs. However, DNA fragments which span 
the N terminal protein kinase domain of HSV-2 UL39 have been 
implicated in the transformation of cultured cells (Jones et 
al., 1986; Ali et al., 1991), although there is no definite 
evidence that it is the protein kinase activity that is 
directly responsible for the transformed phenotype.
1.5. STRUCTURE OF HSV-1
1.5.1. Structure of the HSV-1 Virion
The HSV-1 virion consists of a core containing a linear, 
double-stranded DNA enclosed within an icosahedral capsid 
which is surrounded by an amorphous proteinaceous layer known 
as the tecrument. This, in turn, is surrounded by a lipid 
envelope carrying surface glycoproteins (Roizman & Furlong, 
1974; see Figure 1.1). The number of proteins reported to be 
contained in the virion ranges from 30 to 35 (Spear &
Roizman, 1972; Heine et al., 1974; Marsden et al., 1976; 
Dargan, 1986).
1.5.1.1. The capsid
Knowledge of the structure of the HSV-1 capsid has recently 
been extended using the techniques of cryoelectron microscopy 
and image reconstruction (Schrag et al., 1989; Booy et al.,
1991). The outer shell of the capsid, which is 14-15nm 
thick, consists of 162 capsomers which lie on a T=16
Figure 1.1 Structure of the herpesvirus virion.
(Reproduced from Levine, 1991)
A. Schematic diagram of a herpesvirus particle. The 
icosahedral inner core (capsid), shown with two-fold 
symmetry, is surrounded by the tegument and enclosed 
within an envelope from which glycoprotein spikes 
protrude.
B. Electron micrograph of a cross section through an HSV 
particle, showing the nucleocapsid core, the amorphous 
tegument, the outer membrane and glycoprotein spikes.
A
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icosahedral lattice. There are 150 hexavalent capsomers 
(hexons) and 12 pentavalent capsomers (pentons) which are 
connected to each other in groups of three by trimers. A 
channel about 40& in diameter runs through the long axis of 
each capsomer. Schrag et al. (1989) also reported a second, 
internal shell with T=4 icosahedral symmetry within which 
they predicted the DNA would lie. The studies of Booy et al. 
(1991) however provided no evidence for this inner shell and 
indicated that the viral DNA extends as far as the outer 
shell, appearing as a uniformly dense mass (the core). The 
inner shell is now presumed to have represented an artifact 
of image reconstruction.
The capsid is composed of the following proteins: VP5, VP19C, 
VP21, VP22a, VP23, VP24 (Gibson & Roizman, 1972, 1974) and a 
12K protein known as VP26 (Heilman et al., 1979; Cohen et 
al., 1980; Newcomb & Brown, 1991; see Table 1.1). VPS is 
essential for capsid assembly (Weller et al., 1987). It is 
thought to be the main component of the hexons (Vernon et 
al., 1981; Schrag et al., 1989) and may also comprise the 
pentons (Schrag et al., 1989). VP19C, also essential for 
capsid assembly (Pertuiset et al., 1989), is linked by 
disulphide bonds to VP5 (Zweig et al., 1979) and has been 
proposed to be a constituent of the pentons (Vernon et al., 
1981). VP21 is present only in capsids which contain DNA and 
has been proposed to be a constituent of the core (Gibson & 
Roizman, 1972). The VP22a family of proteins, which is 
present only in partially cored capsids (Braun et al., 1984b;
Table 1.1 Capsid proteins
The seven capsid proteins are listed, together with their 
genes, and their alternative names.
-p
-p
rH
-P
-P
O vO 
M 00
rH O'*
> *H
-P
(0
00
O'* -P
rH Q)
CO
o'*
O  u
■P •rH
-p  vo
tfl 00 
0 cr* 
U  i-h
in
oo
co
oo in
co
vo
CN
inco
in
in CN(N
CO
in
IN
O
in
o•H
m m vo
•H
CN
CN
CO
CNCN CNin
Sherman & Bachenheimer, 1988; Rixon et al., 1988) is involved 
in packaging viral DNA into capsids (Preston et al., 1983) 
and has been compared to the scaffolding protein of double­
stranded DNA bacteriophages (Newcomb & Brown, 1991). VP23 is 
located on the outer capsid surface (Braun et al., 1984b) and 
may comprise the trimer which connects adjacent capsomers 
(Schrag et al., 1989). Barker & Roizman (1992) have recently 
suggested that VP26 is encoded by a novel gene designated 
UL49.5 or UL49A (Barnett et al., 1992). However, two 
concurrent studies have shown that VP26 is in fact encoded by 
gene UL35 (McNabb & Courtney, 1992; F. J. Rixon, personal 
communication).
1.5.1.2. The tegument
The tegument of HSV-1 appears as an electron-opaque amorphous 
region located between the capsid and the envelope. Vernon 
et al. (1982) proposed that the tegument acquired structure 
by attaching to the capsid at the vertices. However, on 
removal of the envelope from non-infectious virus-like 
particles (L particles) which lack capsids (Szilagyi & 
Cunningham, 1991), the tegument displays considerable 
structural integrity indicating that tegument structure is at 
least in part independent of the presence of either the 
capsid or the envelope (McLauchlan & Rixon, 1992) . A major 
component of the tegument is the trans-acting protein Vmw65 
(VP16), the product of gene UL48, which is responsible for 
stimulation of immediate early transcription (Post et al.,
1981; Batterson & Roizman, 1983; Campbell et al., 1984). The 
tegument also contains a virion host shut off (vhs) protein, 
encoded by gene UL41 (Kwong et al., 1988; McGeoch et al., 
1988a). The UL13 gene product, predicted to be a novel 
protein kinase (Smith & Smith, 1989; Chee et al., 1989), has 
recently been identified as a constituent of the tegument 
(Cunningham et al., 1992; Coulter et al., 1993) and may 
account for some of the protein kinase activity which has 
been associated with HSV-1 virions (Rubenstein et al., 1972; 
Lemaster & Roizman, 1980; Blue & Stobbs, 1981; Stevely et 
al., 1985). The tegument proteins VP13/14, encoded by UL47 
(McLean et al., 1990; Whittaker et al., 1991), together with
the UL46 gene product have been shown to modulate the
Vmw65-mediated transcriptional induction (McKnight et al., 
1987a). Other tegument proteins include VP22, a 38K protein 
encoded by gene UL49 (Elliott & Meredith, 1992), a 273K
protein (VP1/2) which is the product of UL36 (Batterson et
al., 1983), a 10K protein which is encoded by US9 (Frame et 
al., 1986) and a family of myristylated proteins encoded by 
UL11 (MacLean et al., 1992). It is interesting to note that 
all of the tegument proteins described here are 
phosphorylated either in the purified virion or in the 
infected cell.
1.5.1.3. The envelope
The envelope of HSV-1 virions consists of a lipid membrane 
(Asher et al., 1969, Ben-Porat & Kaplan, 1971) with
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glycoprotein spikes of 8-10nm projecting fom its outer 
surface (Wildy et al., 1960; Stannard et al., 1987). HSV-1 
encodes ten glycoproteins - gB, gC, gD, gE, gG, gH, gl 
(Buckmaster et al., 1984; Longnecker & Roizman, 1987; Richman 
et al., 1986; Spear, 1984), gJ (McGeoch et al., 1985; Roizman 
& Sears, 1990), gK (Hutchinson et al., 1991) and gL 
(Hutchinson et al., 1992). These glycoproteins are encoded 
by genes UL27, UL44, US6, US8, US4, UL22, US7, US5, UL53 and 
UL1 respectively (McGeoch et al., 1988a; Hutchinson et al., 
1991; Hutchinson et al., 1992). The products of genes UL10, 
UL20, UL34, UL43, UL53 and UL49A may also be associated with 
the virion envelope as they all have hydrophobic regions 
which could be membrane-spanning domains (McGeoch et al., 
1988a; Barnett et al., 1992).
1.5.2. Structure of the HSV-1 Genome
1.5.2.1. Structural properties of the HSV-1 crenome
The HSV-1 genome is a linear, double-stranded DNA 
approximately 152 Kbp in length (McGeoch et al., 1988a). It 
consists of two covalently joined components, L and S, which 
consist of unique sequences (Ul and Us) flanked by inverted 
repeat sequences. The sequences flanking Ul are designated 
TRl (terminal repeat) and IRl (internal repeat), those 
flanking Us are TRs and IRs (Sheldrick & Berthelot, 1974; 
Wadsworth et al., 1975). The sequences of Rl and Rs are 
distinct. A 400bp direct repeat, known as the a sequence, is
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present at the genome termini and, in the inverse 
orientation, at the L-S junction. The L terminus and the 
joint may possess multiple copies of the a sequence (Wagner & 
Summers, 1978). The a sequence of HSV-1 strain F consists of 
a 20bp repeat (DR1), a 64bp unique sequence (Ub), 22 repeats 
of a 12bp sequence (DR2), three repeats of a 37bp sequence 
(DR4) , a 58bp unique sequence (Uc) and another copy of DR1 
(Mocarski & Roizman, 1982). The number of DR elements can 
vary, accounting for the observed heterogeneity in the size 
of the a sequence (Davison & Wilkie, 1981; Mocarski &
Roizman, 1981; Mocarski et al., 1985). The a sequence also 
contains cleavage and packaging signals designated p a d  and 
pac2 which are contained within Ub and Uc, respectively 
(Deiss et al., 1986; Varmuza & Smiley, 1985). The terminal a 
sequences possess 3* overhangs which are involved in 
circularization of the DNA during replication (Mocarski & 
Roizman, 1982). Rl and Rs also contain multiple copies of 
short, directly repeated sequences with unit lengths of up to 
54 residues (McGeoch et al., 1985; Rixon et al., 1984).
The L and S components of HSV can invert relative to one 
another giving equimolar amounts of four isomers which appear 
to be functionally equivalent (Delius & Clements, 1976; 
Wilkie, 1976; Davison & Wilkie, 1983a, 1983b; Longnecker & 
Roizman, 1986) . One isomer has been designated P (prototype) 
and the others have been designated II, Is and Isl (Roizman, 
1979) (Figure 1.2). The function of isomerization is unclear 
as mutants which are frozen in one orientation are viable
Figure 1.2 Isomerization of HSV DNA
(Reproduced from McGeoch, 1987).
The HSV genome consists of two covalently linked segments,
L and S. Each of these contains an unique sequence (Ul or 
Us, solid lines) flanked by inverted repeats (TRl and IRl, 
IRs and TRs, open boxes). The a sequence is present as a 
direct repeat at the genome termini and, in inverted 
orientation, at the L-S junction. Inversion of the L and S 
segments occurs between inverted copies of the a sequence 
to generate four isomers found in equimolar amounts. These 
are designated P (prototype), Is (inverted S), II (inverted 
L) and Ils (both L and S inverted).
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(Jenkins & Roizman, 1986; Poffenberger et al., 1983). It has 
been suggested that these inversions are due to homologous 
recombination between Rl and R s . Later studies have 
suggested that recombinational isomerization is mediated by 
cis-acting sites within the a sequence (Mocarski et al.,
1980; Mocarski & Roizman, 1981; Smiley et al., 1981; Chou & 
Roizman, 1985), however, recent work has indicated that HSV 
DNA fragments which lack an a sequence can also recombine, 
when duplicated in the genome (Longnecker & Roizman, 1986; 
Pogue-Geile et al., 1985; Pogue-Geile & Spear, 1986; Varmuza 
& Smiley, 1985; Weber et al., 1988). It has also been 
demonstrated that both the HSV DNA replication system and the 
cleavage-packaging system are inherently recombinogenic 
(Weber et al., 1988; Smiley et al., 1990). The a sequence, 
however, does appear to be more recombinogenic than other DNA 
fragments (Weber et al., 1988; Chou & Roizman, 1985; Weber et 
al., 1990; Deiss et al., 1986; Umene, 1991).
1.5.2.2. Nucleotide sequence of HSV-1
The HSV-1 genome has been completely sequenced (McGeoch et 
al., 1988a) giving a total genome length of 152260 residues. 
The genome has a high overall G+C content of 68.3% ranging 
from 64% in Us to 80% in Rs. McGeoch et al. (1988a) 
identified a total of 72 genes encoding 70 distinct proteins; 
56 genes in Ul, 12 genes in Us and one gene in each copy of 
Rl and R s . In addition to these genes, two novel genes have 
been identified in Ul; UL26.5 (Liu & Roizman, 1991a) and
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UL49.5 (Barker & Roizman, 1992) or UL49A (Barnett et al.,
1992). The presence of the gene encoding ICP34.5 (RL1) in 
the long repeat region (Rl) of HSV-1 strain 17 has been 
confirmed (Dolan et al., 1992) and a product has recently 
been reported for the LATs (Doerig et al., 1991, see section
1.3.4.). A correction has recently been made to the 
published UL56 reading frame (McGeoch et al., 1991; see 
Figure 1.3).
Approximately one third of the genes encoded by HSV-1 have no 
known function and, perhaps surprisingly, at least 20 have 
been shown to be non-essential for virus growth in tissue 
culture. The genes to which functions have been assigned can 
be categorised into (a) regulatory genes, (b) genes involved 
in the replication machinery, and (c) structural genes.
Table 1.2 lists the HSV-1 genes and their functions, where 
known. (This table was compiled using unpublished 
information from D. J. McGeoch and P. A. Schaffer.)
Other features of the HSV-1 genome include: three origins of 
replications, one in U l (oriL) and one in each copy of Rs 
(oris); the presence of several 3 1-coterminal families; and a 
scarcity of spliced genes.
1.6. GENETICS OF HSV-1
The isolation and characterisation of HSV-1 mutants has 
proven to be an effective technique in the elucidation of HSV
Figure 1.3 Organization of genes in the HSV-1 genome
(Reproduced from McGeoch et al., 1988a, with 
modifications).
The HSV-1 genome is shown on four successive lines, with 
unique regions represented by solid lines and the repeat 
elements as open boxes. The sizes and orientations of the 
proposed ORFs are shown by arrows. The genes within U l 
have been labelled UL1 to UL56 (including the two novel 
genes, UL26.5 and UL49A). In the Us region the genes are 
labelled US1 to US12. Within the repeat elements the two 
copies of the genes encoding ICP34.5 (RL1), IE110 (RL2) and 
IE175 are labelled. Locations of proposed transcription 
polyadenylation sites are indicated as short vertical bars. 
The origins of replication are marked as X. The lower 
scale represents kilobases and the upper scale represents 
fractional map units.
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Table 1.2 HSV-1 genes and their functions
This table was compiled from the lists of McGeoch et al. 
(1988a); McGeoch (1989) and McGeoch & Schaffer (1993, in 
press) .
GENE FUNCTION REFERENCES
RL1(734.5) Neurovirulence factor (ICP34.5) Chou et al., 1990; Dolan et al., 1992
McGeoch & Barnett, 1991 
RL2(IEl,aO) IE protein (IE110, VmwllO, ICPO) Everett, 1989; Stow & Stow, 1986
UL1 gL, complexes with gH Hutchinson et al., 1992
UL2 Uracil-DNA glycosylase Mullaney et al., 1989; Worrad et al., 1988
UL3 Unknown Baines &  Roizman, 1991
UL4 Unknown Baines &  Roizman, 1991
UL5 Component of D N A  helicase-primase Crate et al., 1989; Zhu &  Weller, 1992
complex; posseses helicase motifs 
UL6 Role in virion morphogenesis (VP11-12) Sherman & Bachenheimer, 1988
UL7 Unknown
UL8 Component of helicase-primase complex Carmichael & Weller, 1989;
Crate et al., 1989
UL9 Ori-binding protein; D N A  helicase Olivo et al., 1988; W u  et al., 1988
UL10 Unknown; probable membrane protein MacLean et al., 1991
UL11 Myristylated tegument protein MacLean et al., 1989, 1992;
Baines &  Roizman, 1992 
UL12 Deoxyribonuclease Weller et al., 1990
UL13 Protein kinase; tegument phospho- Cunningham et al., 1992; this thesis
protein (VP18.8)
UL14 Unknown
UL1S Unknown; possible NTP-binding motifs Baines &  Roizman, 1991; Dolan et al., 1991
Davison, 1992
UL16 Unknown Baines & Roizman, 1991
UL17 Unknown Baines &  Roizman, 1991
UL18 Capsid protein (VP23) Rixon et al., 1990
UL19 Major capsid protein (VP5) Weller et al., 1987
UL20 Membrane protein involved in viral egress Baines et al., 1991; MacLean et al., 1991
UL21 Unknown
UL22 gH; complexes with gL; cell entry Forrester et al., 1992; Gompels et al., 1991
UL23 Thymidine kinase Darby et al., 1981
UL24 Unknown; possibly cell fusion Jacobson et al., 1989a
UL2S Virion protein Addison et al., 1984
UL26 Capsid protein (VP24); proteinase Liu & Roizman, 1991a, 1991b;
Preston et al., 1992
UL26.5 Internal protein of immature capsids Liu &  Roizman, 1991a, 1991b;
(VP22a); processed by UL26 proteinase Preston et al., 1992
UL27 gB; cell entry Cai et al., 1987; Little et al., 1981
UL28 Capsid maturation Addison et al., 1990
UL29 ssDNA binding protein (ICP8) Gao et al., 1988
UL30 DNA polymerase; complexes with UL42 Gottlieb et al., 1990 —
protein 1 Gallo e t al., 1988
UL31 Unknown
UL32 Unknown Weller et al., 1983
UL33 Structural, involved in DNA packaging Al-Kobaisi et al., 1991
UL34 Membrane associated protein; substrate
for US3 protein kinase 
UL35 Capsid protein (VP26)
UL36 Large tegument protein (VP1-3)
UL37 DNA-binding protein
UL38 Capsid protein (VP19c)
UL39 Ribonucleotide reductase large subunit
(Rl, ICP6, Vmwl36)
UL40 Ribonucleotide reductase small subunit
(R2, Vmw38)
UL41 Virion protein; host shutoff factor
UL42 Subunit of D N A  polymerase; increases
processivity
UL43 Unknown; probable membrane protein
UL44 gC; cell entry
UL45 Virion protein
UL46 Modulates activity of UL48 protein
UL47 Tegument protein (VP13/14); modulates
activity of UL48 protein 
UL48 Major tegument protein; transactivates IE
genes (VP16, Vmw65, a-TIF)
UL49 Tegument protein (VP22)
UL49A Putative membrane protein
UL50 Deoxyuridine triphosphatase
ULS1 Unknown
UL52 Component of helicase-primase complex
UL53 gK
UL54 IE protein (ICP27, Vmw63)
UL55 Negative regulation of gene expression
UL56 Unknown
LATs Family of transcripts expressed in
latency
IE175 IE protein (ICP4, Vmwl75)
US1 IE protein (ICP22, Vmw68)
US2 Unknown
US3 Protein kinase; phosphorylates
UL34 protein 
US4 gG
US5 gJ
US6 gD; cell entry
US7 gl
US8 gE
US9 Virion protein
US 10 Virion protein
US 11 Virion protein; RNA-binding protein
US12 IE protein (ICP47, Vmwl2)
Purves e t a l, 1991, 1992
McNabb A  Courtney, 1992 
Batterson et al., 1983 
Shelton et al., 1990 
Rixon et al., 1990
Goldstein A  Weller, 1988a, 1988b -  
Preston et al., 1988b
Fenwick &  Everett, 1990
Gottlieb et al., 1990 
1 Gallo et al., 1988
MacLean et al., 1991
Homa et al., 1986
Visalli A  Brandt, 1991
Zhang et al., 1991; Barker A  Roizman, 1990
Zhang et al., 1991; Barker &  Roizman, 1990;
McLean et al., 1990
Ace et al., 1989; Campbell et al., 1984
Elliott A  Meredith, 1992 
Barker A  Roizman, 1992;
Barnett et al., 1992
McGeoch, 1990; Fisher A  Preston, 1986 
Barker A  Roizman, 1990 
Crute et al., 1989
Hutchinson et al., 1991; MacLean et al., 1991 
Smith et al., 1992; McCarthy et al., 1989 
Block et al., 1991 
McGeoch et al., 1991 
Perry A  McGeoch, 1988;
Javier et al., 1988 
Paterson A  Everett, 1990 
Post A  Roizman, 1981 
Longnecker A  Roizman, 1987 
Purves et al., 1991, 1992
Longnecker A  Roizman, 1987 
Weber et a!., 1987 
Ligas A  Johnson, 1988 
Johnson et al., 1988 
Johnson et al., 1988 
Umene, 1987 j Frame et al., 1986 
Longnecker A  Roizman, 1987 
Roller A  Roizman, 1992 
Longnecker A  Roizman, 1987
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gene function and is the approach used in the research 
described in this thesis. Although spontaneous mutants do 
occur in wt stocks, most HSV-1 mutants have either been 
induced or engineered. The main types of mutants are 
described below:
1.6.1. Temperature-sensitive (ts) Mutants
Ts (conditional-lethal) mutants are most commonly produced by 
missense mutations that alter the amino acid sequence of the 
encoded protein. This alteration decreases the stability of 
the three-dimensional structure of the protein at higher 
temperatures, resulting in a loss of function. If the 
mutation is present in an essential gene, the mutant will be 
unable to grow at the non-permissive temperature (NPT).
Ts mutations have been induced randomly through the HSV
genome using 5-bromo-21-deoxyuridine (BUdR), nitrous acid
(NA), hydroxylamine (HA), nitrosoguanidine or UV light 
Brown et al., 1973; Timbury & Calder, 1976 
(Schaffer et al., 1970, 1973; Manservigi, 1974) or, in
specific cloned HSV DNA fragments, using NA or HA (Chu et
al., 1979; Sandri-Goldin et al., 1981). Many of these
mutations have been mapped to specific genes using the marker
rescue technique (Wilkie et al., 1974; Stow, 1978; Preston,
1981). The nature of the screening procedure for ts mutants
means that only mutants with defects in essential genes are
isolated. Over 22 essential genes have now been identified
using this technique.
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1.6.2. Drug-resistant (dr) Mutants
Many HSV-1 dr mutants were isolated during the evaluation of 
compounds as potential antiviral agents. All contain 
mutations in the thymidine kinase (TK) gene or the DNA 
polymerase gene. The main types of drugs used and the dr 
mutants isolated are described below.
1.6.2.1. Nucleoside analogues
Substituted deoxyuridines such as 5-bromo-2'-deoxyuridine 
(BUdR) and 5-bromo-21-deoxycytidine (BCdR) inhibit viral DNA 
synthesis when phosphorylated by TK. BUdR also inhibits 
cellular DNA replication necessitating the use of TK~ cell 
lines for virus growth. Several BUdR and BCdR-resistant 
mutants have been isolated, all of which contain lesions in 
TK and therefore have to depend on the de novo pathway of 
thymidine synthesis to supply TTP (Kit & Dubbs, 1963; Dubbs & 
Kit, 1964; Jamieson et al., 1974; Cooper, 1973).
Arabinose nucleosides, such as araATP (araA), inhibit HSV-1 
DNA polymerase (Muller et al., 1977). An araA-resistant 
mutant containing a lesion in the DNA polymerase has been 
isolated (Coen et al., 1982).
The most effective antiherpetic nucleoside analogue is 
acycloguanosine (acyclovir, ACV) which acts as a chain
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terminator during viral DNA synthesis. Many ACV-resistant 
mutants have been isolated and two ACV-resistant loci have 
been identified, the TK gene and the DNA polymerase gene 
(Elion et al., 1977; Field et al., 1980; Crumpacker et al., 
1980; Darby et al., 1981; Darby et al., 1984; Larder & Darby, 
1985). Within the DNA polymerase gene, the mutations 
conferring ACV-resistance have been mapped to regions which 
are highly conserved among the human herpesviruses (Larder et 
al., 1987).
1.6.2.2. Pyrophosphate analogues
Phosphonoacetate (PAA) inhibits viral DNA polymerase by 
binding to its pyrophosphate-binding site (Leinbach et al., 
1976). Several PAA-resistant mutants, containing lesions in 
the DNA polymerase gene, have been isolated (Hay & Subak- 
Sharpe, 1976; Purifoy & Powell, 1977).
1.6.3. Plaque Morphology Mutants
HSV-1 mutants have been isolated which cause neighbouring 
cells to fuse instead of undergoing lysis (Brown et al.,
1973). These mutants are known as syncytial (syn) mutants 
and contain lesions which have been mapped to at least seven 
different loci in the HSV-1 genome (reviewed in Marsden,
1987). At least five of these loci have been found to 
correspond to distinct genes, all of which are glycoproteins 
or putative membrane poteins; UL1 (gL), UL20, UL24, UL27 (gB)
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and UL53 (gK) (Bzik et al.,, 1984; Debroy et al. , 1985; Little 
& Schaffer, 1981; Pogue-Geile & Spear, 1987; Jacobson et al., 
1989a; Baines et al., 1991). The molecular basis of the syn 
phenotype remains unclear.
1.6.4. Host-range (hr) Mutants
The study of HSV-1 genes essential to the virus life cycle 
has been aided by the construction of cell lines carrying 
appropriate fragments of HSV DNA. The protein expressed by 
the integrated HSV DNA complements the mutation in the 
infecting virus thereby permitting the growth of mutants 
containing lesions in essential genes. Conditional-lethal 
host-range (hr) mutants have been obtained in at least seven 
genes including genes required for DNA replication and genes 
encoding glycoproteins (Carmichael et al., 1988; Ligas & 
Johnson, 1988; Weller et al., 1990).
1.6.5. Monoclonal Antibody-resistant (mar) Mutants
Mar mutants contain altered surface antigens which are not 
recognized by monoclonal antibodies raised against wt viral 
proteins. These monoclonals are recognized by a second 
antibody to which horseradish peroxidase (HRP) has been 
conjugated. The HRP reacts with chloronaphthol to form a 
dark precipitate, thus all wt plaques are stained black while 
mutant plaques are clear. Mar mutants have proved useful in 
identifying functional regions of HSV glycoproteins (Holland
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et al., 1983; Marlin et al., 1986; Highlander et al., 1987,
1989).
1 .6.6. In vitro Mutagenesis
Knowledge of the HSV-1 nucleotide sequence and the 
development of in vitro mutagenesis techniques have enabled 
the introduction of precise mutations into the HSV-1 genome 
permitting detailed analysis of all aspects of the virus life 
cycle.
1 .6.6.1. Disruption of ORFs by insertion/deletion
Post & Roizman (1981) described a method for introducing 
deletions into non-essential genes of HSV-1 using the TK gene 
as a selectable marker. HSV-1 DNA carrying a deletion in the 
TK gene is co-transfected with a cloned HSV-1 DNA fragment 
containing the gene under study into which the intact TK gene 
has been inserted. The insertion mutants are selected for on 
the basis of their TK+ phenotype. Deletions can then be 
introduced by transfection of plasmid-borne HSV-1 fragments 
carrying the appropriate deletion. The deletion mutants are 
isolated by selecting for the TK- phenotype. These 
procedures have been used to generate deletions in 11 of the 
12 Us genes (Longnecker & Roizman, 1987).
A second approach is the insertion of a transposable element 
such as miniMu (Roizman & Jenkins, 1985) or Tn5 (Weber et
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al., 1987), into a cloned HSV-1 DNA fragment. The transposon 
inserts randomly into the HSV fragment, only once, disrupting 
any ORFs present at the site of insertion. The fragment is 
then transfected into the wt HSV-1 genome. This technique 
has been used to investigate the non-essential genes of Us 
(Weber et al., 1987).
Another approach is the disruption of an ORF by the insertion 
of the lacZ gene of Escherichia coli (Chakrabarti et al., 
1985; Panicali et al., 1986). The lacZ gene, inserted under 
the control of a separate promoter such as the SV40 early 
promoter (Rixon & McLauchlan, 1990) or the HSV-1 UL39 
promoter (Goldstein & Weller, 1988a), acts as a screenable 
marker with viruses containing the insert forming blue 
plaques in the presence of 5-bromo-4-chloro-3-indolyl- J3 - 
D-galactopyranoside (X-Gal). The insertion mutant can then 
be used to generate deletion mutants which produce colourless 
plaques in the presence of X-Gal. This approach has been 
successful in the investigation of several HSV-1 genes 
(Goldstein & Weller, 1988a; 1988b; Ligas & Johnson, 1988; 
Mullaney et al., 1989; Carmichael & Weller, 1989; Weller et 
al., 1990; MacLean et al., 1991) and is the approach used in 
the research described in this thesis.
1.6.6.2. Analysis of functional domains
The insertion of small oligonucleotides, the generation of 
small deletions, and site-specific mutagenesis all create
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local changes in proteins without causing any gross changes 
in their tertiary structure. These approaches have been used 
to study the functional domains of many HSV-1 proteins 
including Vmw65 (Ace et al., 1988), Vmwl75 (Paterson &
Everett, 1988a; 1988b), gB (Cai et al., 1988b; Qadri et al.,
1991) and TK (Inglis & Darby, 1987; Liu & Summers, 1988).
1.6.6.3. Analysis of non-codincr regions
The techniques described above have also been used to analyse 
sequences controlling the expression of viral proteins. For 
example, Post et al. (1981) and Mavromara-Nazos & Roizman 
(1987) have constructed several chimeric genes, where the 
structural gene sequence has been fused to promoters of
different genes. The promoters of UL23 (TK), UL44 (gC) and
UL22 (gH) have been analysed by linker scanning (Coen et al., 
1986; Steffy & Weir, 1991) and Smiley et al. (1992) have used 
deletion analysis to determine the effect of Vmwl75 on the gD 
promoter.
1.7. HSV-1 LYTIC CYCLE
1.7.1. Initial Stages of HSV-1 Infection
The initial interaction between HSV-1 and the host cell is 
the binding of the virion to heparan sulphate present on the 
cell surface (WuDunn & Spear, 1989; Shieh et al., 1992). Two 
viral proteins have been implicated in this interaction: gC,
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which is thought to be primarily responsible, and gB (Herold 
et al., 1991; Cai et al., 1988a). This initial binding of 
the virion to heparan sulphate is thought to promote the 
subsequent interaction of other virion glycoproteins, such as 
gD, with cellular receptors (Campadelli-Fiume et al., 1988; 
Johnson & Spear, 1989; Johnson et al., 1990). It has been 
reported that the basic fibroblast growth factor (bFGF) 
receptor acts as a receptor for HSV-1 (Kaner et al., 1990; 
Baird et al., 1990). However, subsequent studies have 
provided evidence that HSV-1 infection does not require the 
presence of this receptor (Shieh & Spear, 1991; Mirda et al., 
1992; Muggeridge et al., 1992).
The next stage in HSV-1 infection is penetration of the cell, 
which is generally accepted to occur by membrane fusion 
rather than by endocytosis (Para et al., 1980; Campadelli- 
Fiume et al., 1988; Wittels & Spear, 1991). Penetration 
requires the presence of at least three glycoproteins, gB, gD 
and gH, and another virion protein, UL25. gB- and gD- 
negative viruses are unable to penetrate cells but can still
bind to the cell surface, however, gH-negative virions are
defective in both penetration and binding, suggesting that gH 
functions after gD, possibly in membrane fusion (Forrester et 
al., 1992). The role of UL25 in penetration is unknown
(Addison et al., 1984).
Following penetration, the capsids are transported to the 
nucleus by a mechanism which probably involves the cellular
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cytoskeleton (Kristensson et al., 1986). The DNA is then 
released from the capsid by a process that requires the 
virion/tegument phosphoprotein UL36 (Batterson et al., 1983; 
McGeoch et al., 1988a).
1.7.2. Regulation of HSV-1 Gene Expression
The genes of HSV-1 are expressed in a cascade fashion 
(Marsden et al., 1976; Honess & Roizman, 1974; Clements et 
al., 1977) which is tightly controlled by both 
transcriptional and post-transcriptional regulatory 
mechanisms (Godowski & Knipe, 1986; Weinheimer & McKnight, 
1987; Smith & Sandri-Goldin, 1988; Smith et al., 1992).
There are at least three phases of expression; immediate 
early (IE,®^), early (E,/£ ) and late (L,% ) (Honess & 
Roizman, 1974; Clements et al., 1977; Jones & Roizman, 1979). 
The five immediate early proteins are expressed at high 
levels in the absence of de novo viral protein synthesis. 
Their expression has been reported to peak at the early 
stages of infection and decline thereafter. However, the 
accumulation of both IE mRNA and IE proteins has been 
observed during the middle and late stages of infection 
(Ackerman et al., 1984; Harris-Hamilton & Bachenheimer, 1985; 
Metzler & Wilcox, 1985; Everett & Orr, 1991; Everett, 1991). 
The IE proteins activate the early genes which encode the 
proteins necessary for DNA replication. The late genes, 
which encode mainly structural proteins can be subdivided 
into leaky late ( i) genes which are induced shortly after
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the E genes, and true late.( $ 2 ) genes which are activated 
only after the onset of DNA replication.
The mechanisms by which the host RNA polymerase II 
differentiates between the IE, E and L genes are based on the
presence of cis-acting DNA sequences and trans-acting
factors.
1.7.2.1. Cis-acting DNA sequences
(a) Immediate early gene promoters
Transcription of the five IE genes (IE1-IE5) is mediated by 
both promoter and enhancer sequences. The promoter component 
is found within lOObp upstream of the transcription start 
site and contains elements, such as the TATA box, which is 
recognised by the transcription factor TFIID, and the GC box 
which is recognised by the transcriptional activator Spl
(Jones & Tjian, 1985).
The enhancer-like elements of IE promoters are situated far 
upstream from the transcription start site (-140 to -340) and 
include the consensus sequence 5 1-TAATGARAT-3' (R=purine) 
which is present in one or more copies in either orientation 
and has been shown to be essential for trans-induction by the 
virion component Vmw65 (Mackem & Roizman, 1982a, 1982b; 
Cordingley et al., 1983; Preston et al., 1984a; Kristie & 
Roizman, 1984; Gaffney et al., 1985; Bzik & Preston, 1986;
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O'Hare & Hayward, 1987). This trans-induction is mediated by 
the cellular factor OTF-I, also known as NF-AI, NFIII and 
OCT-1 (Staudt et al., 1986; Fletcher et al., 1987; Pruijan et 
al., 1986; Stern et al., 1989) which complexes with Vmw65 and 
binds to the TAATGARAT sequence (Gerster & Roeder, 1988; 
Kristie &. Roizman, 1986; McKnight et al., 1987a; O'Hare &. 
Goding, 1988; O'Hare et al., 1988; Preston et al., 1988;
Stern et al., 1989). A GA-rich element, present in close 
proximity to at least one TAATGARAT sequence, also confers a 
strong, independent, response to Vmw65 (Bzik & Preston, 1986; 
Triezenberg et al., 1988a).
The promoters of the IE genes 1, 2 and 3 also possess copies 
of the Vmwl75 binding site (Faber & Wilcox, 1986b, 1988; 
Kristie & Roizman, 1986; Muller, 1987). The binding of 
Vmwl75 to the IE1 and IE3 promoters results in repression of 
the promoter in transfection assays suggesting a mechanism 
for the observed autoregulation of IE proteins (Gelman & 
Silverstein, 1987a, 1987b; Resnick et al., 1989; Everett & 
Orr, 1991; DeLuca & Schaffer, 1988; Paterson & Everett,
1988a, 1988b; Roberts et al., 1988; DiDonato & Muller, 1989). 
However, Everett & Orr (1991) have reported that mutation of . 
the Vmwl75 binding sites in both copies of the IE1 promoter 
in the viral genome has no effect on IE1 expression during 
normal HSV-1 infection.
(b) Early gene promoters
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The promoters of the thymidine kinase (TK) gene and the 
glycoprotein D (gD) gene have been extensively studied. The 
control region of the TK promoter extends 135 bp upstream of 
the transcription start site and contains five regulatory 
elements; a TATA box element, a CCAAT box, two GC box 
elements and an octamer binding site (Zipser et al., 1981; 
McKnight et al., 1981; McKnight & Kingsbury, 1982; Smiley et 
al., 1983; Halpern & Smiley, 1984; Eisenberg et al., 1985; 
Coen et al., 1986; McKnight & Tjian, 1986; Parslow et al., 
1987; Btini & Coen, 1989). The gD promoter requires only 83bp 
upstream of the transcription start site for efficient 
induction and, like the TK promoter, contains several 
regulatory elements including a TATA box and two GA-rich 
sequences (Everett, 1983, 1984a).
The TK and gD promoters also contain Vmwl75 binding sites 
(Kristie & Roizman, 1986; Imbalzano et al., 1990; Beard et 
al., 1986; Tedder et al., 1989) although the binding of 
Vmwl75 to the TK promoter is not necessary for 
transactivation (Imbalzano et al., 1990; Shepard & DeLuca,
1991) and the removal of the three binding sites in the gD 
promoter does not affect the efficiency of gD transcription 
during a normal HSV-1 infection (Smiley et al., 1992).
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(c) Late gene promoters
The promoters of true late genes such as US11, UL44 (gC) , 
UL38, UL49 and UL22 (gH) appear to have a simpler structure 
than IE or E promoters. The only consensus sequence element 
identified in these promoters is the TATA box. However, 
several studies have indicated the presence of additional 
cis-acting sequences in the late gene promoter, downstream 
from the TATA box (Mavromara-Nazos & Roizman, 1989; Steffy & 
Weir, 1991; Kibler et al., 1991). These sequences do not 
form a recognisable consensus and the specific binding of 
factors to these sequences has not been observed.
Efficient expression of late promoters requires the presence 
of IE gene products (DeLuca et al., 1984, 1985; DeLuca & 
Schaffer, 1985; Michael et al., 1988) and functional Vmwl75 
binding sites have been identified in the promoters of two 
late genes; gene UL38 (Flanagan et al., 1991) and gene UL49 
(Michael & Roizman, 1989; Michael et al., 1988). It is not 
known if these binding sites are required for activation of 
late gene expression.
Another cis-acting requirement for late gene expression is 
DNA replication (Mavromara-Nazos & Roizman, 1987). The onset 
of DNA replication may remove a transcriptional block or may 
provide a factor which is necessary for transcriptional 
activation.
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There is also evidence of a negative regulatory element in 
late gene promoters. Costa et al. (1985) and Blair & Wagner 
(1986) have reported that the sequence between 75 and 165 bp 
upstream of the UL19 (VP5) cap site suppresses the activity 
of the promoter.
1.7.2.2. Trans-acting factors
(a) Vmw65
Vmw65 (VP16, c*-TIF, ICP35) is an HSV-1 virion/tegument 
phosphoprotein (Heine et al., 1974; Spear & Roizman, 1972; 
Lemaster & Roizman, 1980) which is encoded by gene UL48 
(Campbell et al., 1984; Dalrymple et al., 1985; Pellett et 
al., 1985). The protein is essential for normal virion 
assembly (Ace et al., 1988; Weinheimer et al., 1992) and 
specifically trans-activates IE gene expression (Campbell et 
al., 1984; Post et al., 1981; Batterson & Roizman, 1983).
The trans-activating function is important for virus growth 
in vivo and also for normal virus replication at low 
multiplicities of infection (Ace et al., 1989).
Vmw65 interacts with the cis-acting TAATGARAT elements 
present on the IE gene promoters, by forming an IE complex 
(IEC; also known as TRF.C and VIC) with the cellular 
transcription factor OFT-1 and other cellular proteins 
(Gerster & Roeder, 1988; Kristie et al., 1989; McKnight et 
al., 1987a; Preston et al., 1988a; Stern et al., 1989; Katan
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et al., 1990; Xiao & Capone, 1990). OFT-1 is a member of the 
class of proteins known as POU proteins and contains two DNA- 
binding regions, the POU-homeo subdomain which is thought to 
interact with the TAAT sequence on the IE promoters, and the 
POU-specific subdomain which may interact with the sequence 
just upstream of this (Herr et al., 1988; Sturm et al., 1988; 
Sturm & Herr, 1988). Vmw65 may bind to the GARAT sequence 
(Kristie & Sharp, 1990).
The region of Vmw65 required for complex formation lies 
towards the amino terminus, residues 45 to 388 (Ace et al., 
1988; Greaves & O'Hare, 1989; 1990; Werstuck & Capone, 1989; 
Triezenberg et al, 1988b) and includes a potential 
phosphorylation site (serine 375), the phosphorylation of 
which is thought to be necessary for complex formation 
(Greaves & O'Hare, 1990). The domain of Vmw65 responsible 
for trans-activation is situated within the carboxy-terminal 
80 amino acids and is thought to activate transcription by 
interacting with transcription factors or adaptors (Stringer 
et al., 1990; Lin & Green, 1991; Berger et al., 1990;
Kelleher et al., 1990). McKnight et al. (1987b) reported 
that this trans-activation can be modulated by the products 
of genes UL46 and UL47, however, HSV-1 mutants containing 
deletions in the UL46 and/or UL47 genes are viable in tissue 
culture (Zhang et al., 1991; Barker & Roizman, 1990) and show 
no alteration in the synthesis or steady-state levels of 
Vmw65 (Zhang et al., 1991).
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(b) Vmwl75
Vmwl75 (VP4) is the product of IE gene 3 (©<4) which lies 
entirely within Rs and is therefore present in the genome in 
two copies (Rixon et al., 1982). The protein, which is found 
in three electrophoretically distinct forms in extracts of 
infected cells (Pereira et al., 1977), is post- 
translationally modified by phosphorylation and by poly- 
ADP-ribosylation (Preston & Notarianni, 1983; Wilcox et al., 
1980) . The Vmwl75 protein has been reported to be present in 
virions (Yao & Courtney, 1989) but is actually found 
predominantly in Light (L) particles (enveloped particles 
which lack capsids) (McLauchlan & Rixon, 1992) . Vmwl75 
localises to the nucleus in a pattern which alters during 
infection (Randall & Dinwoodie, 1986; Knipe et al., 1987).
Early studies on IE gene 3 ts mutants (including tsK) 
indicated that Vmwl75 is continuously required for the 
transactivation of early and late gene expression and also 
for the repression of IE genes (Marsden et al., 1976;
Courtney et al., 1976; Watson & Clements, 1978, 1980;
Preston, 1979a, 1979b; Dixon & Schaffer, 1980). Recent 
transient transfection assays have confirmed that Vmwl75 can 
transactivate early gene promoters (O'Hare & Hayward 1985a; 
Gelman & Silverstein, 1985) although Everett (1984b, 1986) 
suggests that this activity is the result of synergistic 
cooperation with VmwllO. Similar assays have demonstrated 
that Vmwl75 can also repress transcription from IE promoters
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(O'Hare & Hayward, 1985b; DeLuca & Schaffer, 1985; Gelman & 
Silverstein, 1986). Vmwl75 is known to bind to the promoters 
of IE genes 1, 2 and 3 (Faber & Wilcox, 1988; Kristie & 
Roizman, 1986; Muller, 1987), early genes UL23 (TK) and US6 
(gD) (Kristie & Roizman, 1986; Imbalzano et al., 1990; Beard 
et al. , 1986; Tedder et al., 1989), and late genes UL38 and 
UL49 (Flanagan et al., 1991; Michael & Roizman, 1989; Michael 
et al. , 1988). However, several studies have shown that the 
binding of Vmwl75 to promoter sequences is not necessary for 
transactivation (Everett & Orr, 1991; Imbalzano et al., 1990; 
Shepard & DeLuca, 1991; Smiley et al., 1992).
Vmwl75 is proposed to consist of five domains, (McGeoch et 
al., 1986a; DeLuca & Schaffer, 1988; Paterson & Everett, 
1988a, 1988b). Domain 1 (residues 1-314), which contains a 
conserved potential phosphorylation site, does not appear to 
play a critical role in Vmwl75 function. Domain 2 (315-484), 
however, is absolutely required for both transcription 
activation and repression. The region of the protein 
directly involved in DNA binding lies between residues 229 to 
496. Transactivation is also affected by certain mutations 
in domain 3 (485-796), which contains the nuclear 
localization signal, and also in domain 4 (497-1224). Domain 
5 is not thought to play a critical role in the function of 
Vmwl75.
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(c) Vmwl 10
VmwllO (ICPO) is encoded by IE gene 1 (°^0) which is situated 
entirely within the long repeat region and is therefore 
present in two copies (Preston et al. , 1978). The transcript 
of IE gene 1 is spliced (Perry et al., 1986) and overlaps 
with the LATs, at the 3' end. The VmwllO protein is a 
constituent of the virion tegument (Yao & Courtney, 1992).
It is phosphorylated (Ackermann et al., 1984) and localises 
to the nucleus (Pereira et al., 1977, Hay & Hay, 1980).
Transient transfection assays have shown that VmwllO can 
trans-activate transcription from IE, early, and late gene 
promoters, (O'Hare & Hayward, 1985a, 1985b; Mavromara-Nazos 
et al., 1986; Shapira et al., 1987; Everett, 1986), possibly 
in synergy with Vmwl75 (Everett, 1984b), and also from 
heterologous promoters such as the SV40 early promoter and 
the HIV LTR (Everett, 1988b; Mosca et al., 1987). This 
transactivation activity is not essential for virus growth as 
VmwllO deletion mutants (Stow & Stow, 1986; Sacks & Schaffer, 
1987; Everett, 1989; Cai & Schaffer, 1992; Chen &
Silverstein, 1992) are viable in tissue culture. However, 
the mutants have high particle to pfu ratios and grow very 
poorly at low multiplicities of infection, suggesting that 
trans-activation may be dependent upon an interaction between 
VmwllO and Vmwl75, or that VmwllO may be responsible for 
increasing the concentration of Vmwl75 to a level required 
for entry into the lytic cycle (Everett et al., 1991).
38
Mutational analyses of VmwllO (Everett, 1987, 1988a, 1988b, 
1989) have indicated that five regions of the protein, 
including a potential Zn finger binding domain, are important 
for transcriptional trans-activation, in synergy with Vmwl75. 
However, only three of these regions are required for trans­
activation in the absence of Vmwl75, suggesting separate 
mechanisms of action.
The observation that a VmwllO deletion virus can not 
reactivate latent HSV-2 from an in vitro latency system 
(Russell et al., 1987b; Harris et al., 1989) has led to the 
conclusion that VmwllO must play a significant role in the 
reactivation of virus from in vitro latency
systems.
(d) Vmw63
Vmw63 (ICP27) is encoded by IE gene 2 (°<-27, gene UL54) 
(McGeoch et al., 1988a). It is modified by the addition of 
phosphate groups which cycle on and off during infection 
(Wilcox et al., 1980; Pereira et al., 1977; Ackermann et al.,
1984), and localises to the nucleus during infection (Fenwick 
et al., 1978; Knipe & Smith, 1986).
Transfection assays (Everett, 1986; Rice & Knipe, 1988; 
Sekulovich et al., 1988; Hardwicke et al., 1989; Su & Knipe, 
1989; McMahan & Schaffer, 1990) and studies with ts and
deletion mutants have indicated that Vmw63, which is 
essential for virus growth, is involved in repression of 
transcription from IE and some E gene promoters, and enhances 
transcription from L gene promoters (Sacks et al., 1985; 
McCarthy et al., 1989; Rice & Knipe, 1990). Vmw63 may 
therefore be involved in the switch from E to L gene 
expression.
Detailed mutational analysis of the Vmw63 polypeptide has 
identified two main regulatory regions; an activator region 
(residues 260 to 434) and a repressor region (within the C- 
terminal 78 amino acids) which contains a putative Zn finger 
binding domain (Hardwicke et al., 1989; Rice et al., 1989; 
McMahan & Schaffer, 1990; Smith et al., 1991).
(e) Others
Vmw68 (ICP22) , encoded by IE gene 4 (cx: 22, US1), is 
phosphorylated and localises in the nucleus (Pereira et al., 
1977; Marsden et al., 1978). A deletion mutant of Vmw68 
shows a decrease in the expression of a chimeric ? 2~TK gene 
(Sears et al., 1985) indicating that, in the absence of an as 
yet, unidentified host cell factor, Vmw68 is required for 
efficient late gene expression.
Vmwl2 (ICP47) is encoded by gene IE5 (©c47, US12). Unlike 
the other four IE polypeptides, Vmwl2 is not phosphorylated 
and localises in the cytoplasm (Marsden et al., 1982). The
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role of Vmwl2 during viral infection is unclear but it is 
known to be dispensable for virus growth (Longnecker &
Roizman, 1986).
1.7.3. Post-translational Modifications of HSV-1 Proteins
1.7.3.1. Glycosylation
HSV-1 encodes at least ten glycoproteins gB, gC, gD, gE, gG, 
gH, gl (Buckmaster et al., 1984; Longnecker & Roizman, 1987; 
Richman et al, 1986; Spear, 1984), gJ (McGeoch et al., 1985; 
Roizman & Sears, 1990), gK (Hutchinson et al., 1991) and gL 
(Hutchinson et al., 1992) which contain both N-linked and 0- 
linked oligosaccharides (Pizer et al., 1980; Hope & Marsden, 
1983; Johnson & Spear, 1983; Serafini-Cessi et al., 1988).
The use of glycosylation inhibitors and endoglycosidases have 
indicated that the N-linked oligosaccharides are important 
for virus infectivity (Kousoulas et al., 1983; Pizer et al., 
1980; Svennerholm et al., 1982; Spivack et al., 1982; Kuhn et 
al., 1988). However, recent oligonucleotide-directed 
mutagenesis studies on the three N-linked oligosaccharides of 
gD have shown that they are not necessary for gD function 
during viral infection, although the oligosaccharide at site 
1 does play an important role in forming and/or maintaining 
the structure of the glycoprotein (Sodora et al., 1991).
Three tegument proteins, VP13/14, encoded by UL47 (Whittaker 
et al., 1991; McLean et al., 1990), and VP22, encoded by UL49
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(Elliott & Meredith, 1992), have been shown to contain a 
small quantity of O-linked oligosaccharides (Meredith et al.,
1991). The function of this modification is unclear.
1.7.3.2. Phosphorylation
At least eleven HSV-1 encoded proteins are post- 
translational ly modified by the addition of phosphate 
(Pereira et al., 1977; Marsden et al., 1978). These proteins 
include: the transcriptional regulatory proteins Vmwl75, 
VmwllO, Vmw68 and Vmw63; virion structural proteins including 
Vmw65 (Lemaster & Roizman, 1980); UL42, a subunit of the HSV- 
1 DNA polymerase which appears to increase the processivity 
of the enzyme during replication (Marsden et al., 1987); and 
enzymes such as the large subunit of ribonucleotide reductase 
(RRi, ICP6). Wilcox et al. (1980) demonstrated that 
phosphate cycles on and off several of these proteins during 
the course of infection. For example, two of the three 
electrophoretic forms of Vmwl75 cycle between phosphorylated 
and non-phosphorylated states while the third species is 
stably phosphorylated throughout infection. Phosphate has 
also been shown to cycle on and off Vmw68, Vmw63 and RRi. 
Wilcox et al. (1980) also demonstrated that phosphorylation 
affects the DNA-binding properties of several HSV-1 
phosphoproteins, such as ICP6 and ICP29.
HSV-1 encodes three protein kinases, US3 (Frame et al., 1987; 
Purves et al., 1987), UL13 (Smith & Smith, 1989; Chee et al.,
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1989; this thesis) and UL39 (Chung et al., 1989; Paradis et 
al., 1991), however, the only known substrates for these 
kinases are the virion protein UL34 (Purves et al., 1991,
1992), Vmw 68, the product of US1 (Purves & Roizman, 1992) 
and the tegument protein UL49 (this thesis). It is likely 
that the majority of HSV-1 phosphoproteins are phosphorylated 
by cellular protein kinases.
The functional significance of HSV-1 protein phosphorylation 
is unclear, but it is possible that much of the observed 
phosphorylation is fortuitous and not necessary for virus 
growth.
1.7.3.3. Proteolytic cleavacre
The ICP35 polypeptide (p40, VP22a, NCP-3) undergoes extensive 
post-translational processing, forming at least 20 different 
species (Preston et al., 1983; Braun et al., 1984b). The 
protease responsible for this processing has recently been 
identified as the product of gene UL26 (Liu & Roizman, 1991b; 
Preston et al., 1992). Proteolytic cleavage is also known to 
be involved in the processing of HSV-1 glycoproteins. 
Glycoproteins gB, gC, gD, gE, gG, gH, g l , gJ and gK all have 
hydrophobic sequences near their N terminus and most contain 
cleavage sites for signal peptidase. Cleavage of these 
signal sequences has been demonstrated for gD, gB and gK 
(Matthews et al., 1983; Claesson-Welsh & Spear, 1987; 
Ramaswamy & Holland, 1992).
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1.7.3.4. Acylation
The most common fatty acid modifications are the co- 
translational addition of myristic acid to an N terminal 
glycine residue, and the addition of palmitic acid, to 
cysteine residue. A family of myristylated polypeptides (MW 
13000 to 16000), encoded by gene UL11, has been identified in 
HSV-1 virions (MacLean et al., 1989) and Chung et al. (1990) 
have reported that the protein kinase domain of ICP10, the 
HSV-2 homologue of RRi (ICP6), is myristylated. There is no 
evidence to suggest that HSV-1 RRi is similarly modified. To 
date, the only HSV-1 protein known to be palmitoylated is gE 
(Johnson & Spear, 1983).
1.7.3.5. ADP-ribosylation
Poly(ADP-ribosyl)ation involves the covalent attachment of 
ADP-ribose residues to a polypeptide using nicotinamide 
adenine dinucleotide (NAD) as a substrate. Preston & 
Notarianni (1983) identified two poly(ADP-ribosyl)ated HSV-1 
polypeptides, the immediate early polypeptide Vmwl75, and a 
38K polypeptide which corresponds to the 38K phosphoprotein 
reported by Marsden et al. (1978) and which has subsequently 
been shown to be VP22, the product of gene UL49 (Elliott & 
Meredith, 1992).
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1.7.3.6. Sulphation
At late times in infection the HSV-1 glycoproteins become 
sulphated by attachment of inorganic sulphate to the N-linked 
oligosaccharides. The major sulphated glycoprotein is gE 
(Hope et al., 1982; Hope & Marsden, 1983).
1.7.4. HSV-1 Replication
It has been proposed that, shortly after entering the host 
cell, the viral DNA circularises, by a process which does not 
require de novo protein synthesis (Davison & Wilkie, 1983a; 
Poffenberger & Roizman, 1985; Jacob & Roizman, 1977; Jacob et 
al., 1979). The DNA is then thought to replicate by a 
rolling circle mechanism which generates large concatemers of 
tandemly repeated viral genomes (Jacob et al., 1979). These 
concatemers are then cleaved into unit length genomes prior 
to packaging into capsids.
Both cis- and trans-acting elements are necessary for 
replication. Evidence for cis-acting sequences came from 
studies of defective viruses generated during serial passage 
of HSV at high multiplicities of infection (Frenkel et al., 
1975, 1976). These sequences have been designated oris and 
oriL* Trans-acting elements include a set of seven HSV-1 
genes (UL5, UL8, UL9, UL29, UL30, UL42 and UL52) which were 
first identified by means of a transient complementation 
assay (Wu et al., 1988). Recently, Stow (1992) has
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demonstrated that all seven of these genes expressed in 
recombinant baculoviruses are necessary for DNA replication 
from an HSV-1 ori.
1.7.4.1. cis-acting elements
(a) Oris
HSV-1 oris is located within the c sequence of the short 
repeats, between divergently transcribed genes (IE3 and 
IE4/IE5) and is therefore present in the genome in two copies 
(Stow, 1982; Stow & McMonagle, 1983). The core region of 
oris (67 to 90 bp long) contains four domains: three 11 bp 
UL9 binding sites -CGTTCGCACTT-(sites I to III) and an 18 bp 
AT-rich region. Sites I and II are inverted with respect to 
each other and form the arms of a 45 bp palindrome with the 
AT-rich region at its centre. Both of these sites have a 
high affinity for UL9, whereas site III, which lies just to 
the left of site I in inverted orientation, is a low affinity 
site. All four domains have been shown to be necessary for 
efficient replication in transient assay systems (Lockshon & 
Galloway, 1988; Weir & Stow, 1990; Hernandez et al., 1991; 
Martin et al., 1991). The sequences flanking the core region 
contain binding sites for a variety of transcriptional 
activators such as Vmw65 (Bzik & Preston, 1986) , Spl and NF- 
III (apRhys et al., 1989). Removal of these sequences 
reduces the efficiency of replication by approximately 80- 
fold (Wong & Schaffer, 1991). A virus lacking one copy of
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oris is viable in tissue culture (Longnecker & Roizman,
1986) .
(b) OriL
O r h  is located near the middle of the long unique region of 
the genome between the divergently transcribed genes, UL29 
and UL30 (Weller et al., 1985). O r h  is much larger than 
oris/ consisting of a 144 bp perfect palindrome. Due to the 
size of this palindrome, plasmids containing orix, are highly 
unstable in E. coli (Weller et al., 1985), thus the 
functional domains of o r h  have not been investigated as 
throughly as oris. A mutant virus lacking orii is viable in 
tissue culture and in vivo (Polvino-Bodnar et al., 1987).
1.7.4.2. Proteins directly involved in DNA replication
(a) UL30 (DNA polymerase)
HSV DNA polymerase is biochemically distinct from host DNA 
polymerase and is the target of many anti-viral drugs, such 
as acyclovir. It has been purified as a monomer of M r 
140,000 (Powell & Purifoy, 1977; O'Donnell et al., 1987) and 
does not appear to be post-translationally modified (Thomas 
et al . , 1988). In infected cells, the polymerase associates 
with the UL42 gene product to form the active polymerase 
"holoenzyme", however, the polymerase subunit alone has 
catalytic activity on simple primer-templates such as
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activated DNA. The subunit also possesses a 3 1 to 5 1 
exonuclease activity, which probably plays a role in proof­
reading (Powell & Purifoy, 1977; Knopf, 1979), and a 5 1 to 3' 
exonuclease/RNase H activity (Crute & Lehman, 1989).
The UL30 gene product contains six regions of conserved amino 
acids (Wong et al., 1988; Larder et al., 1987). Regions I to 
III (residues 694 to 896) contain most of the mutations which 
alter the drug sensitivity of the polymerase and are 
therefore thought to form the catalytic domain. Region IV 
(residues 432 to 479) is thought to be important for the 3' 
to 5' exonuclease activity and sequences near the N terminus 
have been implicated in the 5' to 3' exonuclease activity. A 
region of 227 amino acids near the C-terminus (residues 1008 
to 1235) is required for the specific interaction with the 
UL42 polypeptide (Digard & Coen, 1990).
(b) UL42 (Double-stranded DNA binding1 protein)
The UL42 protein is a 65 KDa phosphoprotein which binds 
double-stranded DNA in a sequence-independent, non- 
cooperative manner (Vaughan et al., 1985; Marsden et al., 
1987; Gallo et al., 1988; Parris et al., 1988). It is a 
subunit of the HSV DNA polymerase "holoenzyme" complex
(Powell & Purifoy, 1977; Vaughan et al., 1985; Gallo et al.,
1988) and appears to increase the processivity of the
polymerase (Gottlieb et al., 1990; Hernandez & Lehman, 1990).
This increase in processivity is probably related to the DNA-
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binding properties of UL42 which may be modulated by 
phosphorylation.
(c) UL9 (Origin binding protein)
The product of gene UL9 in an 83 KDa protein which binds to 
three sites in oris which contain the 11 bp consensus 
sequence CGTTCGCACTT (Elias & Lehman, 1988; Olivo et al,, 
1988; Weir et al., 1989). The DNA binding domain of UL9 has 
been mapped to the carboxy terminal third of the protein 
which contains a helix-turn-helix motif and a pseudo-leucine 
zipper (Weir et al., 1989; Deb & Deb, 1991). UL9 possesses 
helicase activity and may therefore be involved in the 
initial unwinding of the two parental DNA strands(Bruckner et 
al., 1991).
(d) UL5/UL8/UL52 complex
The products of genes UL5, UL8 and UL52 form a complex which 
exhibits both helicase and primase activities (Crute et al.,
1989). UL5 contains six motifs which are characteristic of 
helicases and which are essential for UL5 function (McGeoch 
et al. , 1988; Zhu & Weller, 1988, 1992), however, helicase 
activity is not observed unless UL52 is present (Dodson et 
al., 1989; Calder & Stow, 1990). UL8 is not required for 
either the helicase or the primase activity of the complex 
(Calder & Stow, 1990; Dodson & Lehman, 1991). It may be 
necessary for primer utilization, possibly by stabilizing the
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association of primers with the template (Challberg, 1991) or 
it may facilitate entry into the nucleus of the UL5 and UL52 
proteins (Calder et al., 1992). The UL52 gene product may 
possess primase activity, however this has not been 
demonstrated.
(e) UL29 (ICP8, major DNA binding protein)
The UL29 gene product (ICP8) is a 130 KDa DNA binding protein 
which localises to the nucleus where it accumulates at 
specific foci known as replication compartments (Quinlan et 
al., 1984; Randall & Dinwoodie, 1986). The protein binds 
preferentially to single-stranded DNA in a cooperative and 
sequence-independent manner (Bayliss
et al., 1975; Powell & Courtney, 1975; Powell & Purifoy,
1976; Powell et al., 1981; Ruyechan, 1983; Ruyechan & Weir,
1984) and may therefore bind to the ssDNA formed at the 
replication fork. UL29 may also play a role in organizing a 
multi-protein complex at the replication fork as it is known 
to interact with UL9 (Challberg, 1991), UL30 (Chiou et al.,
1985), UL42 and UL12 (DNase) (Vaughan et al., 1984; Thomas et 
al., 1992). The domain of UL29, responsible for binding 
ssDNA has been located to the carboxy-terminal portion of the 
protein (residues 564 to 1160; Gao & Knipe, 1989).
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1.7.4.3. P roteins indirectly involved in DNA replication
(a) DNase (UL12)
The HSV-encoded nuclease exhibits both exo- and endonuclease 
activities and has a markedly alkaline pH optimum (Morrison & 
Keir, 1968; Hoffman & Cheng, 1979; Hoffman, 1981). The 
protein has a MW of 85 KDa (Banks et a l . r 1983), is 
p hosphorylated, (Banks et al., 1985; Thomas et al., 1988). 
and localises to the nucleus although it does not move into 
the specific replication compartments, despite its 
association with the major DNA binding protein (UL29)
(Randall & Dinwoodie, 1986; Vaughan et al., 1984; Thomas et 
al., 1992). The nuclease is encoded by gene UL12 (Preston & 
Cordingley, 1982; Costa et al., 1983; Wathen & Hay, 1984; 
Draper et al., 1986; McGeoch et al., 1986b, 1988b). Early 
studies, using ts mutants, came to different conclusions 
regarding the requirement of the DNase for viral DNA 
synthesis (Moss et al., 1979; Francke & Garett, 1982; Moss,
1986). However, it is now apparent that the HSV-1 DNase is 
not essential for viral DNA replication but is required for 
the efficient production of infectious virus (Weller et al.,
1990). Possible functions of the DNase include cleavage of 
the viral DNA concatemers into unit length molecules (Chou & 
Roizman, 1989), a role in HSV DNA recombination or host 
chromosomal cleavage (Peat & Stanley, 1986).
(b) Thymidine kinase (TK, UL23)
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HSV-1 thymidine kinase provides nucleotides for viral DNA
synthesis by catalysing the phosphorylation of thymidine and
other pyrimidineldeoxyribonucleosides (Kit & Dubbs , 1953; Dubbs 
Jamieson & Subak-Sharpe, 1974 
& Kitt, 196^). TK also phosphorylates nucleoside analogues
such as acyclovir, converting them into the active form which
results in the inhibition of HSV infection (Elion et al.,
1977; Fyfe et al., 1978; Field et al., 1980). The TK gene
has been mapped to gene UL23 (Halliburton et al., 1980; Reyes
et al., 1982; McGeoch et al., 1988a), which is not essential
I but is essential in resting cells 
for virus growth in!dividing cells ^ (Dubbs & Kit, 1964;
Jamieson et al., 1974) and is not required for establishment
of latency (Efstathiou et al., 1989). The TK gene contains
six regions of conserved residues including a consensus ATP
binding site which is essential for TK activity (Gentry,
1985; Liu & Summers, 1988; Balasubramaniam et al., 1990;
Harrison et al., 1991). These regions are also conserved in
the cellular deoxycytidine kinase (Chottiner et al., 1991)
suggesting that the herpesvirus TKs may have evolved from a
cellular deoxycytidine kinase (Harrison et al., 1991).
(c) Ribonucleotide reductase (UL39/UL40)
Ribonucleotide reductase (RR) provides precursors for DNA 
synthesis by reducing ribonucleoside diphosphates (rNDPs) to 
their corresponding deoxyribonucleotides (dNDPs) using 
cellular thioredoxin as the reducing agent (Darling, 1988).
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HSV RR is composed of two non-identical subunits of molecular 
weight 136K (Ri) and 38K (R2 ) (Frame et al., 1985; Cohen et 
al., 1985; Bacchetti et al., 1986) which are encoded by genes 
UL39 and UL40, respectively (McLauchlan & Clements, 1983).
The subunits form a complex in an ^ 2  p>2 structure 
(Ingemarson & Lankinen, 1987). HSV RR is essential for virus 
growth in "resting" cells, or at elevated temperatures 
(Preston et al., 1984b, 1988b; Goldstein & Weller, 1988a, 
1988b; Jacobson et al., 1989b), and RR mutants exhibit an 
impaired pathogenicity in mice (Cameron et al., 1988;
Jacobson et al., 1989b).
HSV Ri possesses a unique N terminal domain which is not 
directly involved in ribonucleotide reduction (Ingemarson & 
Lankinen, 1987; Lankinen et al., 1989; Wymer et al., 1989; 
Conner et al., 1992b). This N terminal domain contains amino 
acid sequences which are characteristic of serine/threonine 
protein kinases and has been shown to possess protein kinase 
activity (Chung et al., 1989, 1990; Paradis et al., 1991; Ali 
et al., 1992; see section 1.9.5.).
Two peptides have been shown to inhibit RR activity. The 
nonapeptide YAGAVVNDL, corresponding to the C terminal of R 2 , 
inhibits activity by interfering with subunit association 
(McClements et al., 1988; Paradis et al., 1988; Darling et 
al., 1990) and a peptide corresponding to 15 residues of HSV- 
2 Ri, at the junction of the protein kinase domain and the RR
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domain, disrupts a complex consisting of R i , R 2 and a 
previously uncharacterised cellular 180K protein (Chung et 
al., 1991).
(d) dUTPase (UL50)
Following infection with HSV-1, a deoxyuridine triphosphatase 
(dUTPase) activity is induced which catalyses the hydrolysis 
of dUTP to dUMP and pyrophosphate (Wohlrab & Francke, 1980; 
Caradonna & Cheng, 1981; Williams, 1984). This enzyme 
therefore provides a mechanism to minimise the incorporation 
of uridine into newly synthesised DNA and also maintains a 
supply of dUMP which can be converted into dTMP by the 
cellular thymidylate synthase. The dUTPase was mapped to a 
position consistent with UL50 (Preston & Fisher, 1984) and 
was found to be non-essential for virus growth (Fisher & 
Preston, 1986) .
(e) Uracil-DNA glycosylase (UL2)
Uracil-DNA glycosylase catalyses the removal of uracil 
residues from DNA, thereby carrying out a DNA repair and 
proofreading function. HSV uracil-DNA glycosylase was first 
observed by Caradonna & Cheng (1981) and has been mapped to 
UL2 (Caradonna et al., 1987; Worrad & Caradonna, 1988). 
Sequence analysis of UL2 has revealed a striking similarity 
to the uracil-DNA glycosylase of E. coli (Mullaney et al.,
1989). The uracil-DNA glycosylase is not required for virus
growth in tissue culture (Mullaney et al., 1989).
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(f) Others
Topoisomerase activity, which forms or removes supercoi1ing, 
has been reported in HSV-infected cells, but is likely to be 
of cellular origin (Leary & Francke, 1984; Pearson & Conley, 
1984; Muller et al., 1985; Bapat et al., 1987).
Topoisomerase I activity has been co-purified with HSV DNA 
polymerase (Biswal et al., 1983).
Spadari (1976) reported an increase in ligase activity 
following HSV infection. However, the properties of the 
enzyme were similar to those of the cellular ligase.
Protein kinases are involved in the regulation of many enzyme 
catalysed processes and may therefore play a role in HSV 
replication. Indeed, several HSV proteins, directly or 
indirectly involved in replication, are known to be 
phosphorylated (e.g. UL42, RR, DNase). However, none of 
these proteins have yet been identified as substrates of the 
US3 or UL13 protein kinases (Purves et al., 1991; this 
thesis) and must therefore be phosphorylated by cellular 
kinases. Whether the phosphorylation of these proteins is of 
functional significance or is simply fortuitous is not known.
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1.7.5. Packaging of HSV-1 DNA into Capsids
HSV DNA is thought to replicate by a rolling circle mechanism 
generating head-to-tail concatemers which are then cleaved 
into unit-length genomes for packaging into preformed empty 
capsids (Jacob et al., 1979; Vlazny & Frenkel, 1981). The 
processes of cleavage and packaging are linked (Ladin et al., 
1980; 1982; Deiss et al., 1986; Deiss & Frenkel, 1986) and 
involve cis-acting sequences and trans-acting factors.
1.7.5.1. cis-acting sequences
The cis-acting sequences involved in cleavage and packaging 
are contained within the a sequence which consists of three 
direct repeats, designated DR1, DR2 and DR4 and two unique 
sequences, Ub and U c (Mocarski & Roizman, 1982; see section
1.4.2.). The sequences necessary for cleavage and packaging 
are contained within Ub and U c and are designated p a d  and 
pac2, respectively (Deiss et al., 1986; Varmuza & Smiley,
1985) . The site at which the DNA is cleaved is located 
within DR1 (Varmuza & Smiley, 1985; Mocarski et al., 1985).
1.7.5.2. Trans-acting factors involved in cleavage and 
packaging
Three viral proteins with molecular weights of 250 KDa, 140 
KDa and 82 KDa have been found to interact with DNA probes 
containing the pac2/DRl sequences (Chou & Roizman, 1989) .
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The 250 KDa protein, which has been identified as the product 
of UL36 (VP1), and the 140 KDa protein, which has not yet 
been identified, bind to the probes in a sequence-dependent 
manner. The 82 KDa protein, which binds in a non-specific 
manner, has been identified as the HSV-encoded DNase (Chou & 
Roizman, 1989). This study, combined with the observation 
that a DNase-negative mutant is defective in the processing 
of viral DNA (Weller et al., 1990), suggests that the DNase, 
in conjunction with other proteins, may be responsible for 
the cleavage of HSV DNA.
Studies with ts mutants which accumulate unprocessed DNA have 
led to the identification of several viral proteins involved 
in the trans-activation of encapsidation. These proteins 
include UL6 (Weller et al., 1983, 1987), UL26 (Preston et 
al., 1983), UL28 (Matz et al., 1983), UL32 (Weller et al., 
1983), UL33 (Al-Kobaisi, 1990) and UL54 (Sacks & Schaffer,
1987). The roles of these proteins in encapsidation are not 
yet known but some, such as the IE gene UL54, are likely to 
play indirect roles.
1.7.5.3. Proposed packaging model
A cleavage-packaging model has been proposed (Deiss et al.,
1986). The concatemers produced during replication contain 
novel junctions formed by the fusion of the L and S termini. 
These junctions consist of two copies of the a sequence which 
share the intervening DR1 sequence. It is proposed that a
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trans-acting protein forms an attachment between the p a d  
sequence, of the L terminus, and an as yet unidentified
structure on the capsid surface. The DNA is then looped into
the empty capsid until another p a d  sequence, in the same 
orientation, is encountered (representing the S terminus).
The DNA is then cleaved at the DR1 sequence adjacent to this 
p a d  sequence. This model predicts that the packaged DNA 
must always be the length of a unit genome, however capsids 
containing shorter lengths of DNA have been reported although 
they do not become enveloped (Vlazny et al. , 1982), implying 
that the process is more complex.
1.7.6. Envelopment of Virions and Egress From Cells
The route by which full capsids acquire a tegument and
envelope has not been resolved in detail. Original reports
suggested that the primary site of capsid envelopment was the 
inner nuclear membrane (Nii et al., 1968; Schwartz & Roizman, 
1969). However, evidence has also been produced suggesting 
that capsids become enveloped by budding into cytoplasmic 
vacuoles (Nii et al., 1968; Smith & De Harven, 1973).
Recent reports have shown that infection with 
alphaherpesviruses generates enveloped particles which lack 
capsids and DNA. These non-infectious particles have been 
designated light (L) particles (Szilagyi & Cunningham, 1991; 
McLauchlan & Rixon, 1992)i Rixon et al. (1992) have shown 
that these particles assemble independently of virion
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maturation, probably by a mechanism involving the 
condensation of tegument proteins within the cytoplasm 
followed by envelopment at cytoplasmic vacuoles. It is 
envisaged that virions are enveloped in a similar manner, 
except that the tegument proteins condense around the 
capsids.
Irrespective of where the capsids bud, it is generally 
accepted that the acquired envelope contains precursor forms 
of the viral glycoproteins. These precursors are processed 
into mature glycoproteins during migration through the Golgi 
apparatus (Johnson & Spear, 1982; Torrisi et al., 1992).
The egress of the mature virion is thought to occur by 
reverse phagocytosis at the plasma membrane.
1.7.7. Effect of HSV-1 Lytic Infection on the Host Cell
Lytic infection of cells with HSV-1 produces a number of 
changes which ultimately result in cell death.
Several alterations in the.structure of the cell have been 
observed. For example, the nucleolus increases in size, is 
displaced towards the nuclear membrane and disaggregates 
later in infection (Roizman & Furlong, 1974). In addition, 
the host chromatin is seen to unwind and, at later stages, 
chromatid breaks and fragmentation are observed (Hampar & 
Ellison, 1961). This chromosomal damage does not occur
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without the synthesis of IE and E proteins (Waubke et al., 
1968; Donner & Gtincz61, 1971; Peat & Stanley, 1986).
Another consequence of HSV-1 infection is the rapid 
inhibition of host macromolecular synthesis or virion host 
shut-off (vhs) (reviewed by Fenwick, 1984). This is 
characterised by a decrease in the transcription of both 
ribosomal and cellular RNA (Wagner & Roizman, 1969; Stenberg 
& Pizer, 1982; Mayman & Nishioka, 1985), the disaggregation 
of polysomes containing host mRNAs (Sydiskis & Roizman,
1967), and the destabilization and degradation of cellular 
mRNA (Nishioka & Silverstein, 1977, 1978; Fenwick & Walker, 
1978; Schek & Bachenheimer, 1985; Strom & Frenkel, 1987).
The host shut-off occurs by two independent mechanisms, an 
"early" shut-off, which involves a virion component (Fenwick 
& Walker, 1978; Fenwick & Clark, 1982; Nishioka &
Silverstein, 1977; Schek & Bachenheimer, 1985) and a 
"delayed" shut-off, which is dependent upon de novo protein 
synthesis (Honess & Roizman, 1974; Nishioka & Silverstein, 
1978). The virion component responsible for the "early" 
shut-off has been identified as the UL41 gene product, a non- 
essential, 58K tegument phosphoprotein (Read & Frenkel, 1983; 
Kwong et al., 1988; Fenwick & Everett, 1990; Smibert et al.,
1992). It has been suggested that this protein interacts 
with a cellular factor which results in a decrease in mRNA 
stability (Kwong & Frenkel, 1989). The UL41 gene product 
also appears to be responsible for the observed degradation 
of viral mRNAs (Kwong & Frenkel, 1987; Orozkar & Read, 1989;
60
Fenwick & Owen, 1988). This regulates the accumulation of 
viral mRNAs allowing transition from one kinetic class to the 
next.
In contrast to the host shut-off described above, the 
transcription of some cellular proteins is increased 
following infection with HSV-1. A role for the IE protein 
Vmwl75 (IE175, IE3, ICP4) in this induction has been 
suggested (Patel et al., 1986; Latchman et al., 1987), 
although viruses expressing an aberrant form of Vmwl75 also 
induce cellular proteins (Notarianni & Preston, 1982; Russell 
et al., 1987a) and Kemp et al. (1986) have shown that an 
increase in cellular transcription can occur in the absence 
of viral protein synthesis. The cellular proteins induced by 
HSV-1 infection include several heat-shock proteins 
(Notarianni & Preston, 1982; La Thangue et al., 1984; Patel 
et al., 1986; Latchman et al., 1987) and a 90K cellular 
protein (Macnab et al., 1985; Hewitt et al., 1991).
Another effect of HSV-1 infection on the host cell is an 
increase in the phosphorylation of the ribosomal protein S6 
(Kennedy et al., 1981). This increase occurs several hours 
after infection and is thought to be due to an increase in 
the activity of a cellular protein kinase (Kennedy et al., 
1981; Katan et al., 1986). The phosphorylation state of 
ribosomes appears to correlate with their affinity for mRNAs, 
thus this increased phosphorylation may either promote viral 
infection or may represent a protective response to viral
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infection (Kennedy et al.,1981).
1.8. PROTEIN KINASES
Phosphorylation of proteins is one of the most common forms 
of post-translational modification and is a major mechanism 
for the regulation of various cellular functions in both 
eukaryotes and prokaryotes. The phosphorylation state of 
proteins reflects the relative activities of two enzymes with 
antagonistic actions, protein kinases and protein 
phosphatases. Protein kinases catalyse the transfer of the 
$ -phosphate of a nucleoside triphosphate, such as ATP or 
GTP, to an acceptor amino acid in a substrate protein.
Protein phosphatases catalyse the removal of the phosphate 
group (see Figure 1.4).
1.8.1. Classification of Protein Kinases
Over 100 protein kinases have been identified, initially 
through enzymatic studies but more recently through 
recognition of protein kinase sequence motifs in genes and 
the specific isolation of protein kinase genes from cDNA or 
genomic libraries. These protein kinases have been 
classified according to their acceptor amino acid specificity 
(Hunter, 1991). In cases where the amino acid specificity is 
not known, protein kinases have been classified indirectly by 
sequence comparison with protein kinases of known 
specificity. The five main classes of protein kinases are:
Figure 1.4
A. Phosphorylation Reactions. Proteins are 
phosphorylated in a reaction catalysed by protein 
kinases while the removal of phosphate groups is 
catalysed by protein phosphatases.
B. The structures of the three most commonly 
phosphorylated amino acid residues are shown; 
phosphoserine, phosphothreonine and phosphotyrosine.
A.
ATP ADP
Protein kinase
Protein Protein-P
Protein phosphatase
Pi
B. H O  H O  H O
NH2-C-C-OH NH2-C-C-OH NH2-C-C-OH
CH2 H-C-CH3 CH2
1 1
o  o
H 0-P = 0  H 0-P=0
OH OH
Phosphoserine Phosphothreonine
Phosphotyrosine
H 0-P =0
3
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1. Protein-serine/threonine kinases.
2. Protein-tyrosine kinases.
3. Protein-histidine kinases, (these kinases can also use 
arginine and lysine as acceptors).
4. Protein-cysteine kinases.
5. Protein-aspartyl or -glutamyl kinases.
Another class of kinases may also exist, comprising protein 
kinases such as weel+ , Clk and YPK1, which phosphorylate both 
serine/threonine and tyrosine amino acid residues.
Protein-serine/threonine and protein-tyrosine kinases are the 
most common kinases in eukaryotes and have also been detected 
in bacteria (Saier et al., 1990). Protein-histidine kinase 
activity has been reported in eukaryotic cells but the 
enzyme(s) responsible have not been purified. Both protein- 
histidine and protein-cysteine kinases are involved in the 
phosphoenolypyruvate-dependent phosphotransferase system of 
prokaryotes (reviewed in Saier et al., 1990). No protein- 
cysteine kinase activity has been detected in eukaryotic 
cells. Examples of protein-aspartyl kinases can be found in 
another prokaryotic phosphorylating system, the sensor 
kinase/response regulator system. This system involves the 
autophosphorylation of the sensor kinase on a histidyl 
residue with the subsequent transfer of the phosphoryl group 
to an aspartyl residue of the response regulator protein 
(reviewed in Saier et al., 1990).
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Within each main acceptor class the protein kinases are 
further divided into families. The serine/threonine kinases 
are very diverse and include families which are classified 
according to their regulators (e.g. cyclic nucleotide- 
dependent, diacylglycerol-dependent, and calcium/calmodulin- 
dependent), families classified according to their substrates 
(casein kinase I and II and ribosomal protein S6 kinases), 
families involved in cell cycle control (e.g. CDC28 and 
cdc2+), and a family of proto-oncogene products (raf/mos 
kinases). The protein-tyrosine kinases contain only two main 
families, kinases which are the products of oncogenes (e.g.
\ src and abl) and kinases which function as growth factor
iI
receptors (e.g. epidermal growth factor family). Table 1.3
i
r
|gives a concise list of the families within the protein-
i
serine/threonine and protein-tyrosine kinase classes. For 
references and more extensive lists see Hanks et al. (1988)
| and Hunter (1991).
! 1.8.2. Protein Kinase Recognition Sequences
|
During early studies on protein kinases it was noticed that 
certain protein kinases, including cAMP-dependent kinase, 
were able to specifically phosphorylate a very wide range of 
substrate proteins while other kinases were able to 
phosphorylate only a limited number of the available 
phosphorylation sites on a particular substrate. It was 
| therefore concluded that protein kinases phosphorylate their
Table 1.3 Classification of protein kinases
Protein-serine/threonine kinase family members
A. Cyclic nucleotide regulated 
e.g. cAPK
B. Diacylglycerol regulated 
e.g. PKC
C. Calcium/calmodulin regulated 
e.g. Phosphoiylase kinase
D. Ribosomal S6 Protein Kinases
E. Casein Kinases
F. Glycogen synthase 3
G. cdc2/CDC28 Kinases
H. STE7 Kinases
I. SNF1 Kinases
J. Mos/Raf Kinases
K. Others
e.g. HSV1 US3
Protein-tyrosine kinase family members
A. src gene family 
e.g. src, yes, fgr
B. abl gene family
C. fps/fes gene family
D. Growth factor receptors 
e.g. EGF-R subfamily
Insulin receptor subfamily 
PDGF-R subfamily 
CSF1-R subfamily
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substrates only at sites where the appropriate acceptor amino 
acid is surrounded by a specific local sequence. The 
specific phosphorylation site sequences of many protein 
kinases have now been characterised by studying the 
phosphorylation of model peptides. Extensive lists of these 
sequences can be found in Kemp & Pearson (1990) and Pearson & 
Kemp (1991). Protein kinases such as phosphorylase kinase 
and the myosin light-chain kinase have highly restricted 
specificity ranges and may only be able to phosphorylate a 
single substrate while others, such as the multifunctional 
calmodulin-dependent protein kinases, have broad 
specificities consistent with their ability to phosphorylate 
many substrates. Many protein kinases have requirements for 
positively or negatively charged residues surrounding the 
acceptor amino acid, and have been designated basotropic or 
acidotropic. The HSV-1 US3 protein kinase is an example of a 
basotropic kinase in that it requires at least three arginine 
residues on the N terminal side of the acceptor amino acid 
and cannot tolerate acidic residues on the C terminal side 
(Purves et al., 1986b; Leader et al., 1991; Purves et al., 
1991). Protein-tyrosine kinases tend to be acidotropic.
1.8.3. Multiple and Hiercharchical Protein Phosphorylation
Many proteins are phosphorylated at multiple sites by one, or 
more, protein kinases (reviewed in Roach, 1991). Examples 
include: phosvitin, which is one of the most densely 
phosphorylated proteins with over 100 phosphorylated
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residues; neurofilaments; and the large subunit of eukaryotic 
RNA polymerases. These multiple phosphorylation sites are 
often concentrated in relatively short regions of the 
protein, usually at the N or C terminus, e.g. the C terminus 
of the RNA polymerases.
Multisite phosphorylation can occur by two mechanisms. The 
first occurs when the substrate protein contains multiple 
copies of specific phosphorylation sites for one or more 
protein kinases. For example, the neurofilaments NF-H and 
NF-M contain multiple copies of a -K-S-P- sequence (Lee et 
al., 1988; Lees et al., 1988). The second mechanism, known 
as hiercharchical phosphorylation, occurs when the 
introduction of one phosphate group influences the 
introduction of subsequent ones. The most widely known 
example of this mechanism is the phosphorylation of glycogen 
synthase by casein kinase II which provides the recognition 
site required for phosphorylation by the glycogen synthase 
kinase-3 (GSK-3) (Fiol et al., 1987; reviewed in Roach,
1991).
The function of multisite phosphorylation is not known. It 
may be necessary to bring about a critical conformational 
change in the substrate or different combinations of 
phosphorylated sites may produce a variety of protein forms.
In addition, the phosphorylation of a substrate by several 
protein kinases increases the complexity of the mechanisms by 
which the substrate may be regulated.
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1.8.4. Autophosphorylation and Pseudosubstrate Sequences
Another, apparently general, characteristic of protein 
kinases is their ability to autophosphorylate, that is, to 
catalyse the transfer of phosphate groups to acceptor amino 
acids within the protein kinases themselves. This usually 
occurs via an intramolecular reaction. Evidence suggests 
that autophosphorylation may be involved in activation of the 
kinase, apparently by displacing the pseudosubstrate 
sequence. This element of the protein, usually located in 
the regulatory domain of the kinase, resembles the 
phosphorylation site of the protein kinase and interacts with 
the catalytic domain to maintain the enzyme in an inactive 
form. Once activated by the enzyme's regulator, e.g. cyclic 
nucleotides, the enzyme undergoes a conformational change 
which relieves this inhibitory effect and permits the 
autophosphorylation of the pseudosubstrate sequence which 
then serves to maintain the enzyme in its active form. 
However, it has been shown that pseudosubstrate sequences 
which lack a suitable acceptor amino acid also inhibit enzyme 
activity, in a similar manner. Pseudosubstrate sequences 
have been reported for the cAMP-dependent protein kinase, the 
skeletal and smooth muscle myosin light-chain kinases, 
calmodulin-dependent protein kinase II, protein kinase C and 
the p 6 0 v - src protein kinase (Kennelly et al., 1987; Kemp et 
al., 1987; Kelly et al., 1988; House & Kemp, 1987; Grandori, 
1989; reviewed in Hardie, 1988).
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1.8.5. Protein Kinase Catalytic Domain
1.8.5.1. Sequence analysis
In recent years the sequences of many eukaryotic protein 
kinases have been determined. Multiple alignments of these 
sequences have revealed a conserved region of approximately 
300 amino acids, which is considered to represent the 
catalytic domain of the kinases. The first comprehensive 
protein kinase sequence alignment was reported by Hanks et 
al. (1988) using sequences derived from 38 protein- 
serine/threonine kinases (including HSV-1 US3 protein kinase) 
and 27 protein-tyrosine kinases. This study was subsequently 
extended to include a total of 75 protein-serine/threonine 
kinases and 42 protein-tyrosine kinases (Hanks & Quinn,
1991). The catalytic domains are not uniformly conserved 
throughout their length but consist of a number of short 
characteristic conserved motifs, or subdomains, separated by 
regions of lower conservation which may contain large 
deletions or insertions. Hanks et al. (1988) and Hanks & 
Quinn (1991) identified eleven of these subdomains, 
designated I to X I . Table 1.4 lists the conserved sequences 
for both protein-serine/threonine kinases and protein- 
tyrosine kinases (derived from Hanks & Quinn, 1991). The 
conserved motifs differ slightly between the two classes of 
protein kinases with the protein-tyrosine kinases possessing 
a larger number of conserved residues. This could be
Table 1.4 Conserved subdomains of the catalytic
domains of protein-serine/threonine kinases 
and protein-tyrosine kinases
Upper case letters indicate conserved amino acid residues. 
Lower case letters indicate amino acids with similar 
properties where:
o = non-polar, i.e. M, L, I, V, C
a = aromatic, i.e. F, Y, W
b = neutral/small, i.e. A, G, S, T, P
c = basic/polar, i.e. K, R, H
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interpreted as an indication that the protein-tyrosine 
kinases are more closely related to each other than are the 
protein-serine/threonine kinases although this may simply be 
a reflection of the smaller number of protein-tyrosine 
kinases used in the alignment.
Similarity to protein sequences of known function, chemical 
modification and the use of mutagenesis techniques have given 
an indication of the roles these conserved motifs play in 
catalysis. For example, the consensus G-X-G-X-X-G of 
subdomain I is thought to be involved in nucleotide binding 
as it is present in many nucleotide binding proteins. The 
invariant lysine residue of subdomain II has been shown to be 
essential for kinase activity (Chen et al., 1987; Hannick & 
Donoghue, 1985) and has been implicated in the 
phosphotransfer reaction, due to its reaction with the ATP 
analogue p-fluorosulphonyl 5*-benzoyl adenosine. Subdomains
VI to IX form the core of the catalytic domain. Subdomain
VII is thought to contribute to nucleotide binding, on 
account of its homology with a sequence.found in a number of 
bacterial phospho-transferases, while the -A-P-E- consensus 
of subdomain VIII is thought to be located near the catalytic 
site and is known to be required for activity in v-src 
(Bryant & Parsons, 1983). Subdomains VI and VIII are thought 
to be involved in recognition of the acceptor amino acid. In 
subdomain VI the consensus -D-L-K-P-E-N- is an indicator of 
serine/threonine specificity while the protein-tyrosine 
consensus is either -D-L-R-A-A-N- or -D-L-A-A-R-N-. In
subdomain VIII the protein-serine/threonine kinase consensus 
is G-T/S-X-X-Y/F-X-A-P-E- and the protein-tyrosine kinase 
consensus is P-I/V-K/R-W-T/M-A-P-E-.
A greater understanding of the functions of these conserved 
sequences has been possible with the recent solution of the 
crystal structure of the catalytic subunit of the cAMP- 
dependent protein kinase (cAPK) (Knighton et al., 1991a, 
1991b; see below).
1.8.5.2. Structural analysis
The three-dimensional structure of the catalytic domain of 
the cAMP-dependent protein kinase has been determined by 
X-ray crystallography (Knighton et al., 1991a, 1991b). The 
cAMP-dependent protein kinase was chosen for these studies 
because, unlike most protein kinases, the catalytic domain is 
located on a separate polypeptide from the regulatory domain 
and is relatively easy to purify. The kinase has also been 
well characterised (reviewed in Taylor et al., 1990). The 
results of the X-ray crystallographic analysis indicate that 
the catalytic domain has a bilobal structure (Figure 1.5).
The smaller lobe, consisting mostly of N terminal sequences, 
is characterised by a dominance of p  strands and is 
associated with nucleotide binding. The larger lobe is 
predominantly alpha helical and is involved in peptide 
binding and catalysis. The cleft between the lobes 
represents the active size of the enzyme. The majority of
Figure 1.5 Diagram of the cAMP-dependent protein kinase
catalytic domain.
(Reproduced from Knighton et al., 1991a)
The small lobe (shaded) is characterised by a predominance 
of |2> strands (marked 1 to 5) while the large lobe consists 
of seven ©< helices (D to J ; I and J are not marked on this 
diagram). The position of inserts in the protein kinase 
catalytic domain from the Hanks et al. (1988) alignment are 
indicated with arrows; n # amino terminal; c, carboxy 
terminal.
mos, cellular homologue of Moloney murine sarcoma virus oncogene; 
kinl, S. cerevisiae protein kinase; CDC7, cell division cycle 7 
protein kinase; ran+l, ras-related nuclear protein; HSVK, herpes 
virus US3 protein kinase; PDGFR, platelet-derived growth factor 
receptor; 71ess, sevenless protein kinase and PKC, protein kinase
mos
CDC 7
km 1PKC
CDC 7
7 less> -, r a n ’l
HSVK
PDGFR
COC 7
the conserved subdomains identified by Hanks et al. (1988) 
are located on the surfaces that line this cleft and form 
three functionally important regions, the glycine-rich loop 
in the small lobe, the catalytic loop in the large lobe and a 
triad of charged residues (see Figure 1.6).
The glycine-rich loop is composed of the residues of 
subdomain I and forms a nucleotide binding site that is 
structurally distinct from both the Rossmann fold and the P 
loop motif which are found in many nucleotide binding sites 
(Saraste et al., 1990). The purpose of the glycine loop is 
to anchor the phosphate moiety and, in particular, to hold 
the % -phosphate in the correct position for transfer to 
occur.
The catalytic loop is composed of the conserved residues of 
subdomain VI. The invariant residues are important for 
catalysis while the less conserved residues are involved in 
guiding the substrate peptide into the correct orientation 
for catalysis to occur. The invariant aspartic acid residue 
of subdomain IX, Asp220, (numbering refers to the cAMP- 
dependent protein kinase) contributes to the stability of 
this loop.
The Lys72 residue of subdomain II, the Glu91 residue of 
subdomain III and the Asp184 residue of subdomain VII form a 
triad which lies close to the ^(-phosphate of MgATP. The 
Asp184 residue can also form a second triad with Asp166 and
Figure 1.6 Positions of invariant amino acids at the
active site of cAMP-dependent protein 
kinase.
(Reproduced from Knighton et al., 1991b, 
with modifications)
Three of the conserved residues which form the active site 
(Gly52, Lys72 and Glu92) are located within the small lobe. 
The remaining invariant residues are located in the large 
lobe. The subdomains in which these invariant residues are 
present are marked (I, II, III, VI, VII and IX). Residues 
close enough for hydrogen bonding or ion pairing are 
indicated by a dashed line while residues within 4 to 5 X 
of one another are connected by a dotted line.
Small Lobe
Phosphate
Anchor
Asn171 of subdomain VI (the catalytic loop) and therefore ha 
the potential to shuttle between the two conserved loops. 
Asp184 may participate in the chelation of Mg2 + in the MgATP 
complex which may alter the charge distribution in the 
catalytic loop. This may be necessary for efficient 
catalysis.
Subdomain VIII, which lies close to the catalytic loop, 
contains Asp208 which forms an ion pair with the conserved 
Arg280 of subdomain XI. This helps to maintain the tertiary 
structure of the domain.
The non-conserved amino acids of the catalytic domain form 
loops on the surface of the protein and are important for 
substrate recognition. These loops often contain insertions 
e.g. PDGFR kinase possesses a 99 residue insertion between 
subdomains V and VI, and HSV US3 kinase has an extra 11 
residues between subdomains IX and X (Figure 1.5).
The functions of the subdomains are summarised in Table 1.5.
1.8.6. Known Functions of Non-viral Protein Kinases
Protein phosphorylation is one of the most important 
mechanisms by which intracellular processes are regulated, 
indeed, there are few, if any, metabolic processes in 
eukaryotes that are not dependent upon the action of protein 
kinases. The following examples are some of the better
Table 1.5 Functions of the conserved subdomains.
Subdomain Function
I Glycine-rich loop - anchors phosphate moiety 
and helps position y-phosphate for transfer
n Recognition of phosphate groups
m Recognition of phosphate groups
VI Catalytic loop
vn Conserved Asp residue shuttles between the 
two conserved loops - possible role in charge 
transfer
Vffl Forms an ion pair with subdomain XI - 
maintenance of tertiary structure
IX Stabilises catalytic loop
XI Forms an ion pair with subdomain VIII - 
maintenance of tertiary structure
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characterised functions.
1.8.6.1. Regulation of metabolism
Protein kinases are involved in the regulation of many 
metabolic pathways. For example, in glycogen metabolism the 
shut off of glycogen synthesis and the stimulation of 
glycogen breakdown are both directed by the action of the 
cAMP-dependent protein kinase (reviewed by Cohen, 1982).
Other pathways regulated by phosphorylation include fatty 
acid synthesis, glycolysis, gluconeogenesis and cholesterol 
synthesis.
1.8.6.2. Transmembrane signal transduction
!
Many protein kinases either span the plasma membrane or are
I
| associated with its inner face and are able to transduce
i
| signals from external stimuli, such as hormones and 
neurotransmitters. For example, many growth factors, such as 
EGF and PDGF, transmit their mitogenic effects by activating 
I the protein-tyrosine kinase domains of their receptors 
(reviewed in Hunter & Cooper, 1985). These signalling 
pathways also play a central role in both invertebrate and 
vertebrate development. Examination of Drosophila and mouse 
mutants has revealed that many of the genes required for 
normal embryonic development contain motifs characteristic of 
receptor protein-tyrosine kinases or protein-serine/threonine
I kinases. Examples of Drosophila receptor protein-tyrosine
I
ii
kinases include the torso (tor) gene, the gene for the 
Drosophila EGF receptor homologue (DER) and the sevenless 
(sev) gene. In the mouse, the W locus is related to the c- 
kit protoncogene and the Patch phenotype results from the 
loss of the ^-type PDGF-R gene. The protein- 
serine/threonine kinases involved in embryonic signal 
transduction include the zeste-white 3 gene, the fused gene, 
the D-raf gene and the nina C locus. Drosophila may also 
possess an eye-specific protein kinase C. It is envisaged 
that these serine/threonine-specific protein kinases function 
after the protein-tyrosine kinases, (reviewed in Pawson & 
Bernstein, 1990; Siegfried et al., 1990).
Protein-tyrosine kinases are also involved in the signalling 
pathways which activate the T cell antigen receptor. This 
activation underlies the ability of T cells to distinguish 
between self and non-self and to initiate the immune response 
(reviewed in Klausner & Samelson, 1991) . It has also been 
suggested that protein tyrosine phsophorylation is a pre­
requisite for activation of the cytotoxic function of natural 
killer cells (Einspahr et al., 1991).
1.8.6.3. Ion conductance
Evidence suggests that protein kinases modulate ion 
conductance by phosphorylating membrane proteins such as 
channels, pumps and ion exchange proteins. Protein kinase C 
is thought to regulate the extrusion of Ca2+ from the cell by
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phosphorylating the Ca2+-transport ATPase and, the cAMP- 
dependent protein kinase has been shown to regulate the CFTR 
(cystic fibrosis transmembrane conductance regulator) 
chloride channel (Cheng et al., 1991). In addition, two 
transport mechanisms involved in cell volume regulation, the 
Na/K/2C1 system and the KC1 cotransport system, are regulated 
by phosphorylation (reviewed in Cossins, 1991).
1.8.6.4. Neuronal function
Brain and other neuronal tissues contain high concentrations 
of protein kinases (reviewed by Nairn et al., 1985) and 
phosphorylation has been implicated in the regulation of a
j
wide range of neurophysiological processes. For example,
!
some neurotrophic factors exert their effects through
i
protein-tyrosine kinase receptors such as trk B (Klein et 
al., 1991), protein kinases, including protein kinase C, are 
! involved in the synthesis and release of neurotransmitters 
(Nairn et al., 1985; Nishizuka, 1986), and casein kinase II 
has been implicated in microtubule protein phosphorylation 
which leads to neurite outgrowth (Diaz-Nido et al., 1991).
It is interesting to note that hyperphosphorylation of 
microtubule proteins is associated with Alzheimer's disease 
(Steiner et al., 1990b).
1.8.6.5. Regulation of the cell cycle
Perhaps one of the most important functions of protein
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kinases has been identified as a result of the study of cell 
division cycle (CDC) mutants of yeast. The products of the 
CDC28 gene in Saccharomyces cerevisiae and cdc2+, the
.homologous gene in Schizosaccharomyces pombe, have been shown
t
to be necessary for entry into S phase and also for 
linitiation of mitosis in late G 2 . Both of these genes encodeI
proteins which possess protein-serine/threonine activity. A
I
ihomologue has also been isolated from human cDNA. The 
mechanisms by which the p34cdc2 kinase regulates the cell
i
‘cycle appear to be complex and have not yet been resolved.
s
, However, it is known that during the S phase and G2 the 
kinase associates with a protein known as cyclin A and is 
progressively phosphorylated. The hyperphosphorylated kinase 
then forms a complex with cyclin B and, at the end of G 2 , 
dephosphorylation occurs, activating the complex and 
initiating mitosis (reviewed in Draetta, 1990).
1.8.6.6. Regulation of protein synthesis
Several lines of evidence indicate that protein kinases play 
a role in the regulation of protein synthesis. For example, 
the phosphorylation of eukaryotic RNA polymerase II by cdc2 
may be involved in transcriptional control (Cisek & Corden, 
1989) and the extent of phosphorylation of ribosomal protein 
S6 may affect the rate at which translation occurs. The 
initiation of protein synthesis is controlled by the 
phosphorylation of elF-2«* by protein kinases such as the 
haem-regulated protein kinase and the double stranded
RNA -dependent 
1987) .
1.8.6.7. Prokaryotic systems
The above examples have all concerned eukaryotic systems. 
However, it is now clear that many bacterial processes, such 
as intermediary metabolism, gene transcription, 
differentiation, virulence and photosynthetic C O 2 fixation, 
are also regulated by protein kinases (Saier et al., 1990).
1.8.7. Phosphatases
Protein phosphatases, like protein kinases, can be classified 
into two main families, protein-serine/threonine phosphatases 
and protein-tyrosine phosphatases. Very little is known 
about the structure and regulation of the tyrosine-specific 
phosphatases, possibly due to the lack of suitable 
physiological substrates (Tonks et al., 1988a, 1988b). 
Protein-serine/threonine phosphatase activity can be 
accounted for by four distinct enzymes which are grouped into 
two classes. The type 1 protein phosphatases (PP-1) 
selectively dephosphorylate the (3 subunit of phosphorylase 
kinase, are inhibited by inhibitor 1, inhibitor 2 (proteins 
purified from liver and muscle extracts; Cohen, 1989) and 
okadaic acid and are regulated by cAMP and C a 2 + . The type 2 
protein phosphatases can be subclassified into three enzymes, 
PP-2A, PP-2B and PP-2C. All three enzymes selectively
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protein kinase (reviewed in Edelman et al.,
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dephosphorylate the oC subunit of phosphorylase kinase and are 
insensitive to inhibition by inhibitors 1 and 2. They differ 
however, in their dependence on divalent cations, for example 
PP-2B and PP-2C have an absolute requirement for Ca2+ and 
Mg2+, respectively, while PP-2A is active in the absence of 
divalent cations. In addition, PP-2A is completely inhibited 
by okadaic acid while PP-2B is only weakly inhibited and PP- 
2C is completely unaffected.
Protein phosphatase activity is required for the efficient 
regulation of all the processes involving protein kinases, 
e.g. metabolism, protein synthesis and the cell cycle 
(reviewed in Ingebritsen & Cohen, 1983; Cohen, 1989; Cyert & 
Thorner, 1989).
1.8.8. Role of Protein Kinases in Viral Transformation
It is well known that infection of cells with certain 
viruses, under appropriate conditions, results in abnormal 
cellular growth or transformation. These viruses include the 
acute transforming retroviruses, adenovirus, papillomavirus, 
polyomaviruses, and herpesviruses (reviewed in Bishop, 1985).
1.8.8.1. Acute transforming retroviruses
Acute transforming retroviruses owe their transforming 
capacity to the acquisition of cellular genes which are 
either mutated or abnormally expressed, and are designated
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oncogenes. Many of these oncogenes encode protein kinases 
although this is not a universal attribute of a transforming 
gene as v-ras, v-myc and v-sis oncogenes do not possess any 
protein kinase activity.
The protein kinase-encoding oncogenes can be classified into 
two groups, those which resemble protein-tyrosine kinases and 
those which possess serine/threonine-specific 
characteristics. Most of the oncogenes fall into the 
[ protein-tyrosine kinase group and these can be further 
I divided into those that span the membrane and those which 
i associate with the membrane. The membrane-spanning oncogenes
j include v-fms, v-erb-B and v-ros. The fms gene was first
|
| isolated from a feline sarcoma virus and is a homologue of
j the cellular macrophage-colony stimulating factor (M-CSF)
[
| receptor. The v-fms gene product however no longer requires 
[M-CSF to function and is constitutively activated (reviewed 
in Rohrschneider & Woolford, 1991). The cellular homologue 
of v-erb B is the epidermal growth factor receptor (Downward 
et al., 1984). Oncogenes such as v-src, v-abl, v-fes/fps, v- 
fgr and v-yes all associate with the inner surface of the 
plasma membrane, usually by means of a myristyl group 
posttranslationally added to the N terminal glycine residue 
(Hunter & Cooper, 1985). v-src, the transforming gene of the 
Rous sarcoma virus, was the first oncogene to be identified 
and is derived from a cellular gene, c-src. The product of 
v-src, designated pp60v_*rc, has been extensively 
characterised, however, its mode of action is still
79
unresolved (reviewed in Hunter & Cooper, 1985; Koegl & 
Courtneidge, 1991).
The protein-serine/threonine kinase-encoding oncogenes 
include v-mil/raf and v-mos. The products of these oncogenes 
are found in the cytosol rather than on membranes (Bunte et 
al., 1983; Papkoff etal., 1983).
1.8.8.2. Other transforming viruses
In contrast to the transforming retroviruses, the oncogenes 
of adenovirus (E1A and E1B), papillomavirus (E6 and E7), 
polyoma virus (large T and middle T antigens) and SV40 (large 
T antigen) do not show any extensive homology to known 
cellular proto-oncogenes. Investigation of the.products of 
these oncogenes has revealed that none possess any protein 
kinase activity although phosphorylation does appear to play 
some role in T antigen-induced transformation. The middle T 
antigen of polyoma virus, which is partly located in the 
plasma membrane, forms a complex with pp6 0 <?“***^ , which has 
protein-tyrosine kinase activity. It has been reported that 
middle T activates this kinase activity and it has been 
suggested that this forms the basis of its ability to 
transform cells (Bolen et al., 1984; Courtneidge, 1985). In 
addition, studies suggest that phosphorylation of the large T 
antigen of SV40 modulates many of its activities including 
its association with p53 (Carroll & Gurney, 1982). This 
activity is important as large T appears to induce
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transformation by binding to p53 and the retinoblastoma gene 
product (RB). These two proteins play an important role in 
suppressing the transformed phenotype and may also 
participate in regulation of the cell cycle. Adenovirus and 
papillomavirus also induce transformation by binding to p53 
and RB (reviewed in Bishop, 1985; Monier, 1986; Green, 1989; 
Schlegel, 1990; Vousden, 1991). HSV-induced transformation 
is unusual in that no oncogenes have been identified (see 
section 1.4.).
1.8.9. Viral Phosphoproteins - Occurrence and Functions
Many viruses encode proteins which during productive 
infections become phosphorylated. These viruses include 
examples from all families of the animal viruses (see Leader 
& Katan, 1988) . There have also been reports of a plant 
virus phosphoprotein (Hahn & Shepherd, 1980) and 
bacteriophage phosphoproteins (Robertson & Nicholson, 1990).
Within the herpesviruses, phosphoproteins have been reported 
in all three subfamilies. Over twelve phosphoproteins have 
been reported in the alphaherpesviruses, HSV type 1 and type 
2 (Pereira et al., 1977; Marsden et al., 1978; Wilcox et al., 
1980). Some are present in virion preparations and may 
therefore play a structural role in the virus, for example, 
gD, UL36, UL47, UL49 and the product of UL48 (Vmw65), while 
others are non-structural, for example the IE trans- 
activating proteins VmwllO, Vmwl75, Vmw63 and Vmw68
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(Ackermann et al., 1984), and the DNase (Banks et al., 1985). 
Within the betaherpesvirus subfamily, HCMV virions are known 
to contain three main phosphoproteins including a 150 KDa 
major capsid protein (Roby & Gibson, 1986) . A set of four 
early phosphoproteins, with common N termini, have also been 
reported in HCMV (Wright et al., 1988). Within the recently
isolated HHV-6 a phosphoprotein of MW 41 KDa has been
■
[identified (Chang & Balachandran, 1991). The phosphoproteins
I
of EBV, a gammaherpesvirus, have not been as thoroughly
if
jinvestigated as the alphaherpesviruses, however certain early 
proteins have been shown to be phosphorylated (Epstein,
r
j1984).
f
| . . .
Despite the widespread occurrence of viral phosphoproteins,
|
jthe relationship between their phosphorylation state and
|
their function is largely unknown. Functions which have been 
assigned to certain phosphoproteins are described below.
1.8.9.1. Transcriptional activity
In vesicular stomatitis virus (VSV) a phosphoprotein (P) 
(previously known as NS) associates with the large protein 
(L) to form the RNA-dependent RNA polymerase. It has been 
shown that a complex of the L protein and a phosphate-free P 
protein is transcriptionally inactive but that 
transcriptional activity is restored upon phosphorylation of 
P protein, initially by a cellular kinase(s), and 
subsequently by an L-associated kinase. Thus, the
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phosphorylation/dephosphorylation of P protein may represent 
a transcriptional control mechanism (Barik & Banerjee, 1992).
The large T antigen of SV40 plays an important role in both 
DNA replication and regulation of transcription. 
Transcriptional control is thought to depend upon the 
antigen's ability to bind DNA (DiMaio & Nathans, 1982) which, 
in turn, is modulated by the extent of phosphorylation of the 
polypeptide (Simmons et al., 1986; Klausing et al., 1988).
The E2 ORF of bovine papillomavirus type 1 (BPV-1) encodes 
three proteins with regulatory functions, the full length E2 
gene product, which functions as a transcriptional 
transactivator, and two small proteins translated from the 3' 
end of the ORF, which inhibit the E2-mediated 
transactivation. All three of these proteins are 
phosphorylated at sites within the common C terminal domain 
(McBride et al., 1989). It has been reported that 
mutagenesis of one of these phosphorylation sites results in 
an increase in transactivation, however it is not yet known 
if this effect can be attributed solely to the loss of 
phosphorylation at this site (McBride & Howley, 1991).
It has also been suggested that the phosphorylation of 
vaccinia virus core proteins may contribute to the regulation 
of early transcription, however, the evidence is primarily 
circumstantial (Moussatche & Keller, 1991).
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1.8.9.2. Replication
The DNA-binding properties of the SV40 large T antigen are 
jthought to regulate DNA replication, in addition to 
I transcription. The specific binding of large T antigen to 
! control sequences at the origin of replication has been 
^reported (Tjian, 1978; Tegtmeyer et al., 1983) and mutant 
viruses which lack some of the C terminal phosphorylation 
sites exhibit reduced DNA replication (Pipas et al., 1983).Itt
I In BPV-1, replication requires only the products of the El
[i
j and E2 ORFs, which form a complex (Ustav & Stenlund, 1991; 
^Blitz & Laimins, 1991). It has recently been demonstrated
i that El only complexes with an underphosphorylated form of E2
i
! (Lusky & Fontane, 1991), suggesting a role for
j
phosphorylation in BPV-1 replication. This is supported by
I
McBride & Howley (1991) who found that a mutation of the
f
i;
'phosphorylation site within the C terminal domain of E2 
resulted in an increase in the genome copy number.
1.8.9.3. Virion uncoating
Ratka et al. (1989) suggest that phosphorylation of 
poliovirus capsid proteins plays a role in uncoating of the 
virus. The phosphorylation is mediated by the presence of 
Zn2+ which activates one or more protein kinases and which 
also destabilizes the poliovirus capsid, thereby exposing the 
phosphorylation sites on the capsid proteins. Phosphorylation
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has also been implicated in the uncoating of VSV (Witt et 
al., 1981) and an insect granulosis virus (Wilson & Consigli, 
1985).
1.8.9.4. Virion maturation
A prerequisite for virion assembly is the association of the 
viral nucleic acid with the structural proteins. In avian 
retroviruses the extent of RNA binding is decreased markedly 
when the phosphoprotein pl2 is unphosphorylated (Sen &
Todaro, 1977). Phosphorylation of the core protein of duck 
hepatitis B virus is also thought to play a role in virion 
maturation (Pugh et al., 1989).
1.8.9.5. Nuclear transport
Nuclear transport of the SV40 large T antigen can be 
facilitated by phosphorylation of the serine residues which 
flank the nuclear localisation signal (Rihs & Peters, 1989).
A similar role has also been suggested for the 
phosphorylation of the precore and core proteins of hepatitis 
B virus (Yeh & Ou, 1991) .
1.8.10. Effect of Viral Infection on Cellular Protein Kinase 
Activity
Infection of cells with several different viruses activates 
the cellular dsRNA-dependent kinase which phosphorylates the
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oL subunit of the transcription factor elF-2. The function 
jof elF-2 is to bind the initiator Met-tRNAF to the 40S 
ribosomal subunit, in a reaction in which GTP is hydrolysed 
•and an elF-2-GDP complex is formed. The GDP is removed from 
this complex by elF-2B and active elF-2 is released.
i
Phosphorylation of elF-2 by the dsRNA-dependent kinase
i
interferes with the action of elF-2B, thus the GDP is not
fdisplaced, the elF-2 remains inactive and protein synthesis|
: is inhibited. This system therefore represents an important
I
antiviral mechanism. Indeed, during infection of cells with
t
. encephalomyocarditis virus (EMCV) the dsRNA-dependent kinase 
localises to the replication complexes of EMCV in an 
activated form (Dubois & Hovanessian, 1990), possibly 
representing a mechanism for the specific inhibition of viral 
protein synthesis.
Many viruses have developed mechanisms to nullify this 
protein synthesis shut-off system. For example, the 
adenovirus VA1 RNA and an influenza virus-encoded factor are 
thought to bind to the protein kinase (Gallabru et al., 1989; 
Katze et al., 1988), while proteins encoded by reovirus and 
vaccinia virus bind to dsRNA, the activator of the protein 
kinase (Imani & Jacobs, 1988; Akkaraju et al., 1989). It is 
thought that HIV downregulates the expression of the protein 
kinase (Roy et al., 1990) and poliovirus infection results in 
specific degradation of the kinase (Black et al., 1989).
Following infection of cells with vaccinia virus, adenovirus,
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PRV and HSV-1, phosphorylation of the ribosomal protein S6 is
iI
jalso stimulated (Kaerlein & Horak, 1976; Russell & Blair, 
1977; Kennedy et al., 1981). For the herpesviruses, it has
I
|been shown that this phosphorylation is not carried out by 
.the virus-encoded US3 protein kinase (Katan et al., 1986). 
.Thus, it is considered likely that the increased 
phosphorylation of ribosomal protein S6 results from
i
stimulation of a cellular kinase. The functional 
significance of this increased phosphorylation is not known.
11.8 .11. Viral Protein Kinases
Protein kinases have been associated with the virions of many 
different viruses, including Rauscher murine leukaemia virus, 
avian myeloblastosis virus (Strand & August, 1971), frog
[
virus 3 (Silberstein & August, 1976), VSV (Strand & August, 
1971; Watanabe et al., 1974; Imblum & Wagner, 1974), Sendai 
virus (Lamb, 1975; Einberger et al., 1990), vaccinia virus 
(Kleiman & Moss, 1975; Watanabe et al., 1974; Paoletti &
Moss, 1972), adenovirus (Blair & Russell, 1978) and foot and 
mouth disease virus (Grubman, 1982) . Protein kinases are 
also associated with many members of the herpesviruses, e.g. 
HSV (Rubenstein et al., 1972; Lemaster & Roizman, 1980; Blue 
Sl Stobbs, 1981), PRV (Stevely et al., 1985), VZV (Montalvo & 
Grose, 1986), EHV (Randall et al., 1972), HCMV (Michelson et 
al. , 1984) and tupaia herpesvirus (Flligel & Darai, 1982). It 
is likely that many of these protein kinases are of cellular 
origin, perhaps arising from contamination during
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purification procedures or acquired from the host cell 
membrane during budding. Indeed, Stevely et al. (1985) have 
shown that the herpesvirus virion contains enzymes which 
resemble cellular casein kinases I and II and protein kinase 
C.
Only a few protein kinases have been convincingly 
demonstrated to be the product of a viral gene. These are 
described below.
1.8.11.1. Herpesvirus protein kinases
A novel protein kinase purified from HSV-1 infected cells 
(Purves et al.r 1986a) was shown to be the product of the US3 
gene (Frame et al., 1987; Purves et al., 1987) which 
possesses the sequence motifs characteristic of a protein 
kinase (McGeoch & Davison, 1986). This protein kinase gene 
has homologues in all sequenced alphaherpesviruses.
The UL13 gene of HSV-1, and its homologues in the three 
classes of herpesviruses, have also been identified as 
probable protein kinase genes, based on the presence of 
characteristic sequence motifs (Smith & Smith, 1989; Chee et 
al., 1989). The work presented in this thesis confirms that 
the UL13 gene product has protein kinase activity.
It has recently been reported that the N terminal region of 
the large subunit of ribonucleotide reductase of HSV also
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possesses protein kinase sequence motifs (Chung et al., 1989; 
Paradis et al. , 1991).
These three protein kinase genes and their products are 
described fully in the next section (1.9.).
1.8.11.2. Vaccinia virus protein kinase
DNA sequence analysis revealed that vaccinia virus possesses 
two genes which contain conserved motifs characteristic of 
protein-serine/threonine kinases: B1R, which is essential for 
virus replication (Howard & Smith, 1989; Traktman et al., 
1989), and B12R (Howard & Smith, 1989). The B1R gene has 
sequences corresponding to all of the major conserved regions 
except for region VIII (according to the designation of Hanks 
et al. , 1988), where the conserved glutamate residue is 
replaced with an aspartate residue, and region IX where a 
glutamate residue substitutes for an aromatic residue (Howard 
& Smith, 1989). B1R had 27% amino acid identity with HSV US3 
over an 85 amino acid region. Two groups have recently 
expressed the B1R gene product in bacteria. Lin et al.
(1992) showed that the purified 34 KDa protein possesses 
protein-serine/threonine kinase activity, utilises ATP, but 
not GTP, as a phosphate donor, phosphorylates casein and 
histone HI and is located in virions. The 34 KDa protein 
kinase purified by Rempel & Traktman (1992), however, 
possessed slightly different properties, in that it could 
utilise GTP as a phosphate donor, albeit inefficiently, and
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did not phosphorylate histone HI. The physiological 
substrate(s) of the B1R kinase are not known. Mutational 
analysis of the B1R gene has indicated that the invariant Lys 
residue of subdomain II is absolutely required for kinase 
activity (Lin et al., 1992) and that substitution of the 
conserved Gly residue in subdomain IX reduces activity to 3% 
of the wt level (Rempel & Traktman, 1992).
The second protein kinase-related gene of vaccinia virus, 
B12R, shows only weak homology to the conserved protein 
kinase sequences. There does not appear to be a glycine-rich 
nucleotide binding region (subdomain I) and invariant 
aspartate and glycine residues in subdomains VI and VII, 
respectively, are absent. Thus, it is considered unlikely 
that the product of this gene possesses protein kinase 
activity (Howard & Smith, 1989).
1.8.11.3. Bacteriophage T7 0.7 protein kinase
The 0.7 protein kinase of bacteriophage T7 has been purified 
from infected cells as a 37 KDa monomer (Pai et al., 1975) 
and has recently been cloned and expressed (Michalewicz & 
Nicholson, 1992). The kinase activity is specific for serine 
and threonine residues and is cAMP-independent (Rahmsdorf et 
al., 1974). Substrates of the kinase include the RNA 
processing enzyme RNase III and the (3 subunit of RNA 
polymerase (Robertson & Nicholson, 1990). The function of 
this protein kinase is unclear, however it is known that the
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kinase activity is independent of the RNA polymerase- 
catalysed transcription shut-off which is also a function of 
the 0.7 gene product (Michalewicz & Nicholson, 1992).
The nucleotide sequence of the 0.7 gene has been determined 
(Dunn & Studier, 1983) and it is interesting to note that, 
with the exception of the nucleotide binding site of 
subdomain I, the 0.7 protein kinase does not exhibit any of 
the conserved sequence motifs seen in eukaryotic 
serine/threonine-specific protein kinases. In addition, the 
kinase does not exhibit strong homology with any other 
prokaryotic protein kinases. This gene therefore represents 
a novel class of protein kinase.
1.8.11.4. Hepatitis B virus protein kinase
The HBV genome contains four ORFs, three of which code for 
proteins which are essential for the viral life cycle, namely 
DNA polymerase-reverse transcriptase, hepatitis B surface 
antigen and hepatitis B core/e antigen. The fourth and 
smallest ORF, the hbx gene, is conserved among all mammalian 
hepadnaviruses and codes for a 17-KDa virion protein which is. 
able to trans-activate transcription. The hbx gene has been 
expressed in E. coli and the product has been shown to 
possess an intrinsic serine/threonine protein kinase activity 
(Wu et al., 1990). Thus, the hbx protein kinase may activate 
transcription by phosphorylating transcription factors. A 
recent study has indicated that the hbx gene is not essential
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for the virus growth in vitro, but may be involved in the 
pathogenesis of the virus (Blum et al., 1992).
Like the bacteriophage 0.7 protein kinase, the hbx kinase 
shows little homology to the sequence which characterise 
eukaryotic protein kinases. In addition, the protein 
contains only 154 amino acids, which is approximately half 
the size of the catalytic domain of most protein kinases. 
The hbx protein may therefore represent a novel protein 
kinase (Wu et al., 1990).
1.9. HERPESVIRUS PROTEIN KINASES
1.9.1. US3
The HSV-1 US3 gene is rightward oriented with an ORF of 481 
codons (residues 135222-136665), encoding a protein of MW 
52831 (McGeoch et al., 1985, 1988a). Mapping experiments 
have detected two distinct 5' termini for mRNA species, 
corresponding to residues 134964 to 135189. These m R N A s , 
designated US3a and US3b, respectively, have identical coding 
capacities. The 3' termini of both mRNAs correspond to 
residue 137508 which also represents the 3' terminus for the 
US4 mRNA; thus, the US3 and US4 genes form a 3' co-terminal 
family. The US2 gene, which lies to the left of US3 and is 
transcribed in the opposite direction, initiates at residue 
135304 which lies 83 bp within the proposed ORF of US3 and 
the upstream control sequences for US3a may extend into the
U S 2 ORF (Rixon & McGeoch, 1985) (Figure 1.7). The US3 mRNAs 
are transcribed early in infection (4 h p.i.) and have 
declined in abundance by 7 h p.i. (Rixon & McGeoch, 1985).
Sequence analysis of the US3 gene, and its homologues in HSV 
2 and VZV, revealed homology to the protein kinase family, 
with greatest similarity (33%) to the yeast cell division 
control protein CDC28 (McGeoch & Davison, 1986).
Longnecker & Roizman (1987) described a mutant of HSV-1 
strain F which contains a deletion in the US3 gene. This 
virus, which is T K ~ , grows to similar titres to wt on Vero 
cells, indicating that the US3 gene is not essential for 
virus growth in tissue culture. In vivo growth studies 
showed that the U S 3 - mutant (a TK + version) exhibits a 
significantly reduced virulence (LD50 = 1.8 x 106 ) compared 
to the wt (LD50 = 102). The virus was able to establish 
latency in the mouse eye model but with reduced efficiency 
(Meignier et al., 1988).
A possible candidate for the US3 gene product was a novel 
protein kinase detected in cytoplasmic extracts of cells 
infected with PRV or HSV-1. The enzymatic characteristics o 
these alphaherpesvirus-induced kinases are indistinguishable 
from each other and distinct from cellular protein kinases 
such as protein kinase C. They utilise ATP, but not GTP, as 
a phosphate donor, they are active at unusually high salt 
concentrations (1M and above) and their activity is not
Figure 1.7 Genomic location and organisation of the US3 
gene.
The upper line of the figure represents the HSV-1 genome 
with unique sequences as lines and major repeat elements as 
open boxes. The lower part expands the region of Us 
(residues 134610 to 137510) which contains gene US3 and its 
neighbours, genes US2 and US4. The filled circles 
represent the 5' termini of the transcripts, arrowheads 
indicate the 3' termini of the transcripts and the open 
boxes indicate the locations of the predicted protein 
coding regions.
134610 137510
US3
I •  4 V
US2 US4
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stimulated by any known effectors. The kinases have been 
found to have a specificity for serine and threonine residues 
in basic proteins, such as protamine, but not on acidic 
proteins, such as casein or phosvitin. They are also capable 
of autophosphorylation. Both kinases are thought to exist as 
dimers but the subunit size differs for the two viruses; the 
PRV subunit has an apparent MW of 38K and the MW of the 
HSV-1 subunit is approximately 68K (Stevely et al., 1985; 
Katan et al., 1985; Purves et al., 1986a; reviewed in Leader 
& Katan, 1988; Leader & Purves, 1988). Experiments by Katan 
et al. (1985) and Stevely et al. (1985) suggested that the 
alphaherpesvirus protein kinase was not a constituent of the 
virion. However, a more recent study has indicated that both 
the PRV and HSV-1 protein kinases can be immunoprecipitated 
from virion preparations (Zhang et al., 1990).
Two lines of evidence confirmed that the novel HSV-l-induced 
protein kinase was the product of the US3 gene. Firstly, the 
kinase activity was not present in mock-infected cells or in 
cells infected with the US3 deletion mutant constructed by 
Longnecker & Roizman (1987). Kinase activity was restored 
when the US3 deletion was repaired (Purves et al., 1987). 
Secondly, an antibody raised against the terminal octapeptide 
of the predicted US3 amino acid sequence was found to react 
with a protein of apparent MW 68K from an extensively 
purified preparation of the HSV-1 protein kinase (Frame et 
al., 1987).
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The substrate specificity of the alphaherpesvirus protein 
kinase has been investigated using synthetic peptides and the 
following consensus sequence has been defined: RnX(S/T)YY, 
where n must be equal to or greater than 3, S/T represents 
the target residue, X can be R, A, V, P or S and Y can be R, 
A, V or S. Acidic residues and P are not tolerated at the Y 
position (Purves et al., 1986b; Leader et al., 1991; Purves 
et al., 1991).
A physiological substrate for the HSV-1 US3 protein kinase 
has recently been identified. Purves et al. (1991) reported 
that in cells infected with a US3 deletion virus, a 30K 
phosphoprotein, which was mapped to the UL34 gene, is 
replaced by a higher molecular weight phosphoprotein of 33K, 
which was presumed to be related to UL34. Analysis of the 
UL34 amino acid sequence showed that the protein contains the 
US3 protein kinase phosphorylation consensus sequence: 
-RRRRTRR- (residues 191 to 197) , although this is not 
conserved in the VZV UL34 homologue (gene 24) nor in the EHV- 
1 homologue (gene 26). Purves et al. (1991) therefore 
proposed that the US3 protein kinase mediates the 
posttranslational modification of the UL34 gene product, 
converting it from the 30K protein to the 33K species.
Subsequent studies (Purves et al., 1992) have shown 
that the 30K UL34 protein is still present in cells infected 
with the US3- virus, but in an unphosphorylated form. These 
studies also indicated that the previously observed 33K 
phosphoprotein was one of four novel phosphoproteins with MWs
I
[
9 5
25K-35K (designated A to D) present during infection with the 
US3~ virus. These phosphoproteins are not genetically 
related to the UL34 protein but do appear to associate with 
the unphosphorylated form of UL34 in infected cells. The 
UL34 protein is a constituent of virions (Marsden et al.r 
1978; Purves et al., 1992) and Purves et al., 1991 have 
suggested that it is membrane associated, since the N 
terminal domain has properties similar to those of signal 
sequences and the C terminus is very hydrophobic (Purves et 
al., 1991). Indeed Purves et al. (1992) have reported that 
during infection both the phosphorylated and unphosphorylated 
forms of the UL34 protein localise to cellular membranes. It 
has therefore been proposed that the UL34 protein regulates 
the function of infected cell kinases which associate with 
cellular membranes and that this regulation is dependent upon 
the phosphorylation state of the protein (Purves et al.,
1992). It is thought that the UL34 protein is essential for 
viral growth, although its phosphorylation by the US3 protein 
kinase is not (Purves et al., 1991).
Homologues of the HSV-1 US3 gene have been found throughout 
the alphaherpesviruses: gene US3 of HSV-2, gene 66 of VZV 
(McGeoch & Davison, 1986), PK gene of PRV (Zhang et al.,
1990; van Zijl et al., 1990) and gene 69 or EUS2 of EHV-1 
(Telford et al., 1992; Colle et al., 1992). A homologue has 
also been detected in MDV (Ross & Binns, 1991) which, 
although classified as a gammaherpesvirus, is now thought to 
be of alphaherpesvirus lineage (Buckmaster et al., 1988). An
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alignment of the sequences of the catalytic domains of the 
six alphaherpesvirus protein kinases has been made using the 
PILEUP and PRETTY programs (University of Wisconsin, Genetics 
Computer Group) and the conserved residues compared with the 
motifs of Hanks et al. (1988) (Figure 1.8). Most of the 
invariant residues identified by Hanks et al. (1988) are 
conserved among the alphaherpesvirus protein kinases with the 
exception of the first G residue and the V residue of 
subdomain I, and the conserved aromatic residue (a) in the 
D-a-G triplet of subdomain VII. This sequence analysis has 
also revealed conserved residues which appear to be 
characteristic of this group of protein kinases, for example: 
a conserved E residue in subdomain I; conserved V three 
residues N terminal to the K of subdomain II; conserved C, P 
and D-L residues in subdomain V; a characteristic E-N-I-F 
motif in subdomain VI; two conserved A residues C terminal to 
the D-a-G triplet of subdomain VII; conserved V, F and E 
residues in subdomain XI; and an R-P-S-A motif in subdomain 
XI. In addition, the distance between subdomains II and III 
is characteristically short and all six protein kinases have 
an insertion between subdomains X and XI.
In contrast to the catalytic domains, the N terminal domains 
of these six protein kinases bear little similarity to each 
other. They vary considerably in size, for example, the N 
terminal domains of HSV-1 and HSV-2 US3 are 200 amino acids 
long, those of VZV, EHV-1 and MDV are approximately 100 
residues long and the N terminal domain of PRV is only 55
Figure 1.8 Sequence alignment of the catalytic domains 
of the US3 gene and its homologues from 
other alphaherpesviruses.
The catalytic domains of HSV-1 US3, HSV-2 US3, EHV-1 gene 
69, PRV PK gene, VZV gene 66 and the MDV PK gene were 
aligned using the PILEUP program (Genetics Computing Group 
(GCG), University of Wisconsin) and a consensus sequence 
generated using the PRETTY program (GCG, University of 
Wisconsin). On the consensus line the upper case letters 
represent conserved amino acid residues, lower case letters 
indicate amino acids with similar properties where:
o = non-polar, i.e. M, L, I, V, C
a = aromatic, i.e. F, Y, W
b = neutral/small, i.e. A, G, S, T, P
c = basic/polar, i.e. K, R, H
The conserved sequences of the subdomains (I to XI) 
identified by Hanks et al. (1988) are shown above the 
aligned sequences.
I II III
oG-G— G-V aoK-O E
HSVI 191 FTIHGALTPGSEGCVFDSSH. . PDYPQRVIVKAGWYTSTS . HEARLLRRL
HSV2 191 FAIHGALIPGSEGCVFDSSH. . PNYPHRVIVKAGWYASTS . HEARLLRRL
EHV1 93 YTVIKTLTPGSEGRVMVATK. . DGQPEPVVLKIGQKGTTL. IEAMMLRNV
PRV 53 FEVLQPLQSGSEGRVFVARR. . PGEADTVVLKVGQKPSTL. MEGMLLQRL
VZV 93 FVILKTFTPGAEGFAFACMD. . SKTCEHVVIKAGQRQGTA. TEATVLRAL
MDV 102 YNIVSSLSPGSEGYIYVCTKRGDNTKRKVIVKAVTGDKTLGSEIDILKKM
Consensus a-o bGbEG---------------- VooK------ T---E--- L— o
IV V
HSVl 238 DHPAILPLLDLHVVSGVTCLVLPKYQADLYTYLSRRLNPLGRPQIAAVSR
HSV2 238 NHPAILPLLDLHVVSGVTCLVLPKYHCDLYTYLSKRPSPLGHLQITAVSR
EHV1 140 NHPSVIQMKDTLVSGAITCMVLPHYSSDLYTFLTKESRRIPIDQALIIEK
PRV 100 SHDNVMRMKQMLARGPATCLVLPHFRCDLYSYLTMRDGPLDMRDAGCVIR
VZV 140 THPSVVQLKGTFTYNKMTCLILPRYRTDLYCYLAAKRN. LPICDILAIQR
MDV 152 SHRSIIRLVHAYRWKSTVCMVMPKYKCDLFTYIDI.MGPLPLNQIITIER
Consensus -H— oo-o----------- CoooPca— DLa-ao------ o------- o-c
VI VII
DoK— No o-DaG
HSVl 288 QLLSAVDYIHRQGIIHRDIKTENIFINTPEDICLGDFGAACFVQGSRSSP
HSV2 288 QLLSAIDYVHCKGIIHRDIKTENIFINTPENICLGDFGAACFVRGCRSSP
EHV1 190 QILEGLRYLHAQRIIHRDVKTENIFINSVDQVCIADFGAA. . .QFPVVEP
PRV 150 AVLRGLAYLHGMRIMHRDVKAENIFLEDVDTVCLGDLGAA. . .RCNVAAP
VZV 189 SVLRALQYLHNNSIIHRDIKSENIFINHPGDVCVGDFGAACF. PVDINAN
MDV 201 GLLGALAYIHEKGIIHRDVKTENIFLDK PENV VLGDFGAACKLDEHTDK P
Consensus -oL-bo-YoH 1oHRDoKbENIF-------ooobD-GAA----------
VIII IX
b— a-bPE D-ab-G
HSVl 338 FPYGIAGTIDTNAPEVLAGDPYTTTVDIWSAGLVIFETAVHNASLFSAPR
HSV2 338 FHYGIAGTIDTNAPEVLAGDPYTQVIDIWSAGLVIFETAVHTASLFSAPR
EHV1 237 ADLGLAGTVETNAPEVLARAKYNSKADIWSAGIVLFEMLAYPSTLFEDPP
PRV 197 NFYGLAGTIETNAPEVLARDRYDTKVDVWGAGVVLFETLAYPKTI.....
VZV 238 RYYGWAGTIATNSPELLARDPYGPAVDIWSAGIVLFEMATGQNSLFE. . .
MDV 251 KCYGWSGTLETNSPELLALDPYCTKTDIWSAGLVLFEMSVKHITFFGKQV
C onsensus G-bGTo-TNbPEoLA Y DoWbAGoVoFE--------------
X
HSVl 388 GPKRGP. . .CDSQITRIIRQAQVHVDEFSPHPESRLTSRYRSRAAGNNRP
HSV2 388 DPERRP. . .CDNQIARIIRQAQVHVDEFPTHAESRLTAHYRSRAAGNNRP
EHV1 287 STPEEYVKSCHSQLLKIISTLKINPEEFPRDPGSRLVRGY.IEYSRLERK
PRV 242 TGGDEPAINGEMHLIDLIRALGVHPEEFP. . PDTRLRSEF. VRYAGTHRQ
VZV 285 RDGLDGNCDSERQIKLIIRRSGTHPNEFPINPTSNLRRQYIGLAKRSSRK
MDV 301 N G ....... SGSQLRSIIRCLQVHPLEFPQNNSTNLCKHFK. QYAIQLRH
C onsensus------------- o— ol--------- EFb----b-L---a--------- R-
XI
O ----------------R
HSVl 4 35 PYTRPAWTRYYKMDIDVEYLVCKALTFDGALRPSAAELLCLPLFQQK. . 
HSV2 4 35 AWTRPAWTRYYKIHTDVEYLICKALTFDAALRPSAAELLRLPLFHPK. . 
EHV1 3 36 PYTRYPCFQRVNLHIDGEFLVHKMLAFNAAMRPSAEELLSYPMFAQL. . 
PRV 289 PYTQYARVARLGLPETGAFLIYKMLTFDPVRRPSADEILNFGMWTV*. . 
VZV 3 35 PGSRPLWTNLYELPIDLEYLICKMLSFDARHRPSAEVLLNHSVFQTLPD 
MDV 343 PYAIPQIIRKSGMTMDLEYAIAKMLTFDQEFRPSAQDILMLPLFTKEPA 
Consensus b-b--------- o----- a-o-K-LbFd RPSA— oL— boa-----
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residues long. The only cpmmon feature to be detected in 
these N terminal domains is a cluster of acidic residues.
The protein kinases can be placed into three groups according 
to the length of these acidic domains and their position 
relative to the catalytic domain (Figure 1.9). The first 
group consists of the HSV US3 protein kinases which have an 
acidic domain of between 22 and 29 residues and are situated 
approximately 86 residues from the first glycine of subdomain 
I. PRV and EHV-1 form the seond group, with acidic domains 
of approximately 30 residues positioned only 25 residues N 
terminal to subdomain I. The third group, consisting of MDV 
and VZV, have longer acidic clusters of 55 and 43 residues, 
respectively, and are situated only 17 to 18 residues from 
subdomain I. Three of the protein kinases (HSV-1, HSV-2 and 
EHV-1) also possess a proline-rich domain. In HSV-1 and HSV- 
2 this domain is located on the C terminal side of the acidic 
cluster while in EHV-1 it is located on the N terminal side. 
The functional significance of these N terminal subdomains is 
not known, however, Zhang et al. (1990) have proposed that 
the acidic clusters are involved in binding to the protein's 
substrate or to the catalytic domain, thereby regulating the 
enzyme's activity.
1.9.2. UL13
The UL13 gene of HSV-1 is leftward oriented with an ORF of 
518 codons (residues 28504 to 26950), encoding a protein of 
MW 57193 (McGeoch et al., 1986b, 1988a). Genes UL11 to UL14
Figure 1.9 Distribution of charged amino acid residues
in the N-terminal domain of the US3 protein 
kinase and its homologues.
The amino acid sequences of HSV-1 US3 and its 
alphaherpesvirus homologues were analysed using the PEPPLOT 
program (GCG, University of Wisconsin) and aligned over 
their catalytic domains. Only the sequences N terminal to 
the start of the catalytic domains are shown.
Long dashed lines above the base-line represent basic residues whi< 
long dashed below the base-line represent acidic residues. Long an< 
short dashed lines spanning the base-line represent amides and 
alchols, respectively, and long and short unbroken lines spanning 
the base-line represent aromatic residues and aliphatic residues, 
respectively. The short lines on the base-line represent prolines. 
Alanine, glycine and cysteine are unmarked.
Clusters of acidic residues are marked with arrowed lines.
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form a 3 1 co-terminal set of genes with the common 3' 
terminus of the transcripts corresponding to the AATAAA 
sequence at residues 24802-24807 (Costa et al., 1983). The 
5' terminus of the UL13 transcript has been mapped to residue 
28693 (Costa et al., 1983). The 3.9 kb UL13 transcript was 
found to be expressed late in infection and was classified as 
a |3y (intermediate) transcript (Costa et al., 1983).
The UL13 gene overlaps extensively with its neighbours 
(Figure 1.10). The UL13 ORF is separated from the ORF of the 
downstream gene, UL12, by only 58 bp and the 5' terminus of 
the UL12 transcript (residue 27048) and its promoter lie 
within the UL13 coding region. The UL13 ORF is proposed to 
have an out of frame overlap of 83 codons with the coding 
region of its right neighbour, UL14. Thus, the 5' terminus 
of the UL13 transcript (residue 28693) lies within the UL14 
ORF. The coding overlap does not extend into the proposed 
catalytic domain.
The DNA sequence of the HSV-1 (17+) UL13 gene was published 
by McGeoch et al. (1986b). Also in 1986, Draper et al. 
published sequences corresponding to the 3' terminal 101 
codons of the HSV-1 (KOS) UL13 gene and its HSV-2 homologue. 
Homologues for UL13 have been found in all completely 
sequenced herpesvirus genomes (VZV gene 47, EBV BGLF4, HCMV 
UL97 and EHV-1 gene 49) (Smith & Smith, 1989; Chee et al., 
1989; Telford et al., 1992) and also in HHV-6 (Chee et al., 
1989; Lawrence et al., 1990). The gene is therefore present
Figure 1.10 Genomic location and organisation of the
UL13 gene.
The upper line of the figure represents the HSV-1 genome 
with unique sequences as lines and major repeat elements as 
open boxes. The lower part expands the region of U l which 
contains gene UL13 and its neighbours, genes UL11, UL12 and 
UL14 (residues 26500 to 28900). Filled circles represent 
the 5' termini of the transcripts while arrowheads 
represent the transcript stop sites. The open boxes 
indicate the locations of the predicted protein coding 
regions.
24800 28900
i------------- 1-------------- 1______________i______________ i________________i
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in all three classes of the herpesviruses.
In 1989 Smith & Smith and Chee et al. showed that the UL13 
gene and its counterparts in other herpesviruses contained 
sequence motifs characteristic of the serine/threonine 
protein kinase family. The six sequences have been aligned 
using the PILEUP and PRETTY programs (University of 
Wisconsin, Genetics Computing Group) (Figure 1.11). The 
three alphaherpesvirus sequences (VZV, EHV and HSV-1) show 
strong homology to each other and also to the conserved 
subdomains identified by Hanks. The beta- and gamma- 
herpesviruses, however, are considerably diverged and lack 
certain conserved residues, which led Chee et al. (1989) to 
suggest that these proteins may represent some class of 
phosphotransferase other than protein kinase. All six 
sequences contain the glycine-rich nucleotide binding domain 
(subdomain I) including the first G residue and the conserved 
V which were absent from the US3 protein kinase family 
(section 1.9.1.). The conserved K of subdomain II and the E 
residue of subdomain III are also present, however, it should 
be noted that the distance between subdomains II and III in 
the HCMV UL97 and HHV-6 15R proteins is considerably longer 
than in the other UL13 homologues. Subdomain VI is well 
conserved in the alphaherpesvirus sequences but the invariant 
K, which is a determinant of serine/threonine specificity, is 
absent from the beta- and gamma-herpesvirus sequences. 
Subdomain VIII is poorly conserved with only the VZV and HSV- 
1 sequences possessing the invariant P-E residues. In
Figure 1.11 Sequence analysis of the catalytic domains
of the UL13 gene and its homologues.
The catalytic domains of HSV-1 UL13, VZV gene 47, EHV-1 
gene 49, HCMV UL97, HHV-6 15R and EBV BGLF4 were aligned 
using the PILEUP program (Genetics Computing Group (GCG), 
University of Wisconsin) and a consensus sequence generated 
using the PRETTY program (GCG, University of Wisconsin).
On the consensus line the upper case letters represent 
conserved amino acid residues, lower case letters indicate 
amino acids with similar properties where:
o = non-polar, i.e. M, L, I, V, C 
a = aromatic, i.e. F, Y, W
b = neutral/small, i.e. A, G, S, T, P
c = basic/polar, i.e. K, R, H
d = acidic/uncharged, i.e. D, E, N, Q
The conserved sequences of the subdomains (I to XI) 
identified by Hanks et al. (1988) are shown above the 
aligned sequences.
I II
oG-G— b-V aoK-o
VZV 129 LQIRDRPRFAGRGTYGRVHIYPSSKIAVKTMDSR.........FNRELV
EHV1 220 VALGEIPKFGGAGSYGEVQIFKQTGLAIKTASSR........SCFEHEL
HSV1 148 LEIPGARSFGGSGGYGDVQLIREHKLAVKTIKEK........EWFAVEL
HCMV 328 VDMSDESYRLGQGSFGEVWPLDR.YRVVKVARKH SETVLTVWMSGL
HHV6 192 QPEKTMARVLGVGAYGKVFDLD..KVAIKTANEDESVISAFIAGVIRAKS 
EBV 101 HLPITCEYLLGRGSYGAVYAHAD.NATVKLYDSV...TELYHELMVCDMI 
Consensus--------- G-G— G-V--------oK-------------------
III
E
VZV 169 INAILASEGSIRAGERLGISSIVCLLGFSLQTKQLLFPAYDMDMDEYIVR 
EHV1 261 AVSLLTGEDSLRAQASLGIGGIICLMAFSLPSKQMVFPAYDADLNAYGYR 
HSV1 189 IATLLVGECVLRAGRTHNIRGFIAPLGFSLQQRQIVFPAYDMDLGKYIGQ 
HCMV 37 3 IRTRAAGEQQQPPSLVGTGVHRGLLTATGCCLLHNVTVHRRFHTDMFHHD
HHV6 240 GADLLSHECVIN.........NLLISNSVCMSHKVSLSRTYDIDLHKFE
EBV 147 QIGKATAEDGQDKALVDY........LSACTSCHALFMPQFRCSLQDYG
Consensus ------ E---------------------------------------
VI 
DOK— NO
VZV 219 LSRRLTIPDHIDRKIAHVFLDLAQALTFLNRTCGLTHLDVKCGNIFLNVF 
EHV1 311 LSRSGPPSVLVTESIERAFIGLGRALVYLNTSCGLTHLDVKGGNIFVNHF 
HSV1 239 LASLRTTNPSVSTALHQCFTELARAVVFLNTTCGISHLDIKCANILVMLR
HCMV 42 3 QW KLACIDSYRRAFCTLADAIKFLNHQCRVCHFDITPMNVLIDVN
HHV6 280 DW DVRNVMNYYSVFCKLADAVRFLNLKCRINHFDISPMNIFLN. .
EBV 188 HW HDGSIEPLVRGFQGLKDAVYFLNRHCGLFHSDISPSNILVDF.
Consensus---------------- F— L— Ao-aLN— C-o-H-Do---No----
VII 
o-DaG
NFASLEITTAVIGDYSLVTLNTYSLCTRAIFEVGNPS.HPEHVLRVPRDA 
HFV...ISDCVIGDLSLMTLNTNSMAMRAEFEIDTGE.EEIKTLRLPRSA 
S.DAVSLRRAVLADFSLVTLNSNSTIARGQFCLQEPDLKSPRMFGMPTAL
PHNPSEIVRAALCDYSLSEPY......PDYNERCVAVFQETGTARRIPN
.HKKEIIFDAVLADYSLSEMH......PNYNGTCAIAKEYDKNLQLVPI
TDTMWGMGRL V LTD Y GT AS LH......DRNKMLDVRLKSSKGRQLYRLY
----------O-D-b--------------------------------
VIII 
b— a-bPE
VZV 318 SQMSFRLVLSHGTNQPPEILLDYINGTGLTKYTGTLPQRVGLA..... I
EHV1 407 SQMTFSFVIGHGLNQPISVIADFINNSGLAKSTGPIKHDVGLT..... I
HSV1 3 38 TTANFHTLVGHGYNQPPELLVKYLNNERAEFTNHRLKHDVGLA..... V
HCMV 511 CSHRLRECYHPAFRPMPL QKLLICDPHARFPVAGLR . RYCMS
HHV6 365 SRNKFCDMFNPGFRPLVA...... NAMILVNVCGAFDGENNPLRHCNL
EBV 275 CQREPFSIAKDTYKPLCLLSKCYILRGAGHIPDPSACGPVGAQTAL..RL 
Consensus -----------------------------------------------
IX
D-ab-G
VZV 362 DLYALGQALLEVILLGRLPGQLPISVHRTPHYHYYGHKLSPDLALDTLAY 
EHV1 451 DLYALGQALLELLLVGCISPCLSVPILRTATYYYYSNKLSVDYALDLLAY 
HSV1 382 DLYALGQTLLELVVSVYVAPSLGVPVTRFPGYQYFNNQLSPDFALALLAY 
HCMV 552 ELSALGNVLGFCLM..RLLD...RRGLDEVRMGT..E..ALLFKHAGAAC 
HHV6 407 DLCAFAQVVLSCVL..RMTD...KRGCREAQLYY..E..KRLFALANEAC 
EBV 323 DLQSLGYSLLYGIM..HLADSTHKIPYPNPDMGF..DRSDPLYFLQFAAP 
Consensus dL-b-b--------------------------------------- A-
XI
VZV 412 RCVLAPYILP.SDIPGDLNYNPFIHAGELNTRISRNSLRRIFQCHAVRYG 
EHV1 501 RCSLYPALFP.TTPLTTIYGIPWDQVEGVFESIAGAHHREAFRAHLERYR 
HSV1 4 32 RCVLHPALFV.NSAETNTHGLAYDVPEGIRRHLRNPKIRRAFTDRCINYQ 
HCMV 59 3 RALENGKLTHCSDACLLILAAQMSYGACLLGEHGAALVSHTLRFVEAKMS 
HHV6 448 RLNPLKYPFAYRDACCKVLAEHVVLLGLLFYRDVVEIYEKLYDFLDERGE
EBV 369 KVVLLEVLSQMWN LNLDMGLTSCGESPCVDVTAEHMSQFLQ.WCR
Consensus-------------- - -------------------------------
VZV 269 
EHV1 361 
HSV1 289 
HCMV 468 
HHV6 323 
EBV 232 
Consensus
1 0 0
subdomain IX the invariant D and G residues are conserved 
except in HCMV and HHV-6. In addition to these conserved 
subdomains the alphaherpesviruses also possess a conserved F- 
P-A-Y-D-X-D motif between subdomains III and VI. The 
presence of these conserved subdomains indicates that the 
UL13 gene and its homologues are members of the protein 
kinase family, however, the proteins are not closely similar 
to any known cellular protein kinase and also differ 
considerably from the US3 protein kinase family.
Like the US3 protein kinases, the UL13 homologues vary 
considerably in their N terminal domains. The size of the 
domains vary from approximately 85 residues in the BGLF4 
protein of EBV, to approximately 338 residues, in the HCMV 
UL97 protein. There do not appear to be any conserved 
features among these domains.
The product of the UL13 gene has been visualised as a 50K 
protein following in vitro translation of the UL13 
transcripts (Costa et al.t 1983). Costa et al. (1983) 
tentatively identified the 50K protein as the capsid protein 
VP19C. However, they had apparently confused VP19C with the 
phosphoprotein VP18.8 which Lemaster & Roizman (1980) had 
mapped to this region of the genome (see Braun et al.,
1984a). VP19C is now known to be the product of gene UL38 
(Rixon et al., 1990). More recent experiments by Cunningham 
et al., 1992) have shown that the UL13 gene product is a 
heavily phosphorylated 57K virion structural protein. The
1 0 1
protein kinase responsible for this strong phosphorylation is 
distinct from known cellular protein kinases and also from 
the US3 protein kinase. It is present in the nuclei of HSV-
1-infected cells, it phosphorylates exogenous casein but not 
protamine, it can use both ATP and GTP as a phosphate donor 
and, like the US3 kinase, it is stimulated by high salt 
concentrations. On the basis of the reports by Smith & Smith 
(1989) and Chee et al. (1989), Cunningham et al. (1992) have 
suggested that this novel protein kinase is, in fact, encoded 
by the UL13 gene and that the observed phosphorylation of the 
UL13 gene product represents an autophosphorylation reaction.
The fact that the UL13 protein kinase gene is conserved 
throughout all the herpesviruses suggests that it plays an 
important role in the viral cycle. Thus, the UL13 gene has 
been investigated with respect to its role in antiviral 
production and also antiviral resistance. For example,
Brandt et al. (1991) showed that treatment of HSV-l-infected 
murine corneas with an oligonucleotide antisense to the UL13 
gene, spanning the region encoding the F-P-A-Y-D-X-D motif 
(between subdomains III and VI of the catalytic domain), 
significantly reduced viral titres. However, viral titres 
were not reduced in other infected tissues and it is not 
known if the oligonucleotide specifically binds to the viral 
DNA at the UL13 locus. With regard to antiviral resistance, 
it was found that an HCMV virus containing a mutation in UL97 
was resistant to treatment with the antiviral compound 
ganciclovir (Coen, 1991). It has since been reported that
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the product of UL97 is directly responsible for the 
phosphorylation, and thus the activation, of ganciclovir 
(Littler et al., 1992; Sullivan et al., 1992).
1.9.3. UL39
The rightward oriented UL39 gene consists of 1137 codons 
(residues 86444-89855) and encodes a protein of MW 124,043. 
The 5* and 3' termini of the UL39 transcript have been mapped 
to residues 86217 and 90983, respectively (McLauchlan & 
Clements, 1983). Residue 90983 also corresponds to the 3' 
terminal of the UL40 transcript. The coding regions of UL39 
and UL40 do not overlap.
The UL39 and UL40 genes code for the two subunits of the 
viral nucleotide reductase (RR), a key enzyme in DNA 
metabolism (see section 1.7.4.(c)); the UL39 gene encodes the 
136 KDa large subunit (Rl) and the UL40 gene encodes the 38K 
small subunit (R2). Comparison of the HSV-1 and HSV-2 Rl 
sequences with their homologues in other herpesviruses 
revealed that the HSV Rl proteins possess an additional N 
terminal domain of approximately 360 amino acids (Nikas et 
al., 1986; Swain & Galloway, 1986). This domain shows only 
38% intertypic homology (Nikas et al., 1986), and is not 
required for RR activity (Ingemarson & Lankinen, 1987; Conner 
et al., 1992b). It has therefore been suggested that this 
dorrain possesses a distinct function. This proposal 
correlates with the fact that fragments spanning this N
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terminal domain have been implicated in the transformation of 
cultured cells (Jariwalla et al. , 1980, 1986; Jones et al., 
1986; Ali et al., 1991), and although RR activity is a 
delayed-early function, the Rl promoter includes elements 
associated with immediate-early gene expression (Wymer et 
al., 1989), which Chung et al. (1991) suggest may be 
associated with regulation of a distinct function.
In 1989, Chung et al. reported the presence of protein 
kinase-specific motifs within the N terminal domain of both 
HSV-1 and HSV-2 R l . The two Rl N terminal sequences have 
been aligned using the PILEUP and PRETTY programs (University 
of Wisconsin, Genetics Computing Group) and the location of 
the motifs marked (Figure 1.12). The proposed catalytic 
domain varies considerably from those of the known cellular 
protein kinases; only eight (I-VIII) of the eleven motifs 
identified by Hanks (1988) are present and the first G
residue in subdomain I and the invariant K residue of
subdomain II, reported to be essential for kinase activity, 
are not conserved in the HSV-1 sequence. It is therefore 
surprising that both proteins have been reported to auto- and 
trans-phosphorylate with a specificity for serine/threonine 
residues (Chung et al., 1989; Paradis et al., 1991), and that 
subdomains I and II have been shown to be dispensable for the 
protein kinase activity of the HSV-2 Rl (Luo & Aurelian,
1992). It should be noted that a recent study has shown that
the activity of the BCR protein kinase is unaffected by the 
substitution of an R for the K residue of subdomain II (Maru
Figure 1.12 Sequence analysis of the catalytic domains
of the HSV-1 and HSV-2 UL39 sequences.
The catalytic domains of the HSV-1 and HSV-2 UL39 genes 
were aligned using the PILEUP program (GCG, University of 
Wisconsin) and a consensus sequence generated using the 
PRETTY program (GCG, University of Wisconsin). The 
conserved sequences of the subdomains (I to VIII) 
identified by Hank et al. (1988) are shown above the 
aligned sequences.
G-G--G-V
HSV1 100 SPAPFVAVTNIGAGSDGGTAVVAFGGTPRRSAGTSTGTQ...........
HSV2 91 STGAFVAISNVAAGGDGRTAVVALGGTSGPSATTSVGTQTSGEFLHGNPR 
Consensus S---FVA— N— AG-DG-TAVVA-GGT--- SA-TS-GTQ-----------
II
aoK-o
HSVl 139 TADVPTEALGGPPPPPRFTLGGGCCSCRDTRRRSAVFGGEGDPVGPAEFV
HSV2 141 TPEPQGPQAVPPPPPPPFPWGHECCARRDAR......GGAEKDVGAAESW
Consensus T---------- PPPPP-F— G— CC— RD-R------ GG-----VG-AE—
III
E
HSVl 189 SDDRSSDSDSDDSEDTD......SETLSHASSDVSGGATYDDALDSDSSS
HSV2 185 SDGPSSDSETEDSDSSDEDTGSGSETLSRSSSIWAAGATDDDDSDSDSRS 
Consensus SD--SSDS DS D------ SETLS— SS---- GAT-DD— DSDS-S
IV
HSVl 2 3 3 DDSLQIDGPVCRPWSNDTAPL........ DVCPGTPGPGADAGGPSAVDP
HSV2 235 DDSVQPDVVVRRRWSDGPAPVAFPKPRRPGDSPGNPGLGAGTGPGSATDP 
Consensus DDS-Q-D— V-R-WS--- AP-------------PG-PG-GA— G— SA-DP
VI 
DoK— NO
HSVl 275 HAPTPEAGAGLAADPAVARDDAEGLSDPRPRLGTGTAYPVPLELTPENAE 
HSV2 285 RAS. . .ADSDSAAHAAAPQADVAPVLDSQPTVGTDPGYPVPLELTPENAE 
Consensus -A A--- AA— A----- D----- D— P— GT-- YPVPLELTPENAE
VII
o-DaG
HSVl 325 AVARFLGDAVNREPALMLEYFCRCAREETKRVPPRTFGSPPRLTEDDFGL 
HSV2 3 32 AVARFLGDAVDREPALMLEYFCRCAREESKRVPPRTFGSAPRLTEDDFGL 
Consensus AVARFLGDAV-REPALMLEYFCRCAREE-KRVPPRTFGS-PRLTEDDFGL
VIII
a-bPE
HSVl 37 5 LNYALVEMQRLCLDVPPVPPNAYMPYYLREYVTRLVNGFKPLVSRSARLY 
HSV2 382 LNYALAEMRRLCLDLPPVPPNAYTPYHLREYATRLVNGFKPLVRRSARLY 
Consensus LNYAL-EM-RLCLD-PPVPPNAY-PY-LREY-TRLVNGFKPLV-RSARLY
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& Witte, 1991). Recently, Conner et al. (1992a) have 
reported that HSV-1 Rl undergoes autophosphorylation, 
however, a transphosphorylating activity has not been 
observed.
Cheng et al. (1990) have reported that the HSV-2 Rl N 
terminal domain contains a possible transmembrane sequence 
and also incorporates myristic acid. On this basis they 
suggest that the Rl protein kinase may associate with the 
plasma membrane and transduce external signals in a manner 
similar to that of the mos oncogene. However, this idea is 
entirely speculative.
CHAPTER 2: MATERIALS
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2. MATERIALS
2.1. CELLS
Baby Hamster Kidney (BHK) 21 clone 13 cells (MacPherson & 
Stoker, 1962) were used routinely throughout the study.
Vero cells (African Green monkey kidney fibroblasts), HFL 
and Flow 2002 cells (Human foetal lung fibroblasts), BSC-1 
cells (African Green monkey epithelial cells) and 3T6 cells 
(mouse embryo fibroblasts) were obtained from stocks within 
the Institute or were supplied by Flow Laboratories.
2.2. TISSUE CULTURE MEDIA
All tissue culture media were obtained from Gibco-BRL.
Eagle's Medium (E) 10 x Glasgow Modified Eagle's Medium
(GMEM) was diluted to 1 x GMEM with 
sterile distilled H 2O and 
supplemented with: 4mM L-Glutamine 
and 0.26% sodium bicarbonate.
ETC10 E supplemented with: 5% tryptose
phosphate broth, lOOu/ml Penicillin, 
lOOug/ml Streptomycin and 10% Newborn 
calf serum (NBCS).
E supplemented with: lOOu/ml 
Penicillin, lOOug/ml Streptomycin and 
5% NBCS.
EFi o
DMEM
EMC 5
EMC5 /X
(For growth of Vero, BSC-1 and Flow 
2002 cells.) E supplemented with:
10% tryptose phosphate broth, lOOu/ml 
Penicllin, lOOug/ml Streptomycin and 
10% Foetal calf serum (FCS).
(For growth of HFL and 3T6 cells.) 
Dulbecco's Modified Eagle's Medium 
(DMEM) supplemented with: lOOu/ml 
Penicillin, lOOug/ml Streptomycin and 
10% FCS.
E supplemented with: lOOu/ml 
Penicillin, lOOug/ml Streptomycin, 
1.5% carboxymethylcellulose and 5% 
NBCS.
Gal Overlay EMCb supplemented with ImM X-Gal.
Agar/X-Gal Overlay E (without phenol red) supplemented
with: 0.64% Noble agar, 2% NBCS and
PIC
Emst/5 C 2
Versene
Trypsin
Trypsin/Versene
2.3. VIRUS
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E (without phosphate) supplemented 
with 1% NBCS.
E containing l/5th of normal 
methionine concentration supplemented 
with 2% NBCS.
6mM EDTA in PBS with 0.0015% (w/v) 
phenol red.
0.25% (w/v) Difco trypsin in Tris 
Saline (25mM Tris, 140mM NaCl, 5mM 
KC1, 0.7mM Na 2HP0 4 , lmg/ml dextrose, 
0.0015% phenol red, lOOu/ml 
Penicillin, lOOug/ml Streptomycin, 
pH7.4)
One volume of trypsin plus 4 volumes 
of versene.
The HSV-1 wild-type virus used in these experiments was 
grown from a single plaque of the parental HSV-1 strain 17 
syn+ virus (Brown et al., 1973).
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2.4. BACTERIAL CULTURE MEDIA
L-Broth 10g/l NaCI, 10g/l Difco Bactopeptone, 
and 5g/l yeast extract.
L-Broth Agar L-Broth containing 1.5% (w/v) agar.
2 x YT Broth 5g/l NaCI, 16g/l Difco Bactopeptone, 
10g/l yeast extract.
Antibiotics Ampicillin and tetracycline were 
added, where appropriate, to L-Broth 
and L-Broth Agar at concentrations of 
50ug/ml and 20ug/ml, respectively.
2.5. PLASMIDS
PGX125 (Davison & Wilkie, 1983c) was provided by Dr V. G. 
Preston and contains the UL13 gene of HSV-1 present in the 
Kpnl f fragment (residue 17789 to 28626, according to the 
nunbering system of McGeoch et al., 1988a).
pKhxl was provided by Dr V. G. Preston and contains the US3 
gene of HSV-1 present within the Kpnl h fragment (residue 
134788 to 144893).
pGK45 (Rixon & McGeoch, 1985) was provided by Dr V. G. 
Preston and contains the 5' terminal portion of the US3
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gene of HSV-1 in a Hindlll - BamHI fragment (133466 to 
136289).
pGX169 (Rixon & McGeoch, 1985) was provided by Dr V. G. 
Preston and contains the 3' terminal portion of the HSV-1 
US3 gene present in a BamHI - Hindlll fragment (136289- 
138344).
pFJ3 (Rixon & McLauchlan, 1990), provided by Drs F. J.
Rixon and J. McLauchlan, contains the Escherichia coli lacZ 
gene under the control of the SV40 early promoter.
pJMlA was provided by Dr J. Mullaney and contains the HSV-1 
Kpnl h fragment (134788-144893) with the US3 gene disrupted 
by the insertion of the lacZ gene of Escherichia coli.
pAT153 (Twigg & Sherratt, 1980) was the vector used for the 
construction of pLC3 and pLC5.
2.6. ENZYMES
DNA polymerase I, Klenow fragment, T 4 ligase, calf 
intestinal phosphatase (CIP) and all restriction nucleases 
used were obtained from Bethesda Research Laboratories, New 
England Biolabs, Northumbria Biologicals Ltd or Boehringer 
Mannheim UK Ltd.
All other enzymes were obtained from Sigma Chemical Co Ltd.
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2.7. CHEMICALS
All chemicals were of analytical grade or higher and were 
supplied by BDH Chemicals UK and Sigma Chemical Co Ltd, 
except for the following:
Acetic acid, chloroform, ether, methanol - May & Baker Ltd. 
Ammonium persulphate, Gelatin, TEMED (N,N,N',N1-tetra- 
methylethylenediamine) - Bio-Rad Laboratories, California. 
Ampicillin ("Penbritten") - Beecham Research Laboratories. 
Caesium chloride - Malford Laboratories Ltd.
Ecoscint - Nuclear Medical Electronic Systems & Services 
Ltd, Livingstone.
En3hance - DuPont (UK) Ltd.
Ethanol - Hayman Ltd.
Ficoll 400 - Pharmacia LKB Biotechnology.
X-Gal (5-bromo-4-chloro-3-indolyl-J3-D-galactopyranoside) - 
Boehringer Mannheim UK Ltd.
2.8. RADIOCHEMICALS
Radiochemicals were supplied by Amersham International pic:
32p-orthophosphate (carrier free), lOmCi/ml
L-[35S]-Methionine, 15mCi/ml
[2M2P]-ATP, lOmCi/ml
[o<l-3 2p]-dATP - lOmCi/ml
[i*5i]-Protein A, 38mCi/mg
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2.9. ANTISERA
Antisera 18377 and 18378 had been raised against the 
C-terminal octapeptide of the US3 ORF and were kindly 
provided by Dr H. S. Marsden and Mrs M. Murphy (Frame et 
al., 1987).
The anti-ULll antibody (MacLean et al., 1989) was kindly 
provided by Dr C. A. MacLean.
2.10. SOLUTIONS AND BUFFERS
E Buffer 36mM Tris-HCl (pH 7.8), 30mM NaH2P04 ,
ImM EDTA.
TE Buffer lOmM Tris-HCl (pH 7.5), ImM EDTA.
TBE Buffer 90mM Tris base, 89mM boric acid, 2mM
EDTA.
PBSA 170mM NaCI, 3.4mM KC1, lOmM NaH2P04 ,
1.8mM KH2P04 (pH 7.2).
PBS PBSA suplemented with 6.8mM CaCl2,
4.9mM MgCl2.
HeBS 137mM NaCI, 5mM KC1, 0.2mM NaH2P04 , 
9mM D-Glucose, 21mM Hepes (pH 7.05).
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20 x SSC 
RSB
TBS
WB (wash buffer)
Transfer buffer
Stet Buffer
Detergent Lysis 
Buffer
50 x Denhardt1s 
Solution
10 x N.T. Buffer
3M NaCI, 0.3M trisodium citrate.
lOmM Tris-HCl pH 7.4, lOmM KC1, 1.5mM 
MgCl2 .
20mM Tris-HCl pH 7.5, 0.5M NaCI.
ImM Tris-HCl pH 7.4, 0.09% NaCI,
0.01% NaN3 .
25mM Tris-HCl pH 8.3, 192mM glycine, 
20% methanol.
8% sucrose, 0.5% Triton X-100, 50mM 
EDTA pH 8.0, 50mM Tris-HCl pH 8.0.
0.1M Tris-HCl pH 8.0, 0.5% NP40, 0.5% 
sodium deoxycholate (DOC), 10% 
glycerol.
1% polyvinyl pyrrolidone, 1% BSA, 1% 
Ficoll 400.
0.5M Tris-HCl pH 7.8, 0.05M MgCl2, 
lOmM dithiothreitol (DTT).
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Giemsa Stain 1.5% suspension of Giemsa in glycerol
heated to 56°C for 90-120 min and 
diluted with an equal volume of 
methanol.
Denaturing Buffer 50mM Tris-HCl pH 6.7, 2% SDS, 700mM
2-mercaptoethanol, 10% glycerol, 
bromophenol blue.
DF Dye 50% (v/v) TBE, 50% (v/v) glycerol,
0.1% (w/v) bromophenol blue.
RE Stop 5 x E buffer, lOOmM EDTA, 10% Ficoll
400.
2.11. OTHER MATERIALS
"Miniprep Plus Kit" was supplied by Pharmacia LKB 
Biotechnology.
"Minifold II" apparatus was obtained from Schleicher & 
Schuell, Germany.
"GenescreenPlus" was supplied by DuPont.
"Spin-X" tubes were supplied by Costar.
Phosphorylated Xbal and Xhol linkers were obtained from New 
England Biolabs.
CHAPTER 3: METHODS
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3. METHODS
3.1. GROWTH OF CELL AND VIRUS STOCKS
3.1.1. Tissue Culture
Baby Hamster Kidney (BHK) cells were grown in ETCio in 80oz 
plastic roller bottles at 37°C in an atmosphere of 95% air,
5% CO2 . To harvest, the confluent monolayers were washed
twice with 20ml versene followed by a trypsin/versene wash. 
The detached cells were resuspended in 10ml ETC10 and stored 
at 4°C for up to one week. The cells were used to seed 
roller bottles at a concentration of 2ml/100ml ETC10 and 50mm 
tissue culture plates at a concentration of 200ul/3-4ml 
ETC1 0 .
To store, detached cells were resuspended in 5ml ETC10 
supplemented with 25% calf serum and 10% glycerol. Aliquots 
were stored overnight at -70»C and then transferred to liquid 
nitrogen (-190°C). Cells were recovered from liquid nitrogen 
by bringing quickly to 37°C.
All other cells used in the study were grown in large tissue 
flasks or roller bottles as described above, except that the 
growth medium ETC10 was replaced by EF 10 for Vero, BSC-1 and 
Flow 2002 cells and by DMEM for HFL and 3T6 cells.
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3.1.2. Preparation of "Resting" Cells
"Resting" cells were prepared as described by Howard et al. 
(1974). 50mm tissue culture plates were seeded with BHK 
cells at one fifth of the normal density, in ETCio. After 
24h at 37°C, the cells were then washed three times with 
Eagle's medium supplemented with 0.5% calf serum (ECo.s).
2ml of ECo.5 was added back to the cells which were then 
incubated at 37°C for a further 6-7 days.
3.1.3. Growth of Virus Stocks
Roller bottles of 90% confluent BHK cells were infected at a 
multiplicity of lpfu per 300 cells in 40ml ETCio and 
incubated at 31°C until total c.p.e. was obtained (about 4-5 
days p.i.). The infected cells were shaken into the medium 
and spun at 2000 rpm for 10 min (Beckman GPR centrifuge).
The cell pellet was used to prepare the cell-associated (CA) 
stock while the supernatant was used to prepare the 
Supernatant (SV) stock.
CA Stock. The cell pellet was resuspended in 5ml 
supernatant, sonicated, freeze-thawed, sonicated and spun at 
2000 rpm for 10 min (Beckman GPR centrifuge). The 
supernatant (supernatant 1) was kept on ice. The cell pellet 
was resuspended in 5ml ETCio/ freeze-thawed, sonicated and 
spun for a further 10 min at 2000 rpm (Beckman GPR 
centrifuge). The supernatant was pooled with supernatant 1,
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checked for sterility and stored at -70°C.
SV Stock. The supernatant was spun for 2h at 12,000 rpm 
(Sorvall GSA rotor). The virus pellet was resuspended in 5ml 
supernatant, sonicated, checked for sterility and stored at 
-70°C.
3.1.4. Sterility Checks
Cell and virus stocks were regularly checked for yeast and 
bacterial contamination using Brain Heart Infusion blood agar 
plates: 5.2% (w/v) Difco Bacto Brain Heart Infusion agar was 
autoclaved for 20 min and allowed to cool to 40°C. 10% (v/v)
horse blood (Biocult) was added and the agar poured into 50mm 
petri dishes. The cells or virus stocks were streaked, in 
duplicate, on the plates which were sealed with parafilm and 
incubated at 37<>C. If no contamination was apparent after 7 
days the stocks were deemed to be sterile.
Mycoplasma contamination was checked for by Mrs J. Mitchell 
of Cytology. Briefly, a sub-confluent monolayer of cells was 
grown on a coverslip placed on the bottom of a petri dish.
The cells were fixed by immersing the coverslip in a 3:1 
solution of methanol:acetone for three minutes. A drop of 
Hoescht Stain was then placed onto the coverslip. After ten 
minutes the stain was washed off, the coverslip dried, 
mounted onto a slide and examined under the microscope at 
xlOO, full immersion. If mycoplasma was present it appeared
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as small dots around the nucleus or gave the nucleus a 
"cotton wool" appearance. Pseudomonas contamination was 
kindly identified by the Department of Bacteriology, 
University of Glasgow.
3.1.5. Purification of Virions and Light Particles
Virions and light particles were purified essentially as 
described by Szilagyi & Cunningham (1991). 80-90% confluent
monolayers of BHK cells in 80oz plastic roller bottles were 
infected at 0.01 pfu/cell in 40ml ETC2 . For unlabelled 
virions the cells were incubated at 31°C until c.p.e. was 
widespread (4 to 5 days). For [35S]-methionine labelled 
virions the cells were incubated at 31<>C for 2 to 3 days.
The medium was replaced with 20ml Emet/5C2 and 2-8h later 
[35S]-methionine (0.5mCi/bottle) was added. Incubation was 
continued for a further 2-3 days.
The infected cells were shaken into the medium and pelleted 
by centrifugation at 2000 rpm for 30 min at 4°C (Beckman GPR 
centrifuge). The supernatant was then spun for a further 2h 
at 12,000 rpm (Sorvall GSA rotor) and the virus pellet 
carefully resuspended in minimal volume of Eagle's medium 
without phenol red. 5%-15% Ficoll 400 gradients in Eagle's 
medium without phenol red were prepared in 35ml cellulose 
nitrate centrifugation tubes. The resuspended pellet was 
layered onto the gradients and spun for 2h at 12,000 rpm 
(Sorvall AH629 rotor). The virions, which formed a well-
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defined lower band, and the light particles, which formed a 
more diffuse upper band, were withdrawn separately from the 
gradient using a wide bore needle. The light particles were 
rebanded on another 5%-15% Ficoll 400 gradient. Both virions 
and light particles were pelleted overnight at 21,000 rpm 
(Sorvall AH629 rotor). The pellets were resuspended in 
Eagle's medium without phenol red and stored at -70°C. The 
quality of the preparations, i.e. the number of intact virus 
particles, was checked by Mr J. Aitken using electron 
microscopy.
3.1.6. Titration of Virus Stocks
Serial ten-fold dilutions of virus stocks were made using PBS 
containing 2% calf serum. 0.2ml of each dilution was added 
to plates of 90% confluent BHK cells from which the growth 
medium had been removed. The plates were incubated at 37°C 
for Ih after which the inoculum was removed and the cells 
were overlayed with 4ml EMCs. After 2-3 days incubation at 
37°C the monolayers were stained with Giemsa stain, the 
plaques counted and the titre of the virus stock calculated.
3.1.7. Particle Counts
Equal volumes of the virus stock, latex beads (at a known 
concentration) and stain (1% phosphotungstic acid pH 7.0) were mixed 
and adsorbed onto a parlodion-coated copper grid. Excess liquid was 
drained off and the number of virus particles and latex beads
i
present in the field of view of the electron microscope counted. The 
concentration of the virus particles was calculated by comparison 
with the number of latex beads.
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Particle counts were carried out by Mr J.
Aitken.
3.1.8. Growth Curves
Growth curves were carried out at both high and low 
multiplicities of infection.
High moi. The medium was removed from 50mm plates of 
confluent BHK cells and the virus added, at a moi of 10, in a 
final volume of 500ul. The virus was left to absorb at 37°C 
for lh after which the monolayers were washed three times 
with PBS. 2ml ECs was added and the plates were returned to 
37°C. The Oh sample was harvested immediately after the 
washes with further samples harvested 2, 4, 6, 8, 12, 16, 20,
24 and 30h later. To harvest, the cells were scraped into
the medium and subjected to ultrasonic disruption. The 
volume of each sample was measured. The samples were then 
titrated as described in 3.1.6. The virus yield at each time 
point was calculated as the titre x sample volume.
Low moi. This was carried out as described above except that 
the cells were infected at a moi of 0.001 and samples were 
harvested at 0, 4, 8, 12, 24, 36, 48, 60 and 72h.
3.1.9. Preparation of HSV-1 DNA Stocks
Infected BHK cells, in roller bottles, were shaken into the
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medium and spun at 1000 rpm for 10 min at 4°C (Beckman GPR 
centrifuge). The supernatant was kept on ice while the cell 
pellet was resuspended in RSB containing 0.5% NP40 
(5ml/bottle), incubated on ice for 10 min and spun at 3000 
rpm for 10 min (Beckman GPR centrifuge). The cytoplasmic 
supernatant was kept and the nuclei were extracted again with 
RSB/0.5% NP40. The supernatants of both extractions were 
pooled with the original supernatant and spun at 5,000 rpm 
for 10 min (Sorvall GSA rotor). The pellet was discarded and 
the supernatant spun at 12,000 rpm for 2.5-3h (Sorvall GSA 
rotor). The virus pellet was resuspended in TE (2ml/bottle), 
sonicated and the virus particles lysed by the addition of 
0.04 volumes of 0.25M EDTA and 0.025 volumes of 20% SDS.
Virus DNA was extracted twice with phenol, once with phenol: 
chloroform (1:1) and once with chloroform. RNase A (5ug/ml) 
and RNase T1 (50u/ml) were added to the aqueous phase which 
was incubated at 37°C for 30 min. The DNA was precipitated 
using two volumes of ethanol, dried under vacuum and 
redissolved in TE.
3.2. PREPARATION AND ANALYSIS OF PLASMID DNA
3.2.1. Small Scale Plasmid Preparation
Using STET Buffer. 1.5ml of an overnight culture was spun 
for 10 seconds in a microcentrifuge. The supernatant was 
aspirated, the pellet vortexed and lOOul of STET buffer 
added. After vortexing, 16ul of lysozyme (lOmg/ml in 0.25M
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Tris pH 7.5) was added and the mixture was vortexed again.
The tube was boiled for 12 min and then spun in a 
microcentrifuge for 15 min. The pellet was removed and lOOul 
isopropanol was added. The tube was left to stand at room 
temperature for 10 min after which it was spun for 3 min.
The DNA pellet was drained, dried and dissolved in 40-50ul 
TE.
Using "Miniprep Plus” Kit (Pharmacia). The kit is based on a 
method devised by Birnboim & Doly (1979) and was used exactly 
as described in the instructions. Briefly, bacteria, 
pelleted from an overnight culture, were resuspended in one 
volume of a solution containing 50mM Tris-HCl pH 8.0, 50mM 
glucose, lOmM EDTA and 10% "Kathon". This was followed by 
the addition of two volumes of a 0.2M NaOH, 1% (v/v) Triton 
X-100 solution. Finally, sodium acetate (pH 4.8) was added 
to give a final concentration of 1M. The lysed bacteria were 
pelleted and the DNA precipitated from the supernatant using 
an equal volume of isopropanol. The DNA pellet was 
resuspended in 40-50ul TE.
3.2.2. Large Scale Plasmid Preparation
15ml L-Broth, containing the appropriate antibiotic, was 
inoculated with a loopful of a glycerol stock and shaken 
overnight at 37°C. This culture was added to 600ml of L- 
Broth plus antibiotic and shaken at 37®C until OD630 = 0.8. 
Chloramphenicol was then added at a concentration of 25ug/ml
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and the incubation was continued overnight.
Plasmid DNA was isolated by the soft lysis method described 
by Katz et al. (1973), with modifications. The 600ml culture 
was centrifuged at 9000 rpm for 15 min at 4»C (Sorvall GS3 
rotor). The bacterial pellets were resuspended in a total of 
16ml ice-cold sucrose-Tris (25% sucrose (w/v), 50mM Tris-HCl 
pH 8.0) and placed on ice. Lysozyme was added to a 
concentration of 2.5mg/ml followed by a 5 min incubation on 
ice. 12ml of 250mM EDTA pH 8.0 was then added and the tube 
left on ice for a further 5 min. The bacterial cells were 
lysed by the addition of 36ml 2% Triton X-100 in 50mM Tris- 
HCl (pH 8.0), 62.5mM EDTA followed by 20 min incubation on 
ice. The lysed bacteria were then spun at 15,000 rpm for 30 
min at 4°C (Sorvall SS34 rotor) to pellet the cell debris and 
chromosomal DNA. The lysate was extracted with phenol and 
the upper aqueous layer was dialysed against TE for 1.5h at 
4°C with two changes. After dialysis the DNA was 
precipitated with 0.5 volumes of isopropanol, pelleted by 
centrifugation at 2000 rpm for 10 min (Beckman GPR 
centrifuge) and resuspended in 5ml TE.
The plasmid DNA was then purified on a CsCl gradient. To 
prepare the gradients 15g of CsCl plus 1ml of lOmg/ml EtBr 
was added to the DNA solution. Sufficient TE was then added 
to give a final density of 1.55g/ml. The solution was 
centrifuged at 40,000 rpm at 15°C for 16h (DuPont TV865B 
rotor). The bands were visualised using long wave
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ultraviolet light and the lower band, representing the 
supercoiled DNA, was removed with a syringe. The EtBr was 
removed by successive extractions (at least 4) with CsCl- 
saturated isopropanol. The DNA was dialysed against TE for 
1.5h at 4°C with two changes and then precipitated with 2.5 
volumes of ethanol. The DNA was pelleted by centrifugation 
at 15,000 rpm for 15 min (Sorvall SS34 rotor), dried, 
resuspended in 1ml TE and stored at -20°C.
3.2.3. Glycerol Stocks of Bacteria
50ml of L-Broth, containing the appropriate antibiotic, was 
inoculated with a loopful of a bacterial culture and 
incubated overnight at 37°C in an orbital shaker. The 
culture was centrifuged at 9000 rpm for 15 min (Sorvall SS34 
rotor) and the pellet resuspended in 3-4ml of 2% Bactopeptone 
plus an equal volume of 80% glycerol. The stock was 
aliquoted and stored at -20<>C and -70°C.
3.2.4. Restriction Enzyme Digestion of Plasmid DNA
Plasmid DNA was cut with restriction enzymes, in the presence 
of the appropriate buffer, at a concentration of 
approximately lu enzyme/lug DNA for 3-4h at the specified 
temperature. For analytical use the DNA (approximately 
0.5ug) was digested in a volume of lOul all of which was 
loaded onto a minigel (see 3.2.5.). Preparative digests were 
carried out in a final volume of 30-50 ul and were either
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loaded onto a minigel for separation of restriction fragments 
or were phenol extracted and ethanol precipitated before 
being used further.
3.2.5. Separation of DNA Restriction Fragments on Aorarose 
Gels (Miniqels)
50ml of a 1% agarose solution, in TBE, containing 5ug/ml 
EtBr, was poured into a minigel kit, a teflon comb was 
inserted and the gel was left to set. 5ul of DF dye was 
added to the samples which were then loaded into the wells 
and electrophoresed at 50V using TBE containing 5ug/ml EtBr 
as the buffer. The restriction fragments were visualised 
under long or short UV light.
3.3. GENERATION OF RECOMBINANT PLASMIDS
3.3.1. Extraction of DNA Restriction Fragments from Agarose 
Gels
DNA was cut with the appropriate enzyme (see 3.2.4.) and run 
on an agarose gel (see 3.2.5.). The gel was viewed under 
long wave UV light and the required band was excised. The 
DNA was extracted from the agarose by one of two ways.
Electroelution. The gel slice was placed in a piece of 
dialysis tubing which had been boiled and then rinsed in 
electroelution buffer (20mM Tris-HCl pH 7.4, lOmM sodium
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acetate, 0.5mM EDTA). A minimal amount of buffer was added 
to the gel slice and the tubing was sealed at both ends. The 
gel slice was then immersed in a shallow layer of buffer and 
electrophoresed at 75mA for 3h. The polarity of the current 
was reversed for 1 min to remove DNA from the side of the 
tubing. The gel slice was removed and the DNA was isolated 
from the buffer by phenol extraction and ethanol 
precipitation.
Spin-X tubes. The gel slice was placed in a microcentrifuge 
tube and frozen for 10 min in a dry ice/isopropanol bath.
The slice was then transferred to a Spin-X tube and spun for 
10-15 min in a microfuge. The DNA was isolated from the 
buffer by phenol extraction and ethanol precipitation.
3.3.2. DNA Cloning
The vector was linearised using the appropriate restriction 
endonuclease in the presence of 1 unit of calf intestinal 
phosphatase to minimise recircularisation of the vector DNA 
during subsequent ligations. The DNA was phenol extracted 
and ethanol precipitated.
Blunt ending. For the insertion of blunt-ended fragments 
into sticky-ended vectors, the vector was incubated with 5 
units each of T 4 polymerase and Klenow fragment in the 
presence of T 4 buffer (0.67M Tris-HCl pH 7.9, 67mM MgCl2 ,
50mM DTT) and T 4 chase (2mM dATP, dCTP, dGTP, dTTP) up to a
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final volume of 20ul. The incubation was carried out at room 
temperature for 2h. The DNA was phenol extracted and ethanol 
precipitated.
Ligation. The insert and vector were mixed at a ratio of 3:1 
in the presence of 1-2 units of ligase and made up to 20ul 
with 1 x ligase buffer (Boehringer Mannheim). The mixture 
was incubated at room temperature or 16°C overnight.
3.3.3. Preparation of Competent E. coli
Calcium-shocking. JM109 E. coli were grown in 300ml L-Broth 
at 37°C in a shaking incubator until the OD6 0 0 was 0.3 to 
0.4. The culture was spun at 9000 rpm for 15 min (Sorvall 
SS34 rotor) and the pellet resuspended in 0.5 volumes of 50mM 
CaCl2/10mM Tris-HCl pH 7.5. After 20 min on ice the E. coli 
were spun as before and the pellet resuspended in 0.1 volumes 
of 50mM CaCl2/10mM Tris-HCl pH 7.5. The competent E. coli 
were kept on ice until required.
Commercially obtained. Library Efficiency DH5^4. competent E. 
coli were supplied by BRL. The E. coli had been made 
competent by a modification of the procedure of Hanahan 
(1S83) .
3.3.4. Transformation of Competent E. coli
Calcium-shocked E. coli. lug of DNA was added to 200ul of
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competent E. coli and incubated on ice for 40 min. The E. 
coli were then heat-shocked at 42°C for 2 min, mixed with 
1.8ml of L-Broth and shaken for lh at 37°C. Aliquots were 
spread on L-Broth agar plates, containing antibiotic (if 
appropriate), which were then incubated at 37°C overnight.
Commercially-obtained competent E. coli. The DH5<^ E. coli 
were transformed as described in the instructions. Briefly, 
lul of a 5-fold dilution of the ligation mixture was added to 
20ul of DH5c< cells. The mixture was incubated on ice for 30 
min and then heat-shocked at 42°C for 45 sec. The E. coli 
were returned to ice and 80ul of either SOC medium (2% 
Bactotryptone, 0.5% Yeast Extract, lOmM NaCl, 2.5mM KC1, lOmM 
MgCl2 / lOmM MgS0 4 / 20mM glucose) or 2 x YT Broth was added. 
The mixture was shaken at 37°C for lh and plated onto L-Broth 
agar plates.
3.3.5. Detection of Recombinant Plasmids Containing the 
E. coli lacZ gene
50ul of a 30mg/ml stock of X-Gal, in DMF, was spread evenly 
onto L-Broth agar plates and left to dry for 1-2 min. The 
transformed cells were then spread onto the plates which were 
incubated at 37°C overnight. Colonies expressing the lacZ 
gene turned blue.
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3.4. GENERATION OF RECOMBINANT VIRUSES
3.4.1. Co-transfection of Viral DNA with Plasmid DNA
Co-transfection of virus and plasmid DNA into BHK cells was 
carried out by calcium phosphate precipitation followed by a 
dimethyl sulphoxide (DMSO) boost, as described by Stow & 
Wilkie (1976). HSV-1 DNA (0.4ug or 200 pfu) was mixed with 
varying amounts of linearised plasmid DNA (O.lug to 5ug, 
giving an approximate 2.5-fold to 125-fold molar excess over 
the virus DNA) in the presence of 6ug of calf thymus as 
carrier. Each DNA mixture was made up to 930ul with HeBS 
buffer and, just before use, 70ul of 2M CaCl2 was added. The 
tubes were inverted to gently mix the solutions. The medium 
was removed from the monolayers and the DNA mixtures were 
added dropwise, in duplicate (400ul/plate). The plates were 
incubated at 37°C for 40 min after which 4ml EC5 was added to 
each plate. Incubation was continued for a further 4h. To 
boost the transfection, the monolayers were first washed with 
Eagle's medium without calf serum (E), then 1ml of 25% DMSO, 
in E, was added to each plate. After 4 min incubation at 
room temperature the DMSO was removed, the monolayers were 
washed twice with E and overlayed with 4ml EC5 . The plates 
were incubated at 37°C until cpe was widespread (2-4 days). 
The cells were then scraped into the medium, sonicated to 
release infectious virus, and stored at -70°C.
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3.4.2. Detection and Isolation of Recombinant Viruses
The viruses harvested from the co-transfection, were titrated
as described in 3.1.6. The titrations were initially
overlayed with 4ml EMC5 but when plaques were observed the
EMC5 overlay was replaced with 4ml of either EMC5 or Agar
overlay containing ImM X-Gal. The titrations were incubated
at 37°C for another day after which any plaques formed by the
recombinant virus had turned blue. Individual blue plaques
i * six
were picked and carried throughifive or^more rounds of plaque 
purification. Stocks were grown of 2 or 3 purified plaques 
which were used in subsequent experiments.
3.4.3. Restriction Enzyme Analysis of 32P-labelled Viral 
DNA
The method used was based on that described by Lonsdale 
(1979). BHK cells were grown at 37°C in phosphate-free 
medium (PIC) in a 24 well tissue culture plate. When the 
cells were confluent virus was added directly to the medium 
at a moi of 10 and left to absorb at 37®C for lh. The 
inoculum was then removed and the cells washed in 800ul PIC. 
450ul of PIC was added to each well and the incubation at 
37°C was continued. After 2h 50ul of PIC containing 0.1-0.2 
uCi/ul of 32P-orthophosphate was added to each well and the 
cells were incubated at 37®C for 2-3 days.
To lyse the infected cells, 0.5ml 5% SDS was added to each
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well. The cells were scraped into the medium and transferred 
to a 10ml tube. The DNA was isolated from this lysate by 
extraction with an equal volume of buffer-saturated phenol 
followed by precipitation with 2 volumes of ethanol. The 
virus DNA was then pelleted by centrifugation at 2000 rpm for 
10 min (Beckman GPR centrifuge). The pellet was drained, 
dried at 37°C for 15-20 min, and resuspended in 200ul H 2O 
containing 125ug/ml RNase A and 0.05ug/ml RNase T1 in a 
gently shaking 37°C water bath.
20ul of labelled DNA was mixed with 1-2 units of the 
appropriate enzyme and made up to a final volume of 30ul with 
the buffer supplied by the manufacturers or, in the case of 
BamHI , with BamHI buffer [6mM Tris-HCl pH 7.4, 6mM MgCl 2 /
0. 1M NaCl, O.lmg/ml BSA (Boehringer Mannheim), 0.04% (v/v) 2- 
mercaptoethanol]. The samples were incubated at 37°C for at 
least 4h after which lOul of RE stop was added. The 
restriction fragments were then separated by horizontal 
agarose gel electrophoresis.
To prepare agarose gels tape was placed along the 4 sides of 
a 265mm x 165mm glass plate which was then set in a gel 
former and levelled. 250ml of a 0.6% or 0.8% agarose 
solution in E buffer was poured into the plate and a comb was 
inserted. Once set, the gel was placed in a horizontal gel 
electrophoresis tank and E buffer was added to a level just 
above the gel surface. The samples were loaded using a 
micropipette and electrophoresed at 40V overnight. The gels
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were dried and exposed to X-Omat XS-1 film either at room 
temperature or at -70°C against an image intensifying screen.
3.5. ANALYSIS OF HSV-1 INDUCED POLYPEPTIDES
3.5.1. Sodium Dodecyl Sulphate-Polvacrylamide Gel 
Electrophoresis (SDS-PAGE)
Both 9% (w/v) single concentration gels and 5%-12.5% (w/v) 
gradient gels were used. 30% (w/v) acrylamide stocks were 
prepared in water. The ratio of acrylamide to the 
crosslinking agent N,N1-methylene bisacrylamide was 39:1 and 
19:1 for single concentration gels and gradient gels 
respectively. The stocks were filtered through Waterman No.
1 filter paper before use.
Gel solutions containing the appropriate percentage of 
acrylamide were prepared in buffer of final concentration 
375mM Tris-HCl (pH 8.9) and 0.1% SDS. For gradient gels the 
12.5% (w/v) solution also contained 15% glycerol to stabilise 
the gradient. To polymerise the gel solutions 150ul of 10% 
ammonium persulphate (APS) and lOul of TEMED were added to 
each 24ml of gel solution except for the 12.5% solution for 
which only 65ul of 10% APS was added, together with lOul 
TEMED.
The gel solutions were poured between 2 well-washed glass 
plates which were separated by 1.5mm thick spacers and sealed
134
with rubber tubing. The gels were left to polymerise under a 
thin layer of butan-2-ol. Following polymerisation a 
stacking gel consisting of 5% acrylamide in 122mM Tris-HCl 
(pH 6.7), 0.1% SDS was added. Wells were formed by a teflon 
comb.
Samples were boiled for 5 min in denaturing buffer with 
sufficient bromophenol blue to visualise the dye front. 
Electrophoresis was carried out in a buffer containing 52mM 
Tris, 53mM glycine, 0.1% SDS at 10-12mA, overnight, at room 
temperature.
3.5.2. Visualisation of Proteins Separated by SDS-PAGE
(a) Autoradiocrraphy: Gels were fixed for lh in methanol: 
acetic acid: water (50:7:50) and then soaked in several 
changes of 5% methanol, 7% acetic acid. The gels were then 
gently shaken in 3 volumes of En3hance for 45 min, followed 
by a wash in 10 volumes H 2O, for 10-15 min. The gels were 
dried, under vacuum, onto Whatman grade 182 filter paper and 
exposed to Kodak X-Omat XS-1 film at -70°C.
Gels were also dried prior to treatment with En3hance and 
exposed to film at room temperature or at -70°C with an image 
intensifying screen.
(b) Silver staining: Gels were fixed in 30% ethanol, 10%
acetic acid for at least 30 mins followed by a 30 min
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incubation in a solution of 30% ethanol, 0.5M sodium acetate, 
0.5% glutaraldehyde and 0.2% sodium thiosulphate. The gels 
were rinsed thoroughly in water, for 3 x 10 min and then 
soaked in 0.1% silver nitrate, 0.02% formaldehyde for 15-60 
min. The protein bands were visualised by placing the gels 
in developer (2.5% sodium carbonate, 0.01% formaldehyde) for 
5-15 min. Development was stopped by the addition of 0.05M 
EDTA followed by a wash in water. All water used throughout 
this procedure was of high purity HPLC grade.
3.5.3. Preparation of r3SS1Methionine-labelled Extracts
Confluent monolayers of BHK cells in 50mm plates were 
infected at a moi of 20. The virus was left to adsorb at 
37®C for lh after which the cells were washed twice with 
Eagle's medium containing one fifth the normal concentration 
of methionine supplemented with 2% calf serum (Emet/5 C 2 ).
2ml of Emet/5 C 2 was added to each plate and incubation at 
37®C was continued. At the appropriate time lOOuCi of 
[35S]methionine was added to the medium and the plates were 
returned to 37°C.
At the required time the infected monolayers were washed 
twice with PBS and drained well before the addition of 500ul 
of detergent lysis buffer (Zweig et al., 1980). After 1-2 
min the lysed cells were transferred into a microcentrifuge 
tube, incubated on ice for lh and spun on a microfuge, at 
high speed, for 10 min. The supernatant, containing the
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labelled proteins, was removed and stored at -70°C.
3.5.4. Preparation of In Vitro 32P-Labelled Virions for 
Immunoprecipitation
A 30ul sample of virions was mixed with 1.2ul each of 0.25M 
Tris-HCl pH 7.5, 0.025M MgCl2, 0.025M DTT and 1.25% NP40.
The mixture was incubated on ice for lh and diluted with an 
equal volume of lOmM Tris-HCl pH 7.5, ImM MgCl2 and ImM DTT.
lOul of treated virions were then mixed with 40ul of H 20 or 
1.25M NaCl plus 50ul SM buffer (0.1M Tris-HCl pH 7.5, 20mM 
MgCl2 , 2mM DTT, 0.2mCi/ml [ tf-32P]-ATP) and incubated at 
37°C. After lh, lOOul of 2 x lysis buffer and 300ul of 1 x 
lysis buffer was added, the mixture was incubated on ice for 
lh and then spun for 5-10 min using a microfuge. The 
supernatant, containing the labelled virions, was removed.
3.5.5. Immunoprec i p i tat i on
50ul aliquots of antipeptide antibody were pre-incubated wth 
lOug peptide or PBS at 37®C for 30min. lOOul of 
[35S]methionine-labelled extract (section 3.5.3.) plus lOOul 
of detergent lysis buffer were then added to each tube. The 
tubes were incubated at 4°C overnight. 60ul of Protein-A- 
Sepharose (50% suspension in detergent lysis buffer) was 
added to each tube and the incubation was continued for a 
further l-2h, on ice. The Protein-A-Sepharose was pelleted
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using a microfuge at low speed for 1 min and washed four 
times with detergent lysis buffer. The antibody-antigen 
complexes were eluted by boiling for 5-10 min in denaturing 
buffer. The samples were then spun for 1 min in a microfuge 
at high speed and the supernatant loaded onto SDS- 
polyacrylamide gels.
3.5.6. Immunoblotting
The immunoblotting procedure used was based on that described 
by Towbin et al. (1979), with modifications.
The samples used for immunoblotting were prepared by 
infecting BHK cells in 50mm plates or roller bottles at a moi 
of 10-20. (For [35S]methionine-labelled samples the cells 
were labelled as described in section 3.5.3.) To harvest 
from 50mm plates, 500ul of denaturing buffer was added and 
the plates were then heated to 70-80®C, in an oven, for 10 
min. The sample was transferred to a vial, boiled for 2 min 
and stored at -70°C. For roller bottles, the cells were 
harvested into 25ml denaturing buffer by rotating over a 
boiling water bath for 10 min, aliquoted and stored at -70°C.
The samples were loaded onto SDS-polyacrylamide gels in large 
wells (approximately 1 x 10® cell equivalents per cm). If 
the sample was unlabelled, a marker track containing 
[35S]methionine-labelled extract was added.
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Following electrophoresis the protein was transferred from 
the gel to nitrocellulose using a BioRad "Transblot" 
apparatus. The open gel holder was placed in a shallow tank 
of transfer buffer (cathode side down). A foam pad, 
presoaked in transfer buffer, was placed on top of the 
cathode panel. This was followed by a presoaked sheet of 
Whatman grade 182 filter paper and then the gel. 
Nitrocellulose strips (numbered and presoaked in transfer 
buffer) were place on top of the gel, face down, and air 
bubbles were excluded. The sandwich was completed with 
another sheet of filter paper and another foam pad. The 
holder was closed and placed in the "Transblot" tank 
containing transfer buffer. The proteins were transferred at 
250mA for 3h at room temperature.
Following transfer the free binding sites on the 
nitrocellulose were blocked using one of the three following 
blocking agents: 3% gelatin in TBS; 0.05% Tween 20 in WB; or 
10% FCS in TBS or WB. The strips were placed in one of these 
buffers and incubated at 37®C or 65°C for lh with a change of 
buffer after 30 min. The strips which had been blocked with 
gelatin were then washed twice with 1 x WB containing 0.05% 
Tween 20.
The antiserum was diluted to the appropriate concentration 
with 1 x WB containing 0.05% Tween 20 + 1% BSA. Each strip 
was placed, face up, in a 5mm deep trough in a perspex block, 
and incubated with 3ml diluted antiserum at room temperature
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overnight with gentle shaking. Unbound antiserum was removed 
by 4 washes in 1 x WB/0.05% Tween 20 over a period of 2h at 
37°C.
To detect bound antibody the strips were transferred to clean 
troughs and each covered with 3ml of 1 x WB containing 3%
BSA. 5 x 105 Cpm of i25I-protein-A was added to each trough 
and the strips were shaken gently at 37°c for 2h. The strips 
were then washed in 1 x WB containing 1M KI for 2h at room 
temperature with one change of buffer and then in PBS-A for 
15 min. The strips were air-dried and stuck to card sheets 
which had been marked with ink containing 35S and J-25I.
To detect which of the proteins had reacted with the i2Bi- 
protein-A the strips were exposed to three films 
simultaneously, as described by Haarr et al. (1985). Film 1 
was placed directly on top of the strips and was separated 
from the other two films by a sheet of black paper. An image 
intensifying screen was placed behind film 3. The [35S] [3 
emissions were detected only by film 1. The 125J y 
emissions passed through all three films and hit the image 
intensifying screen producing photons which were detected by 
film 3, giving an intense image and then by film 2, giving a 
much less intense image. Film 1 was protected from the 
photons by the black paper. The three films were then 
aligned using the radioactive ink marker.
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3.6. ANALYSIS OF VIRUS DNA SYNTHESIS
3.6.1. Extraction of Viral DNA from Infected Cells
Monolayers of BHK cells in 50mm plates were mock-infected or 
infected at 5 pfu/cell. After lh incubation at 37°C the 
monolayers were washed 3 times with PBS and overlayed with 
4ml ECs. Incubation was continued for a further 8h or 24h.
(a) Preparation of total cellular DNA. The method used was 
that described by Stow et al. (1983). The medium was removed 
from the infected monolayers and was replaced with 2ml lysis 
buffer (0.6% SDS, lOmM EDTA, lOmM Tris-HCl pH 7.5) containing
500ug pronase per ml. The plates were incubated at 37°C for
4-5h after which the lysed cells were transferred to a 10ml 
tube. NaCl was added to a final concentration of 200mM and 
followed by sequential extractions with phenol and 
chloroform. DNA was precipitated with two volumes of ethanol
and pelleted by centrifugation at 3000 rpm for 15min (Beckman
GPR centrifuge). The pellet was resuspended in water 
containing lOug/ml RNase A.
(b) Preparation of encapsidated DNA. The method used was 
that described by Stow et al. (1983). The medium was removed 
from the infected cells, which were scraped into 1ml RSB and 
subjected to ultrasonic disruption. 50ug of DNase 1 was 
added and the cells incubated at 37®C for 2h. SDS, EDTA and 
pronase were added to the above concentrations and the
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proteins digested for a further 2h. The encapsidated DNA was 
then extracted as described above for total cellular DNA.
(c) Preparation of released DNA. The medium was removed 
from the monolayers and spun at 3000 rpm for 10 min to pellet 
cell debris. An equal volume of 16% polyethylene glycol 
6000, in 1M NaCl, was added to the supernatant which was then 
left at 4°C overnight. The virus was pelleted by 
centrifugation at 12,000 rpm for 30 min (Sorvall SM24 rotor). 
The proteins were digested and the DNA extracted as described 
above.
3.6.2. Transfer of DNA onto a Hybridization Membrane Usincr 
Slot Blot Apparatus
The DNA samples were denatured in 0.25M NaOH for 10 min and 
chilled in ice before being diluted to the desired 
concentration with a solution of 0.125M NaOH, 0.125xSSC. A 
sheet of "GenescreenPlus" membrane was cut to fit a "Minifold 
II" apparatus (Schleicher & Schuell) and soaked in 0.4M Tris- 
HCl pH 7.5 for 30 min. The apparatus was assembled according 
to the manufacturers' instructions and 60ul of the diluted 
DNA samples was loaded into each slot. After 30 min a slight 
suction was applied for 30 sec. The apparatus was dismantled 
and the membrane removed.
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3.6.3. Internal Label liner of Plasmid DNA by Nick 
Translation
Plasmid DNA was labelled according to the method of Rigby et 
al. (1977). lug of DNA was mixed with 20uCi [oC-3 2p]dATP, 2
units of E. coli DNA polymerase I, lul of DNase I
(10"4units/ml), lOug BSA, and 0.2mM each of dCTP, dGTP and 
dTTP in the presence of 1 x NT buffer in a final volume of 20
ul. The mixture was incubated at 14°C for at least 90 min
and diluted to lOOul with H 2O. The labelled DNA was 
precipitated twice by the addition of lOul 3M sodium acetate 
and 80ul isopropanol.
For use as a probe in DNA:DNA hybridisation the DNA pellet 
was resuspended in lOOul of 80% formamide and boiled for 5 
min.
3.6.4. DNA;DNA Hybridisation
Virus DNA, transferred to a membrane by a slot blot, was 
visualised by hybridisation with a 32P-labelled probe 
(section 3.6.3). The membrane was incubated in 100ml 
prehybridisation mix (6xSSC, 5 x Denhardt's, 0.1% SDS, 
0.02mg/ml denatured DNA) for 2h at 65°C. This was discarded 
and replaced with 20ml of hybridisation mix (6xSSC,
2xDenhardt1s , 0.5% SDS, 20mM Tris-HCl pH 7.5, ImM EDTA, 
0.05mg/ml denatured DNA) to which 455ul of 1M HC1 had been 
added. The labelled probe was added and hybridisation was
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carried out at 65°C overnight. The membrane was washed in 
6xSSC, 1% SDS at room temperature for 30 min. This was 
followed by a 30 min wash at 65°C in 3xSSC, 1% SDS and then 
in 2xSSC, 1% SDS. The membrane was rinsed in water and 
exposed to Kodak X-Omat XS-1 film at room temperature or at 
-70°C with an image intensifying screen.
3.7. IN VITRO PHOSPHORYLATION REACTIONS
3.7.1. Preparation of Crude Nuclear and Cytoplasmic 
Extracts from Infected Cells
Extracts were prepared essentially as described by Piette et 
al. (1985). Confluent monolayers of BHK cells, in roller 
bottles, were infected with 5-10 pfu/cell and incubated at 
37oC for 5h. The cells were scraped into 10ml PBS, pelleted 
by centrifugation at 2000 rpm for 10 min (Beckman GPR 
centrifuge) and resuspended in 10ml Buffer A (lOmM Hepes pH
8.0, 50mM NaCl, 0.5M sucrose, ImM EDTA, 0.5% Triton X-100, 
ImM PMSF, 7mM 2-mercaptoethanol). The cells were then 
disrupted, on ice, using 20 strokes of a Dounce homogeniser 
and centrifuged at 3000 rpm for 10 min (Beckman GPR 
centrifuge). The supernatant, representing the crude 
cytoplasmic extract, was removed and stored at -70°C. The 
nuclear pellet was resuspended in 3ml Buffer A and subjected 
to ultrasonic disruption followed by centrifugation at 2000 
rpm for 3 min (Beckman GPR centrifuge). The supernatant 
represents the crude nuclear extract.
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3.7.2. Treatment of Virions for In Vitro Phosphorylation 
Reactions
Virions were treated with NP40 as described in the first 
paragraph of section 3.5.4.
3.7.3. In Vitro Phosphorylation of Infected Cell Extracts 
and Virions
5ul of extract or virion preparation was mixed with 7ul of a 
buffer containing 140mM Tris-HCl pH 7.5, 28.6mM MgCl2 / 2.86mM 
DTT, luCi [ }f-32P]”ATP. 8ul of an NaCl solution, at the 
desired concentration, was added and the mixture was 
incubated at 37°C for 30-45 min. The assay was analysed by 
SDS-PAGE.
3.8. COMPUTING
Evaluations of DNA and protein sequences were carried out on 
the DEC Microvax II computer using the Genetics Computer 
Group Sequence Analysis Software Package (Devereux et al., 
1984).
CHAPTER 4: STUDIES ON THE HSV-1 US3 GENE
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4. STUDIES ON THE HSV-1 US3 GENE
When this research was initiated it was known that the US3 
gene of HSV-1 encodes a protein kinase with serine/threonine 
specificity. However, the substrates of this kinase and its 
role in the virus life cycle were unknown. One of the aims 
of this research was therefore to investigate the function of 
the US3 protein kinase. The approach chosen for these 
investigations was to construct a virus in which the US3 gene 
had been inactivated by the insertion of the Escherichia coli 
lacZ gene. This insertion not only disrupted the US3 ORF but 
also acted as a screenable marker during purification of the 
mutant virus. Once constructed, the growth properties of the 
insertion mutant were characterised in order to determine if 
the US3 protein kinase is required for efficient viral 
growth. The proteins synthesised by the US3-JacZ virus were 
also investigated and the effect of US3 disruption on viral 
DNA synthesis was determined. Physiological substrates of 
the US3 protein kinase were analysed by comparing the 
phosphoprotein profiles of the wt and mutant viruses, 
following in vitro phosphorylation assays.
4.1. CONSTRUCTION OF THE US3-iacZ INSERTION MUTANT
4.1.1. Construction of a Plasmid Containing a Disrupted US3
Gene (pJMlA)
pJMlA was constructed by Dr J. Mullaney, as shown in Figure
Figure 4.1 Construction of pJMlA.
The lacZ gene from pFJ3 was inserted into the US3 gene 
the unique Xhol site, via an Xbal linker.
The boxes represent coding sequences. The solid areas 
represent the predicted catalytic domain.
This construction was carried out by Dr J. Mullaney.
1 .D igestion  with 
Xhol and  
insertion of 
Xbal linker.
2 . D igestion  
with Xbal.
Kpnl
Xbal Linker
lacZ
3. Insertion of lacZ into 
Xbal linker.
pJM1 A Kpnl
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4.1. pKhxl, which contains the Kpnl h fragment of HSV-1 
cloned into pAT153, was cut at the unique Xhol site (residues 
135727-135732) which lies within the US3 coding region 
(135222-136665). The linearised plasmid was blunt-ended and 
a phosphorylated Xbal linker was inserted. The lacZ gene, 
under the control of the SV40 early promoter, was excised 
from pFJ3 using Xbal, and inserted into the US3 gene via the 
Xbal linker.
The structure of the plasmid was verified by restriction 
enzyme digestion followed by electrophoresis on a mini-gel. 
This analysis also indicated that the lacZ gene had been 
inserted in the same orientation as the US3 gene, i.e. from 
left to right.
The lacZ insert (at residue 135727) is 423 bp upstream of the 
US2 transcript start and 1002 bp upstream of the US4 
transcript start site (McGeoch et al., 1988). It was 
therefore considered unlikely that the presence of the insert 
would affect transcription of the neighbouring genes.
The lacZ insert disrupts the US3 ORF at codon 171, just 
upstream of the proposed catalytic domain which begins at 
amino acid 197 (as defined by Smith & Smith, 1989). As a 
result of this disruption, any translation initiated at the 
assigned US3 initiation codon will produce a protein 
consisting only of the first 171 amino acids of the US3 
protein (ORFA in Figure 4.2). An initiation codon present at
Figure 4.2 Predicted open reading frames in US3-Jac£
construct.
ORFs in the disrupted US3 gene, in all six translation 
frames, were predicted using the FRAMES program. Potential 
ORFs are indicated by open boxes. Potential start codons 
are indicated by lines extending above the reading frame 
box and stop codons are indicated by lines extending below 
the box. The four major putative ORFs are marked A-D.
A = the N-terminal 171 amino acids of the wt US3 protein
B = -galactoside (approximately 120K)
C — a putative novel 17K protein
D = a putative 33K protein which includes the intact US3
catalytic domain
The scale represents nucleotides, starting with the 
initiation codon of the wt US3 protein (135222). The 
construct is 5579 nucleotides in length with the lacZ 
insert lying between nucleotides 512 and 4635.
US
3 
U
S3
1, 
00
0 
2. 
00
0 
3, 
00
0 
4. 
00
0 
5. 
00
0
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amino acid 182 could conceivably re-initiate translation, 
resulting in the synthesis of a protein containing an intact 
catalytic domain (ORF D in Figure 4.2).
4.1.2. Co-transfection and Plague Purification of US3-iacZ 
Virus
The US3-JacZ virus was generated by homologous recombination 
between wt HSV-1 DNA and pJMlA DNA during a cotransfection of 
BHK cells. Prior to cotransfection pJMlA was cut with 
BstEII. There are 3 BstEII sites in pJMlA situated close to 
each other (Figure 4.3). The digested DNA was fractionated 
electrophoretically on a minigel and the large restriction 
fragment recovered by electroelution. This DNA fragment was 
then cotransfected with HSV-1 DNA at the appropriate 
concentrations (see section 3.4.1.). The harvested cells 
were titrated in duplicate; one set was stained with Giemsa 
stain and the other was overlaid with Agar/X-Gal. The 
percentage of blue plaques observed was approximately 2%.
For comparison, this frequency is similar to the value of 
1.2% reported by Ace et al. (1989) for the generation of a 
UL48 insertion mutant, and is substantially higher than the 
0.01% reported by Mullaney (1990) for the generation of a 
UL2-lacZ insertion mutant.
Out of the ten blue plaques which were picked, only two 
yielded blue progeny and these were heavily contaminated with 
wt virus. These plaques were therefore carried through a
Figure 4.3 Structure of pJMlA.
The structure of pJMlA was drawn using the PLASMIDMAP 
program. The scale is in nucleotides and starts at the 
first nucleotide of the EcoRI site in the vector pAT153.
The plasmid is 17890 nucleotides in length.
The position and orientation of the lacZ insert, within the 
US3 gene, is shown (nucleotides 3848-7965).
The positions of several restriction enzyme sites are also 
indicated (BstEII, EcoRI, Bindlll and PstI). The DNA 
fragment from the BstEII site at 14149-14155 to the site at 
12307-12313 was used for cotransfection.
17890 / EcoRI
16000 2000
PstI
BstEII 
14000 ■ 4000
Hindlll
BstEII
BstEII
12000
6000
Hindlll K  EcoRI 
\Hindlll 
EcoRI 
8000
10000
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further 4 rounds (for the A54 and A57 isolates) or 5 rounds 
(for the A64 isolates) of plaque purification and stocks were 
grown of three purified isolates designated A54, A57 and A64. 
The genome structures of these viruses were checked by 
restriction enzyme analysis (see below).
It should be noted that these three isolates originated from 
the same co-transfection plate and therefore cannot be 
regarded as independent.
4.1.3. Restriction Enzyme Analysis of US3-lacZ Virus DNA
The genome arrangement of the US3-IacZ isolates was checked 
by restriction enzyme analysis of 32P-labelled DNA, as 
described in section 3.4.3. The DNA was cut with EcoRI or 
Hindlll and the fragments separated by electrophoresis on 
0 .8% agarose gels.
The position of EcoRI restriction sites in the wt genome and 
the US3-lacZ genome are shown in Figure 4.4. The US3 gene 
lies within the EcoRI h fragment. The insertion of the lacZ 
gene introduces two novel EcoRI sites resulting in the loss 
of the h fragment (15.2 kbp) and the generation of three 
novel fragments, one of 11.0 kbp (N1'), which runs below the 
j fragment (12.6 kbp) on an agarose gel, one of 7.8 kbp (N1), 
which runs above the k fragment (5.6 kbp) and a small 
fragment of 0.5 kbp. These differences in the restriction 
enzyme profile of A54, A57 and A64 compared to wt are shown
Figure 4.4 Location of EcoRI restriction sites in the
wt and the US3-lacZ genomes.
The genomes of HSV-1 wt (a) and the US3-lacZ virus (b) are 
shown, with the unique regions represented by solid lines 
and the repeat elements as open boxes. The dotted line 
represents the boundary between the L and the S segments.
The vertical lines mark the position of EcoRI restriction 
sites and the letters represent the names of individual 
restriction fragments (Davison, 1981). N' and N ' ' indicate 
the location of novel fragments in the US3-!acZ genome.

Figure 4.5 EcdB.1 restriction profile of wt virus and
the US3-lac£ isolates.
3 2p-labelled viral DNA was cut with EcoRI and the fragments 
were separated on a 0.8% agarose gel. The gel was dried 
and exposed to X-Omat XS-1 film. Lane 1: wt virus, lanes 
2, 3 and 4; A54, A57 and A64, respectively. The names of 
the wt restriction fragments are to the left of the wt 
lane. Empty arrowheads ([>) indicate wt fragments which 
have been lost while filled arrowheads (►) mark the 
locations of novel fragments.
1 2  3 4
a.b —  
c.d —
e J 9 h ^
i:—
n —
o —
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in Figure 4.5, except for the band representing the 0.5 kbp 
fragment which is presumed to have run off the bottom of the 
gel.
The position of the Hind!!! restriction sites in the wt and 
the US3-lacZ genomes is shown in Figure 4.6. Digestion with 
Hind.II! results in the loss of the wt n fragment (4.9 kbp) 
and the generation of three novel fragments; one of 3.8 kbp 
(N*'), which runs just below the n fragment on an agarose 
gel, and two of 2.6 kbp (N' and N'''), which run together to 
form a two-molar band below the o fragment (2.9 kbp). The 
loss of the n fragment, the appearance of a band below n, and 
the presence of a two-molar band below o is shown in Figure 
4.7.
The observed differences in the mobility of the k fragment in 
the 2?coRI digest and the g and m fragments in the Hind!!! 
digest are unrelated to the lacZ insertion. They occur 
because these fragments encompass the short repeat regions of 
the genome (IRs and TRs) which contain short tandemly 
reiterated sequences, the number of which varies between 
virus isolates (Davison & Wilkie, 1981; Watson et al., 1981; 
Murchie & McGeoch, 1982; Rixon et al., 1984).
In both Figures 4.5 and 4.7 it is apparent that all 
restriction fragments are not present in equal quantities. 
This is due to the isomerization of the HSV-1 genome. 
Restriction fragments which do not include the termini or
Figure 4.6 Location of Hindlll restriction sites in the
wt and the US3-JacZ genomes.
The genomes of HSV-1 wt (a) and the US3-lacZ virus (b) are 
shown, with the unique regions represented by solid lines 
and the repeat elements as open boxes. The dotted line 
represents the boundary between the L and the S segments.
The vertical lines mark the position of Hindlll restriction 
sites and the letters represent the names of individual 
restriction fragments (Wilkie, 1976; Davison, 1981).
N 1, N ' ' and N ' '' indicate the location of novel fragments 
in the US3-JacZ genome.
CD
CD CD
Figure 4.7 HindLIII restriction profile of wt virus and
the US3-lac£ isolates.
3*p-labelled viral DNA was cut with Hind.HI and the 
fragments were separated on a 0.8% agarose gel. The gel 
was dried and exposed to X-Omat XS-1 film. Lane 1: wt 
virus, lanes 2, 3 and 4; A54, A57 and A64, respectively. 
The names of the wt restriction fragments are to the left 
of the wt lane. Empty arrowheads (£>) indicate wt 
fragments which have been lost while filled arrowheads (►) 
mark the location of novel fragments.
1 2  3 4
a , b ^
d e =  
f —
9 —  
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span the L-S junction, such as EcoRI h and Hin&III n, are 
present in all four isomers and therefore appear as 1M bands. 
Restriction fragments which include the termini, such as 
EcoRI k, e, j and Hindlll i, d, m, g are present in only two 
of the four possible isomers and therefore appear as 0.5M 
bands. The L-S junction fragments such as Hindlll c, b, f, e 
form 0.25M bands as they are present in only one isomer.
The results of these digests confirm that the lacZ gene was 
inserted at the correct position and that no other major 
alterations of the genome have occurred.
4.2. GROWTH PROPERTIES OF THE US3-lacZ VIRUS
The fact that three US3-IacZ isolates had been plaque 
purified and stocks grown indicated that the US3 gene is not 
essential for virus growth in tissue culture. The growth 
characteristics of the US3-lacZ isolates were compared with 
those of wt HSV-1.
4.2.1. Plague Morphology
The plaques produced by all three US3-JacZ isolates differed
from those produced by the wt virus in that they were
noticeably smaller.
|The diameters of 20 wt and 20 US3-lacZ plaques were measured and the
i
jmeans calculated. The US3- l a c Z  plaques were found to be 
'approximately half the diameter of w t plaques. In addition, the 
borders of the US3-lacZ plaques were more distinct (Figure 4.8).
Figure 4.8 Plaque morphology of the US3-2acZ virus.
Morphology of (a) wt and (b) US3-JacZ A57 isolate plaques 
on BHK cells. The viruses were titrated in parallel and 
after two days were stained with Giemsa stain and 
photographed.
The bar represents approximately 2mm.
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4.2.2. Growth Curve at a High moi
BHK cells were infected at 10 pfu/cell and harvested at the 
appropriate times, as described in section 3.1.8. The 
results of this one-step growth curve are shown in Figure 
4.9.
The growth of the wt HSV-1 virus was as expected. The three 
US3-iacZ isolates, however, grew more slowly than wt reaching 
final yields which were 12-fold (A54), 8-fold (A57) or 4-fold 
(A64) less than that of wt. In order to determine if these 
differences between the growth of the three isolates were 
reproducible the experiment was repeated. The A54 isolate 
exhibited a 7-fold reduction in growth compared to wt, the 
A57 isolate a 6-fold reduction and the A64 isolate a 7-fold 
reduction (data not shown). Thus, the differences in the 
growth properties of the three US3-lacZ isolates do not 
appear to be significant.
It is therefore concluded that disruption of the US3 gene 
results in a 4- to 12-fold reduction in virus yield, 
foLlowing infection at a high multiplicity.
4.2.3. Growth Curve at a Low moi
Cells were infected at 0.001 pfu/cell and harvested over a 
period of 72h. The final yields therefore represent the 
result of several rounds of virus replication. The results
Figure 4.9 Growth curve of US3-lacZ virus at a high 
moi.
BHK cells were infected with wt virus or one of the three 
US3-lacZ isolates (A54, A57 or A64) at a moi of 10, 
incubated at 37°C and harvested over a period of 30h. The 
samples were subjected to ultrasonic disruption and were 
then titrated.
The virus yield (y axis) represents the titre (pfu/ml) x 
sample volume (ml).
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are shown in Figure 4.10.
The curves for the US3-IacZ isolates showed that their growth 
was impaired compared to wt, with decreases in the final 
yield of 41-fold for A54, 10-fold for A57 and 47-fold for 
A64. This experiment was not repeated and it is therefore 
not known if the higher titre obtained for the A57 isolate is 
reproducible. The reductions for the A54 and A64 isolates 
are considerably greater than those observed following 
infection at a high multiplicity. This is not unexpected 
considering that the virus, which exhibits reduced titres 
following one round of replication (see 4.2.2.) has undergone 
several more rounds of replication with less infectious virus 
entering each subsequent cycle.
Thus, the growth curves at both high and low moi indicate 
that although the US3 gene is not absolutely required for 
virus growth, its absence does cause a significant reduction 
in virus growth on BHK cells.
4.2.4. Investigation of US3-iacZ Virus Growth During the 
Lag (Eclipse) Phase
During the lag phase of virus growth (approximately 0-5h 
p.i.) the virus enters the cell, is uncoated, and is 
transported to the nucleus, prior to the onset of replication 
and transcription. The virus is not infectious during these 
early stages which accounts for the decrease in virus yield
Figure 4.10 Growth curve of US3-JacZ virus at a low moi.
BHK cells were infected with wt virus or one of the three 
US3-JacZ isolates (A54, A57 or A64) at a moi of 0.001, 
incubated at 37®C and harvested over a period of 72h. The 
samples were subjected to ultrasonic disruption and were 
then titrated.
The virus yield (y axis) represents the titre (pfu/ml) x 
sample volume (ml).
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observed at this time. However, it is apparent from figures 
4.9 and 4.10 that the decrease in the yield of the US3-lacZ 
isolates during the lag phase was not as great as that 
observed for the wt virus. One possible explanation for this 
observation is that the US3-lacZ virus is slightly impaired 
for entry into cells. This phase of virus growth was 
therefore investigated more thoroughly by infecting cells at 
a high moi and harvesting samples every 30 min for the first 
5h p.i. The results are shown in Figure 4.11.
The growth curves show that at most points during the first 
5h p.i. the titres obtained for the three US3-iacZ isolates 
are higher than those of wt, supporting the suggestion that 
the US3-lacZ virus does not enter cells as efficiently as wt. 
However, the differences observed during this experiment are 
not as great as those seen during the high moi growth curve 
(Figure 4.9). This experiment should therefore be repeated 
before a final conclusion is reached.
Other means of investigating virus entry into cells include 
using [^H]-thymine-labelled virus preparations, to determine 
the rate of adsorption of the virus particles to the cell 
monolayer, and using Southern blot hybridization on nuclei 
preparations in order to determine the rate at which viral 
DNA migrates to the nucleus (Ace, 1989).
Figure 4.11 Growth of US3-lacZ virus during the lag
(eclipse) phase.
BHK cells were infected with wt virus or one of the three 
US3-lacZ isolates (A54, A57 or A64) at a moi of 10, 
incubated at 37°C and harvested over a 12h period, with 
samples taken every 30 min for the first 5h p.i. The 
samples were subjected to ultrasonic disruption and 
titrated.
The virus yield represents the titre (pfu/ml) x sample 
volume (ml).
oCM o VO
VO
00
VO
PP?A 01 Sol
Ho
ur
s 
(p.
i.)
155
4.2.5. Growth of US3-lacZ Virus at Different Temperatures
The sensitivity of the US3-lacZ virus to different growth 
temperatures was determined.
BHK cells were infected at a moi of 10 and incubated, in
duplicate, at 31°C, 37°C, 38.5°C or 39.5°C overnight. The
samples were harvested and titrated at 37°C. The results are 
shown in Table 4.1.
The growth of the wt virus was optimal at 37©C, with similar 
yields also obtained at 38.5°C. The yields at both 31°C and 
39.5°C were slightly reduced.
The yields of the US3-lacZ isolates were consistently lower
than those of wt at all temperatures. Optimal growth was
achieved at 31°C and 37°C with the yields decreasing at the 
higher temperatures (38.5°C and 39.5°C).
The differences between the wt and the US3-lacZ isolate 
yields at each temperature, have been expressed as the 
average ratio of wt yield:isolate yield (Table 4.1). The 
ratios at 37©C and 38.5°C for all three isolates are similar 
to each other and lie within the range expected from the 
growth curves. The ratios at 31°C however are consistently 
smaller than those at 37°C or 38.5°C, reflecting the fact 
that while the wt yield has approximately halved, the US3- 
la.cZ yields are unchanged. This situation is reversed at
Table 4.1 Growth of US3-lacZ virus at different
temperatures
BHK cells were infected at a moi of 10 with wt or one of 
the three US3-JacZ isolates (A54, A57 and A64) and 
incubated overnight at 31°C, 37°C, 38.5°C or 39.5°C. The 
infected cells were subjected to ultrasonic disruption and 
titrated at 37©C.
The virus yield was calculated by multiplying the titre by 
the sample volume.
The growth of the US3-lacZ isolates at each temperature was 
compared with that of wt by calculating the ratio of wt 
yield:US3-lacZ yield.
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39.5°C where the decrease in the US3-lacZ yields is greater 
than that of wt resulting in higher ratios.
These results suggest that while the US3-iacZ isolates do not 
display a marked ts phenotype they do appear to be slightly 
more tolerant to low temperatures and more sensitive to high 
temperatures than the wt virus.
4.2.6. Growth of US3-iacZ Virus on Different Cell Types
The US3-iacZ isolates were grown on six different cell types 
to see if they exhibited a host range phenotype. Cells were 
infected at a moi of 10, incubated overnight at 37©C, 
harvested and titrated. The yields are shown in Table 4.2.
The US3-lacZ virus, like the wt virus, grew on all the cell 
types tested. However, there was considerable variation in 
the yields obtained on the different cells. The wt virus 
grew well on BHK, HFL, Flow 2002 and Vero (source 2) cells 
but grew poorly on 3T6, BSC-1 and Vero (source 1) cells. The 
US3-iacZ isolates followed a similar pattern of growth except 
for the unexpectedly low yields observed on the HFL (source 
2) cells.
The differences between the wt yields and the US3-JacZ yields 
on each cell type, expressed as the ratio of wt 
yield:US3-lacZ yield, are also shown in Table 4.2. The 
ratios for the BHK, HFL (source 1) and Flow 2002 cells all
Table 4.2 Growth of US3-iacZ virus on different cell
types
BHK, HFL, Flow 2002, 3T6, BSC-1 and Vero cells were 
infected at a moi of 10 with wt or one of the three US3- 
lacZ isolates (A54, A57 and A64) and incubated overnight at 
37°C. The infected cells were harvested and titrated on 
BHK cells.
All of the BHK, Flow 2002, 3T6 and BSC-1 experiments were 
carried out on cells which originated from the same frozen 
stock (within the Institute). For the HFL cells, "source 
1" and "source 2" represent cells from two different frozen 
stocks. For Vero cells, "source 1" represents cells from a 
frozen stock while "source 2" represents cells obtained 
commercially.
Virus yield represents the titre multiplied by the sample 
volume.
The growth of the US3-IacZ isolates on each cell type was 
compared with that of wt by calculating the ratio of wt 
yield:US3-IacZ isolate yield.
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lie within the range expected from previous experiments with 
BHK cells, while the HFL (source 2) cells gave much larger 
ratios (47.3-59.5) due to the lower US3-lacZ yields. The 
3T6, BSC-1 and Vero (source 1) cells all gave very low 
ratios. However, on the Vero (source 2) cells, which 
supported good wt growth, a reduction in the growth of the 
US3-lacZ virus compared to wt became apparent, with ratios 
ranging from 5.1 to 6.6. Thus, the low ratios obtained on 
the 3T6, BSC-1 and Vero cells are probably a consequence of 
the overall low virus yields obtained on these cells.
4.2.7. Growth of US3-iacZ Virus on "Resting" Cells
The previous growth experiments have demonstrated that the 
US3 gene product is not required for virus growth on 
exponentially growing BHK cells. However, it is known that 
exponentially growing cells can supply factors which are able 
to compensate for an introduced mutation. For example, 
Jamieson et al. (1974) have shown that an HSV-1 mutant which 
lacks any thymidine kinase activity can grow well on 
exponentially growing BHK cells but can not grow on serum- 
starved "resting" cells. This has important implications for 
the growth of the mutant in vivo, as it has been suggested 
that the cells infected with HSV-1 in natural infections are 
more likely to resemble "resting" than "non-resting" cells. 
Thus, the growth of the US3-lacZ virus on "resting" cells was 
investigated.
Both "resting" and exponentially growing BHK cells were 
infected with HSV-1 wt or the US3-lacZ isolates at a moi of 
10, incubated at 37°C overnight, harvested and titrated in 
duplicate. The results are shown in Table 4.3.
In this experiment the wt yields obtained from the 
exponentially growing cells were much lower than expected 
from previous experiments. The US3-iacZ isolates, however, 
do not appear to have been similarly affected. Thus, the 
corresponding wt:\JS3-lacZ isolate ratios are considerably 
lower (maximum 1.4-fold reduction) than those obtained in the 
high moi growth curve (maximum 12-fold reduction, see section
4.2.2.).
On "resting" cells, the wt yields were approximately two-fold 
greater than those obtained on the exponentially growing 
cells. This difference is thought to be due more to the 
uncharacteristic reduced growth of wt on the exponentially 
growing cells than to a preference of wt for "resting" cells. 
Comparison of the wt and US3-JacZ isolate yields obtained on 
"resting" cells shows that the growth of the \JS3-lacZ virus 
is only slightly impaired compared to wt (a maximum of 4.6- 
fold). (It should be noted that one plate, infected with the 
A64 isolate, gave a much reduced yield of 4.2 x 10® pfu/ml.
It is thought likely that the cells on this plate had died 
during the seven day incubation.) Thus, it is evident that 
the ability of the US3-IacZ virus to grow on BHK cells is not 
dependent upon a factor which is present only in
Table 4.3 Growth of US3-iacZ virus on "resting" cells
Exponentially growing and "resting" BHK cells were infected 
at a moi of 10 with wt or one of the three US3-lacZ 
isolates (A54, A57 and A64). After an overnight incubation 
at 37°C the infected cells were harvested and titrated.
Virus yields represent the virus titre multiplied by the 
sample volume.
The growth of the US3-lacZ isolates were compared with that 
of wt by calculating the ratio of wt yield:US3-lacZ isolate 
yield.
* indicates an unusually low yield which was ignored when 
the ratios were calculated.
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exponentially growing cells. These results also suggest that 
the US3-lacZ virus will be viable in vivo.
4.3. PARTICLE COUNTS
The number of particles present in SV stocks of wt virus and 
the US3-lacZ isolates were calculated and compared with the 
titres to give particle:pfu ratios. The results are shown in 
Table 4.4. While the number of particles in the US3-lac,Z 
stocks were similar to those in the wt stocks, the titres 
were less, resulting in higher particle:pfu ratios for the 
US3-lacZ isolates. In order to determine if these 
differences in the particleipfu ratios are significant the 
results were analysed statistically.
One of the statistical methods frequently used to analyse 
differences between two populations is comparison of the two 
population means using the Student's t-test. The conditions 
of this test are that the measurements have a normal 
distribution and that the variances (i.e. the scatter of 
values around the mean) of the two groups are equal. This is 
tested statistically using the F-test (Wardlaw, 1985);
Table 4.4 Particle:pfu ratios of US3-lacZ isolates
The number of particles/ml present in three stocks of the 
wt, A54, A57 and A64 viruses were divided by the 
corresponding titres to give the particle:pfu ratios. The 
wt and US3-IacZ isolate ratios were then compared by 
calculating the ratio of mean isolate ratio:mean wt ratio 
(x isolate : X  wt) .
Particle counts were carried out by Mr J Aitken.
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where S* (variance) = 2 x ‘- (2*.)% 
(*-•)
X  = observations 
n = no. of observations
The calculated value of F is then compared with tabulated 
values of F (Wardlaw, 1985) at fi = ni-1 degrees of freedom 
in the numerator and f 2 = n 2”l in the denominator. The data 
for the F-test are shown in Table 4.5(a). The F values for 
the three US3-lacZ isolates, compared to wt all exceed the 
tabulated values (P < 1%) and the results are therefore 
significant, that is, the variances of the US3-lacZ isolates 
are not equal to that of wt and the Students t-test cannot be 
applied.
One of the easiest ways of processing the data from two 
groups with unequal variances is to use the following 
approximation (Bailey, 1981): 
d = x, - Xi
5 S* i  +  fi
/'J
where X =  mean.
d is then treated as being distributed approximately like 
Student's t and the calculated value of d is compared with 
the tabulated values of t (Bailey, 1981) at the appropriate
Table 4.5 Statistical analysis of the particlerpfu
ratios of wt and the US3-lacZ isolates
a) F-test (to determine if the variances of the wt ratios 
and the US3-lacZ isolate ratios were equal). The 
value of F was calculated for each isolate according 
to the formulae given in the text. The calculated 
values were then compared with the tabulated values of 
F and the significance of the results determined.
b) Comparison of the wt and US3-lacZ isolate population 
means using an approximation of the Student's t-test. 
The formulae used to calculate d are given in the 
text. (The values of S2 used in these calculations 
are as given in (a).) The significance of the results 
was determined by comparing the calculated values of d 
with the tabulated values of t, at the appropriate 
d.f. (Bailey, 1981).
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degree of freedom (d.f.) which is given by:
d.f. -  L _ --------
' ( I - U-)1
n, - i  i
vr^cxie, ix s. S , / n ,
The calculated values of d, u and d.f., for this experiment, 
are shown in Table 4.5(b). As can be seen from this table, 
the differences between the means of the US3-JacZ isolates 
and wt are highly significant (P < 0.1%). Thus, it is 
concluded that the US3-iacZ virus particles are significantly 
less infectious than the wt particles.
The reason for the increase in non-infectious particles in 
the US3-IacZ isolates is not known.
4.4. ANALYSIS OF US3-iacZ VIRUS-INDUCED POLYPEPTIDES
The insertion of the lacZ gene into the US3 ORF is expected 
to produce several changes in the polypeptide profile of the 
virus. These changes have been analysed using the FRAMES 
program, which displays all of the possible ORFs in the six 
translation frames (Figure 4.2). Since the wt US3 ORF is no 
longer present the wt US3 protein, with an apparent molecular
weight of 68K (Frame et al., 1987), should be absent from the 
US3-IacZ virus polypeptide profile. Other potential changes 
predicted by this program include the presence of four novel 
ORFs (marked A-D, Figure 4.2). The first of these putative 
ORFs (A) extends from the wt US3 start codon to the in-frame 
stop codon which lies just past the lacZ insert boundary. 
Expression from this ORF is considered likely due to the 
presence of the upstream wt US3 promoter and enhancer 
sequences. The expressed protein will consist of the N- 
terminal 171 amino acids of the wt US3 protein and is 
predicted to have a M r of approximately 19K. The second ORF 
(B), which corresponds to the lacZ gene, will also be 
expressed, under the control of the upstream SV40 promoter. 
The protein produced, -galactosidase, will have a MW of 
approximately 120K. In contrast to the above two ORFs, 
expression of ORF C, which spans the lacZ boundary, and ORF 
D, which includes the intact wt US3 catalytic
domain, is purely speculative, and would be dependent upon 
the presence of suitable upstream promoter elements.
The polypeptide profile of the US3-IacZ virus was closely 
examined for any evidence of these changes.
4.4.1. Analysis of T35S1-methionine Labelled Infected Cell 
Extracts
BHK cells were mock-infected or infected with wt or the US3- 
lacZ isolates at a moi of 20. The cells were either labelled
163
with 35S-methionine overnight or were pulse labelled from 4h 
to 7h p.i. or from 7h to lOh p.i. The proteins were 
separated on a 5%-12.5% gradient SDS-polyacrylamide gel (Fig. 
4.12) or on a 9% SDS-polyacrylamide gel (data not shown).
No change was observed in the pattern of bands around 68K in 
the US3-iacZ isolate extracts, in either gel. This is not 
unexpected as polypeptide profiles are complex; the US3 
protein may be present only in very small quantities or may 
comigrate with another protein. Only one of the possible 
novel proteins was observed, the 120K J3-galactosidase 
protein which appears as a novel band below the 155K major 
capsid protein. There were no other discernable changes in 
the polypeptide profiles, | suggesting that the disruption of 
the US3 protein kinase does not adversely affect the 
characteristic temporal pattern of protein synthesis of the 
virus.
4.4.2. Analysis of Virion Peptides
Zha.ig et al. (1990) have recently reported that the US3 
protein kinase is a constituent of HSV-1 virions. To 
investigate this further, HSV-1 wt and US3-iacZ A57 virions 
were prepared. Untreated samples of the virions were loaded 
on a 9% SDS-polyacrylamide gel, together with virions which 
had been treated with NP40 and phosphorylated in vitro. The 
section of the gel containing the untreated virions was 
silver-stained and the section containing the in vitro
Figure 4.12 [35S]-methionine-labelled polypeptides
induced by wt virus and the US3-lacZ 
isolates.
BHK cells were either mock-infected (lanes 1, 6 and 11) or 
infected with wt (lanes 2, 7 and 12), A54 (lanes 3, 8 and 
13), A57 (lanes 4, 9 and 14) or A64 (lanes 5, 10 and 15) 
and labelled with [35S]-methionine at 4-7h p.i. (lanes 1- 
5), 7-10h p.i. (lanes 6-10) or overnight (lanes 11-15).
The cells were harvested and the proteins separated on a 5- 
12.5% gradient gel.
Known MWs are indicated to the right of lane 15. The novel 
120K protein is indicated (^).
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phosphorylated virions was dried and exposed to film. There 
were no discernable differences in the polypeptide patterns 
of the wt and US3-lacZ untreated virions (data not shown) or 
the phosphorylated virions (Figure 4.13). Thus these results 
do not support the suggestion that the US3 protein kinase is 
a virion component. However, it is possible that the US3 
protein comigrates with another virion protein which masks 
its absence from the US3-lacZ virions.
4.4.3. Analysis of Infected Cell Extracts Using Anti-US3 
Antisera
The proteins produced from the US3 locus in the US3-lacZ 
mutant were examined using two anti-peptide antibodies (18377 
and 18378) which had been raised against the peptide NH 2-Tyr- 
Cys-Leu-Pro-Leu-Phe-Gln-Gln-Lys-COOH, which corresponds to 
the C-terminal octapeptide of the predicted US3 protein 
sequence (with a Tyr residue included for linking purposes). 
These antibodies had previously been used, in immunoblotting 
experiments, to identify the US3 protein kinase as a 68K 
protein present in HSV-l-infected cell extracts (Frame et 
al. , 1987). Both immunoprecipitation and immunoblotting 
experiments were carried out.
For the immunoprecipitations, [35S]-methionine-labelled 
extracts of M.I. wt or US3-lacZ isolate infected cells 
(prepared as in section 3.5.3.) were incubated with antisera 
18377 or 18378 in the presence or absence of peptide, and the
Figure 4.13 Profiles of wt and US3-lacZ virion proteins
labelled with 3*P in vitro.
virions (lanes 1-3)| (lanes 4-6)j
wtftand US3-lacZ A57 virions^were purified, treated with
NP40 and phosphorylated in vitro. The virion
phosphoproteins were then separated on a 9% SDS-
polyacrylamide gel. Known MWs are shown on the right.
•v«s
if*- ~65K -57 K
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immunoprecipitated proteins were separated on 5%-12.5% 
SDS-polyacrylamide gels. Examination of the resulting 
autoradiographs (not shown) revealed that the antisera had 
not specifically precipitated the 68K US3 protein from the wt 
extracts indicating that the antisera do not recognise the 
native US3 protein.
For the immunoblotting experiments, cells were infected with 
wt and incubated at 37°C, in the presence of [35S]- 
methionine, overnight or for five hours, as in vitro 
phosphorylation experiments have shown that the US3 protein 
is maximally phosphorylated at this time, which may indicate 
that maximal quantities of the protein are present (see 
4.6.). The labelled proteins were separated on SDS- 
polyacrylamide gels which were then blotted onto 
nitrocellulose. The nitrocellulose was blocked with gelatin, 
Tween 20 or FCS, at a temperature of either 37°C or 65°C, and 
then incubated with the two anti-US3 antibodies or with 
normal rabbit serum, at 37°C. The resulting autoradiographs 
(not shown) revealed that the antisera had not recognised the 
68K US3 protein.
These results were unexpected as these antisera had been 
successfully used by Frame et al, (1987) to recognise the 68K 
US3 protein. However, it should be noted that, in the 
experiments of Frame et al. (1987) the US3 protein had been 
purified prior to immunoblotting, thereby providing a 
concentrated source of antigen, whereas in these experiments
the US3 protein is thought to be present only as a minor 
protein of the infected cell extracts. In addition, the 
affinity of the antisera may have decreased as the antisera 
have aged.
4.5. ANALYSIS OF US3-lacZ VIRUS DNA SYNTHESIS.
ENCAPSIDATION AND RELEASE
The effect of the lacZ insertion on the synthesis, 
encapsidation and release of viral DNA was investigated, as a 
reduction in any of these processes could explain the 
observed decrease in the growth of the US3-IacZ virus. A 
reduction in the amount of DNA synthesized would result in a 
decrease in the number of virus particles produced and 
consequently, a decrease in the virus titres. A defect in 
DNA encapsidation would also reduce the number of virus 
particles released, as capsids which do not contain DNA are 
not exported from the nucleus. Alternatively, defects in 
encapsidation may result in the production of particles which 
do not contain a complete virus genome. These particles are 
likely to have reduced growth properties, thereby reducing 
the titres of the virus stocks. A block in the release of 
virus particles would also result in a reduction in the 
titres of virus stocks. The DNA synthesis of the US3-IacZ 
virus was therefore investigated, as described below.
BHK cells were infected, at a moi of 5, with wt (22 plates) 
or with US3-IacZ A57 isolate (22 plates), for 8h or 24h at
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37°C. Ten of each set of virus-infected plates were then 
used to prepare total DNA samples and a further 10 plates 
were used to prepare both encapsidated DNA samples (from the 
monolayer) and released DNA samples (from the medium). These 
samples were all resuspended in 300 ul RNase solution (see
3.6.1.). The two remaining wt or A57 infected plates were 
used to determine the virus yields at the time of harvesting. 
Total DNA samples were also prepared from two mock-infected 
plates, as controls. For detection of viral DNA, 10 ul of 
each DNA sample, in a final volume of 60 ul, was loaded onto 
a slot blot and the blot was probed with the HSV-1 Kpnl f 
fragment, which had been labelled with 32P by nick 
translation. The blot was then exposed to film. Figure 4.14 
shows an autoradiograph of the 30 wt samples and 30 A57 
isolate samples harvested at 8h and 24h. As expected, the 
probe did not hybridise to the mock-infected samples.
Considering the weak signals from the encapsidated and 
released DNA samples, the experiment was repeated and these 
samples were resuspended in smaller volumes (150 ul or 50 ul 
RNase, respectively). In addition, the volume loaded onto 
the slot blot was increased from 10 ul to 20 ul or 30 ul, 
respectively, in a final volume of 60 ul (autoradiographs not 
shown).
Inspection, by eye, indicated that there is not a large 
difference in the amounts of DNA synthesised by the two 
viruses. To confirm this the results of these experiments
Figure 4.14 DNA synthesis of wt virus and the US3-jacZ 
A57 isolate.
Total cellular DNA, encapsidated DNA and released DNA were 
prepared from cells infected with wt (slots 1-10), or A57 
(slots 11-20), at 8h or 24h p.i. The samples were loaded 
onto a slot blot which was probed with 32P-iabelled Kpnl f 
fragment and exposed to X-Omat XS-1 film.
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were analysed in two ways; by densitometry (experiments 1 and 
2) and by scintillation counting (experiment 1 only).
Several autoradiographs of the blot, at different exposures, 
were analysed using a Hoefer Scientific Instruments GS300 
scanning densitometer and the area under each peak calculated 
by the GS-360 data system using Gaussian integration 
analysis. The slot areas were then cut out of the blot and 
the radioactivity counted in the scintillation counter at 10 
minutes per sample. The means of these results, together 
with the ratios of the means (xwt/xA57) are shown in Table
4.6.
The statistical significance of any differences in the means 
of the wt and A57 measurements was determined by applying the 
Students t-test.
In this statistical test the difference in the means is 
expressed as a single value, known as t, which is calculated 
using the values of the mean (x), the standard deviation (S) 
and the number of measurements (n) in each of the two groups 
(see below). Once calculated, this value for t is then 
compared with the tabulated t values by consulting t tables 
(Wardlaw, 1985) at ( m + n 2 ”2) degrees of freedom. If the t 
value corresponds to a P-value greater than 5% the difference 
is not deemed to be significant, that is, the means of the 
two groups are not statistically different. Values which lie 
between P-values of 5% and 1% are demmed to be significant 
and values corresponding to P-values less than 1% are highly
Table 4.6 Analysis of results from US3-lacZ DNA
synthesis experiments
BHK cells were infected at a moi of 5 with wt or \JS3-lacZ 
A57 isolate and incubated at 37°C for 8h or 24h. Total 
DNA, encapsidated DNA and released DNA were prepared and 
loaded onto a slot blot which was then probed with 32p- 
labelled Kpnlf fragment. The blot was exposed to X-Omat 
XS-1 film and the resulting autoradiographs were analysed 
by densitometry. The slots were then cut from the blot and 
the radioactivity measured by scintillation counting.
The results of the densitometer analysis are expressed as 
the area under the curve, as determined by Gaussian 
integration analysis. The results of the scintillation 
counting are in cpm.
The wt means and A57 means for the two experiments are 
shown for each DNA sample. To determine if the difference 
in the means was significant, the Student's t-test was 
applied to the data. The values of s, t, the P values used 
and the significance of the results are shown. The ratio 
of wt mean:A57 mean for each DNA sample is also shown.
As different exposures were used for the densitometric analysis of j 
the total, encapsidated and released DNA vertical comparisons of th^ 
densitometric means presented in this table cannot be made. The 
means obtained by scintillation counting can be compared vertically,
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significant, that is, the means of the two groups are 
statistically different.
The formula used to calculate t is as follows:
where X
n
S
I
“ft.
the sample mean of the group
the number of measurements in the group
the pooled estimate of the standard deviation,
which is calculated using the following
formula:
a, + a*-a
x represents the individual measurements within 
a group.
The values of x, n, s, t and the significance of the results 
are shown in Table 4.6.
The difference in the means of the two viruses for the total 
DNA and released DNA samples were not significant, indicating 
that the two viruses synthesise and export equivalent amounts 
of DNA. However, the difference between the means of the 
encapsidated DNA samples (a maximum 2.77-fold difference, at 
8h) was deemed to be statistically significant. This result 
is inconsistent with the conclusions reached from analysis of
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the total and released DNA as any reduction in the level of 
encapsidated DNA should be reflected in the total DNA levels 
and should produce a corresponding, significant, reduction in 
the released DNA, neither of which was observed. In 
addition, the 2.77-fold reduction in encapsidated DNA does 
not account for the 7-fold reduction in virus growth observed 
in these experiments (data not shown).
Thus, although the statistical analysis is inconclusive, 
possibly due to insufficient data, it is considered that the 
observed reduction in growth of the US3-IacZ virus is not due 
to a significant reduction in DNA synthesis, encapsidation or 
release.
4.6. IN VITRO PHOSPHORYLATION OF wt AND US3-lacrZ-INFECTED 
CELL EXTRACTS
(The following experiments were carried out in conjunction 
with Dr H. W. McL. Moss.)
Potential physiological substrates of the US3 protein kinase 
were investigated by comparing the in vitro phosphorylated 
proteins of the wt and US3-IacZ virus. US3-lacZ A54 and wt 
infected cells were harvested after a 5h or an overnight 
incubation, at 37»C. Cytoplasmic and nuclear extracts were 
prepared and incubated with X _32P”ATP, at a range of salt 
concentrations. The phosphoproteins were separated on 9% 
SDS-polyacrylamide gels.
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Figure 4.15 shows the phosphoproteins present in cytoplasmic 
extracts of cells infected with wt (lanes 1-7) or US3-IacZ 
A54 isolate (lanes 8-14). The wt extracts contain many 
labelled proteins, including a protein of apparent MW 68K 
which corresponds to the observed size of the US3 protein 
(Frame et al., 1987). The fact that this phosphoprotein is 
not present in the A54 extracts (lane 8-14) supports the 
conclusion that this is the US3 protein. It is interesting 
to note that the US3 protein is strongly labelled at 
unusually high salt concentrations (up to 1.5M) and is not 
present in nuclear extracts (results not shown). The US3 
protein is also absent from extracts of cells infected 
overnight, at 37°C (results not shown), implying that the 
protein has either been degraded by this stage in the virus 
cycle or is no longer capable of accepting phosphate groups. 
It is not known if the observed phosphorylation of the US3 
protein is a result of autophosphorylation or the action of 
another kinase.
Examination of the A54 extracts (lanes 8-14) shows that the 
absence of the labelled 68K US3 protein is accompanied by a 
marked reduction in the phosphorylation of three other 
proteins. These proteins have estimated MWs of 200K, 80K and 
30K, but they have not been identified as known virus induced 
species. The 200K phosphoprotein does not appear to 
comigrate with Vmwl75 and may represent the 273K 
phosphoprotein (encoded by UL36), or one of its breakdown
Figure 4.15 In vitro phosphorylation of cytoplasmic 
extracts, from wt and US3-lacZ-infected 
cells, at a range of salt concentrations.
BHK cells were mock-infected or infected with wt or the A54 
isolate for 5h at 37©C. Cytoplasmic extracts were prepared 
which were then incubated with [ #-32P]-ATP in the presence 
of a range of salt concentrations. The phosphoproteins 
were separated on a 9% gel. The MWs of certain viral 
proteins are shown to the left of the wt tracks. The 
phosphoproteins which are absent or underphosphorylated in 
the US3-la.cZ extracts are indicated, with arrows, to the 
right of the A54 tracks (the M.I. tracks are not shown).
This autoradiograph was prepared by Dr H. W. McL. Moss.
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products. The 80K phosphoprotein migrates in the same region 
as the 81/82K and the 85/87K phosphoproteins and the 30K 
phosphoprotein may represent the UL34 gene product which has 
been reported to be a substrate for the US3 protein kinase 
(Purves et al. , 1991). It is interesting to note that the 
57K UL13 phosphoprotein (see section 5.6.) is strongly 
phosphorylated in the mutant extracts, indicating that the 
protein is not phosphorylated by the US3 protein kinase.
In vitro phosphorylation experiments were also carried out on 
cytoplasmic extracts of A57 and A64 infected cells with 
similar results (data not shown).
These results provide further evidence that the US3 gene 
product is a protein kinase and indicate three possible 
substrates for the kinase.
4.7. US3-iacZ REVERTANT
When studying the properties of a mutant virus it is 
desirable to have a revertant virus as a control, i.e., a 
virus in which the mutation has been rescued using a DNA 
fragment containing the wt sequences. This ensures that the 
observed phenotype of the mutant virus is due only to the 
introduced mutation and not to a spontaneous mutation which 
has occurred elsewhere in the genome. The construction of 
the US3-lacZ revertant is described below.
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4.7.1. Co-transfection and Plaque Purification of the US3-
lacZ Revertant
pKhxl, which contains the Kpnl h fragment of HSV-1, was 
linearised with EcoRI and cotransfected with DNA prepared 
from the US3-IacZ A57 isolate. Recombinant progeny, lacking 
the lacZ gene, produce 'white' plaques (i.e. not stained 
blue) which are easily detected against the background of 
"blue" plaques produced by the A57 virus.
The efficiency of detection of the recombinant is reduced 
slightly due to the fact that "blue" viruses, in practice, 
often give rise to a certain percentage (usually less than 
1%) of white plaques.
The percentage of "white" plaques produced by this 
cotransfection was higher than expected, ranging from 2.8% to 
a maximum of 17.5%. Out of the ten "white" plaques picked, 
six gave 100% white plaques when titrated. To ensure purity, 
these plaques were carried through several more rounds of 
plaque purification, their wt genome structures were verified 
by restriction enzyme analysis, and stocks were grown of 
three isolates.
It was at this point that the difficulties in other work to 
generate a US3 deletion mutant became apparent (discussed 
fully in section 4.8.). Briefly, it appeared that during the 
transfection of A57 DNA alone into BHK cells a large
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percentage of wt virus was generated. It must be assumed 
that this could also have occurred during the revertant 
cotransfection. Since the revertant did not carry any 
distinguishing marker, it is uncertain that the isolated 
revertant actually originated from a recombination between 
the DNA fragment and the A57 DNA.
4.8. US3-DELETI0N MUTANT
An attempt was made to construct a mutant with a deletion in 
the US3 gene. Such a mutant is preferable to an insertion 
mutant as it contains no foreign DNA. The mutant should 
confirm the phenotype of the US3-JacZ insertion mutant.
4.8.1. Construction of pLC5
pLC5, which contains a deletion in the US3 gene from the Xhol 
site (residues 135727 to 135732) to the BanBI site (residues 
136289 to 136294), was constructed as illustrated in Fig. 
4.16. pGX45, which contains the tfindlll (133466 to 133471) 
to BanBI (136289 to 136294) subfragment of HSV-1, in pAT153, 
was cut with Xhol and the restriction fragments separated on 
an agarose gel. The 2.2 kbp Xhol fragment, containing the 
5 ’-terminal 505 bp of the US3 gene, was purified from the gel 
and stored. pGX169, which contains the BanBI (136289 to 
136294) to ffindlll (138344 to 138349) subfragment of HSV-1 in 
pAT153, was linearised with BanBI, blunt-ended, and a 
phosphorylated Xhol linker inserted. The purified Xhol
Figure 4.16 Construction of pLC5.
p6X45, which contains the H i n d l l l  to 5amHI fragment (residues 
133466 to 136289) of HSV-1 inserted into the complementary 
site of pAT153, was digested with Xhol and the resuiting 2.2 
kbp fragment was purified. pGX169, which contains the Bant\ I 
to H i n d l l l  fragment (residues 136289 to 138344) of HSV-1 
inserted into the comp 1ementary sites of pAT153, was 
linearised with Ba/rt\ I and an Xhol linker inserted. The Xhol 
fragment, purified from pGX45, was then inserted into this 
linker to give a p 1 asmid containing a deletion in the US3 gene 
(pLC5) .
The shaded areas represent the US3 O R F .
Hindlll
Xhol
pGX45
US3
fiamHI
Xhol
HindlJl
US3
BamHl
1. Digestion with Xhol 
and purification of 
Xhol fragment
2. Digestion with BamHI 
and insertion of Xhol 
linker.
US3
Xhol Xhol
Hindlll
US3
Xhol
linker
3. Insertion of Xhol 
fragment into linker.
pLC5
Xhol Hindlll
US3
Xhol
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fragment, from pGX45 was then inserted into the modified 
pGX169, via the Xhol linker to give pLC5. The structure of 
this plasmid was authenticated by restriction enzyme 
digestion followed by electrophoresis on a mini-gel. This 
analysis also confirmed that the insert was in the correct 
orientation, i.e. the two sections of the US3 gene had been 
ligated together to give a US3 gene with a 562 bp deletion.
The deletion represents amino acids 169 to 357 of the US3 
protein which includes motifs I to VII of the catalytic 
domain, thus an intact catalytic domain can not be 
synthesised.
The deletion is not expected to interfere with transcription 
of the neighbouring genes.
4.8.2. Co-transfection of the US3-deletion Mutant
pLC5 was linearised with £coRI (Figure 4.17) and 
cotransfected with DNA from the US3-IacZ A57 isolate exactly 
as described previously (4.1.2.). The products of the co­
transfections were titrated and overlaid with EMCs/X-Gal. As 
in the revertant cotransfection, recombinant progeny, lacking 
the lacZ gene should produce "white" plaques which can be 
easily detected against the background of "blue" plaques 
produced by the A57 virus.
The cotransfection resulted in very large percentages of
Figure 4.17 Structure of pLC5.
The structure of pLC5 was drawn using the PLASMIDMAP 
program. The scale is in nucleotides and starts at the 
first nucleotide of the EcoRI site in the vector pAT153.
The plasmid is 7588 nucleotides in length.
The location and orientation of the deleted US3 gene is 
shown (nucleotides 4991 - 5878). The location of the EcoRI 
site, which was used to linearise the plasmid prior to 
cotransfection, is also indicated.
7588
EcoRI
2000
4000
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"white" plaques ranging from 27% to 100%. This, together 
with the fact that the plaques exhibited a wt morphology 
suggested wt contamination. To confirm this, the 32p- 
labelled DNA of three plaques were analysed by digestion with 
EcdRI and Hin&III. Any virus containing the deleted US3 gene 
is expected to show a decrease of 0.6 kbp in the size of the 
EcdRI h and Hindlll n fragments. These three plaques 
however, gave wt restriction profiles.
The controls for the contransfection experiment indicated 
that neither the DNA solutions nor the buffers were 
contaminated with wt virus. The structure of pLC5 was 
checked again and found to be as expected and no wt virus 
could be detected in the A57 virus stock, from which the DNA 
had been made. Thus, the source of the wt virus was unclear.
The cotransfection was repeated using fresh solutions but, 
once again, large numbers of wt plaques were produced. The 
control containing A57 DNA and calf thymus DNA only was also 
found to contain "white" plaques (approximately 11%), 
suggesting that either these solutions contain a very low 
level of wt contamination, which was not detected in previous 
checks, or that wt virus is generated by the procedure of 
transfection itself, presumably by the loss of the la.cZ gene 
from the A57 DNA.
This phenomenon was not restricted to the A57 isolate, as the 
A54 isolate DNA was found to produce approximately 50% white
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plaques when transfected into BHK cells. (The A64 isolate 
gave only blue plaques.)
Another attempt was made to isolate the US3-deletion mutant, 
using two different batches of BHK cells. 100 plaques were 
picked and analysed by restriction enzyme digestion; 92 
plaques were wt, 3 were a mixture of wt and A57, and 5 
contained no DNA or DNA which could not be digested. It was 
noted that the percentage of wt plaques varied considerably 
between the two batches suggesting that the metabolic state 
of the cell may play a role in this phenomenon.
It was decided that isolation of the deletion mutant would be 
difficult while this problem was unresolved and other means 
of transfecting cells were therefore investigated. Initial 
experiments were performed with lipofectin reagent (BRL), 
however, this was not continued due to a lack of time.
4.9. NEUROVIRULENCE OF THE US3-iacZ INSERTION MUTANT
The neurovirulence of the A57 isolate of the US3 insertion 
mutant was compared to that of wt. Three-week-old BALB/c 
mice were inoculated in the left cerebral hemisphere with 
10-fold serial dilutions (102 to 107 pfu/ml) of either the wt 
or A57 virus. Deaths from encephalitis were scored up to 21 
days post-inoculation and LD 50 values calculated. (This work 
was kindly carried out by Dr Lesley Robertson.) The results, 
shown in Table 4.7 indicate that the A57 virus, with an LD 50
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of 1 x 104 pfu/animal, is at least 300-fold less 
neurovirulent than wt (LD50 ^ 10*5) .
The virus present within the brains of the A57-infected mice 
which had died was analysed by homogenising the brain tissue, 
isolating single plaques and digesting the DNA using an 
appropriate restriction enzyme. (This work was kindly 
carried out by Dr Christine MacLean.) The results (not 
shown) indicated that the A57 virus was contaminated with 
significant amounts of wt virus. Thus, the LD50 value 
calculated for A57 in this experiment is incorrect.
The A57 working stocks were re-checked for wt contamination. 
The working stock was used to set up a low moi infection 
(0.001 pfu/cell) which was incubated at 37°C for 72h. Upon 
titration of this infection, approximately 10% white plaques 
were observed. This experiment was repeated using the A54 
and A64 working stocks which were found to have 8% and 3% 
"white” plaques, respectively. The DNA isolated from these 
"white" plaques were analysed by [restriction enzyme 
digestion. The profiles were found to be consistent with 
those of wt DNA (Dr C. A. MacLean).
As a result of these findings the A57 isolate elite stock was 
subjected to four more rounds of plaque purification to give 
isolate A91. This isolate will be characterised and used in 
any subsequent experiments.
These results obviously have important implications for all 
the work previously carried out using the US3 insertion 
mutant. For example, it is anticipated that the yields 
obtained during all the growth experiments, especially those 
carried out at a low moi, will have been increased by the 
presence of 8% (A54), 10% (A57) or 3% (A64) wt contamination. 
Reductions in the synthesis, encapsidation or release of the 
US3-lacZ virus may not have been detected due to the presence 
of wt DNA and, in the in vitro phosphorylation experiments 
the activity of wt US3 protein kinase may have obscured other 
potential substrates of the kinase. Thus, all of these 
experiments should be repeated with the plaque purified A91 
isolate before any conclusions can be reached.
The wt contamination also explains the difficulties 
encountered when trying to construct a US3 deletion mutant 
and a revertant.
CHAPTER 5: STUDIES ON THE HSV-1 UL13 GENE
5. STUDIES ON THE HSV-1 UL13 GENE
At the start of this project, little was known about the 
function of the UL13 gene of HSV-1. The predicted sequence 
of the UL13 protein had been reported to contain amino acid 
motifs that are characteristic of known protein kinases or 
phosphotransferases (Smith & Smith, 1989; Chee et al., 1989), 
and the gene is known to be conserved throughout the three 
sub-families of the herpesviruses. Thus, it was considered 
likely that the UL13 gene product may play an important role 
in the virus life cycle. This role was investigated by 
constructing a virus which contains the UL13 gene of HSV-1 
disrupted by the insertion of the E. coli lacZ gene. The 
effect of this disruption on the growth properties of the 
virus were investigated and in vitro phosphorylation 
experiments were carried out to determine if the UL13 gene 
product possesses protein kinase activity.
5.1. CONSTRUCTION OF THE UL13- lacZ INSERTION MUTANT
5.1.1. Construction of pLC3
pLC3 contains the UL13 ORF disrupted by the insertion of a 
lacZ gene and was constructed as shown in Figure 5.1.
The source of the UL13 gene (residues 28504 to 26950) was the 
plasmid pGX125 which contains the Kpnl f fragment of HSV-1 
(17789 to 28626) cloned into the vector pAT153. pGX125
Figure 5.1 Construction of pLC3.
pGX125, which contains the Kpnl f fragment of HSV-1, was 
digested with Xhol and the 2.2 kbp Xhol fragment, 
containing the intact UL13 ORF, was purified. This 
fragment was cloned into the complementary 5aJI site of 
pAT153 to give pLCl (not shown) which was then linearised 
at the unique Xhol site, within the UL13 ORF, and an Xbal 
linker inserted (pLC2). The lacZ gene, excised from pFJ3 
using Xbal, was then inserted into pLC2 using the Xbal 
linker to give a plasmid containing a disrupted UL13 ORF 
(pLC3).
The solid area represents the UL13 ORF. The shaded areas 
indicate the lacZ gene.
Xhol
pGX125
UL13
XholXhol Xhol
Xbal Xbal
pFJ3
1. UL13 isolated by partial 
digeston with Xhol and cloned 
into pATl53. Xbal linker inserted 
into unique Xhol site.
2. Digestion with Xbal.
Xbal
linker
3. Insertion of lacZ gene 
into UL13.
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contains four Xhol sites, two of which (26347 to 26352 and 
28555 to 28560) border the UL13 gene and one (28058 to 28063) 
which lies in the middle of the gene. A partial digestion of 
pGX125 with Xhol was carried out and the resulting 
restriction fragments were separated by electrophoresis on a 
minigel. The 2.2 kbp restriction fragment (26347 to 28555), 
which contains the entire UL13 gene, was excised from the 
gel, purified and subcloned into the complementary 5ail site 
of pAT153, to give pLCl. Cloning into the Sail site 
destroyed the terminal Xhol sites of the 2.2 kbp fragment, 
leaving pLCl with a single Xhol site, situated within the 
UL13 gene. pLCl was cut at this unique Xhol site, the 
linearised plasmid was blunt-ended and a phosphorylated Xbal 
linker was inserted. The plasmid was cut with Xbal and 
religated to ensure that only one copy of the linker had been 
inserted. This plasmid (pLC2) was then linearised with Xbal 
and the E. coli lacZ gene, which had been cut from pFJ3 using 
Xbal, was inserted to give pLC3.
The UL13 gene overlaps extensively with its neighbours (see 
Figure 1.10). The transcript site (residue 27048) and the 
promoter of the downstream gene, UL12, lie within the UL13 
coding region and the UL13 ORF is predicted to have an |out 
of frame overlap of 83 codons with the coding region of its 
right neighbour UL14. The position of the lacZ insert (at 
residue 28058) is approximately 1 kbp upstream from the 
transcript start site of UL12 and is outwith the coding 
region of UL14. Thus, the insertion is not expected to
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interfere with the transcription of the neighbouring genes.
The lacZ insert disrupts the UL13 ORF at amino acid 148 which 
is just upstream of the start of the catalytic domain, at 
amino acid 157 (Smith & Smith, 1989). A protein consisting 
of the 148 N terminal amino acids may be expressed in the 
insertion mutant and translation may also be possible 
(depending upon a suitably placed promoter) from an 
initiation codon present at amino acid 230. This latter 
protein would consist of the UL13 catalytic domain which 
lacked motifs I to IV and which would therefore be inactive.
5.1.2. Cotransfection and Plague Purification of UL13-lacZ 
Virus
pLC3 was linearised with PstI (Figure 5.2) and cotransfected 
into BHK cells with wt DNA (see section 3.4.1.). The 
cotransfections were harvested and titrated in duplicate; one 
set was stained with Giemsa stain and the other was overlaid 
with Agar/X-Gal (for the detection of "blue" plaques). This 
was repeated several times without success. The DNA was then 
cotransfected into BHK cells from four different sources. 
Recombinant virus was generated in only one of these batches 
with a recombination percentage of approximately 0.4% (which 
was lower than that observed in the construction of the US3- 
lacZ insertion mutant). "Blue" plaques were picked from 
plates containing large numbers of wt plaques and were 
carried through five rounds of plaque purification before
Figure 5.2 Structure of pLC3.
The structure of pLC3 was drawn using the PLASMIDMAP 
program. The scale is in nucleotides and starts at the 
first nucleotide of the EcoRI site in the vector pAT153. 
The plasmid is 9992 nucleotides in length.
The position of the orientation of the lacZ insert, within 
the UL13 gene, is shown (nucleotides 6484 to 2367).
The position of several restriction enzyme sites are also 
indicated (EcoRI, Xbal, Bgll and PstI) . The PstI site was 
used to linearise the plasmid prior to co-transfection.
8000
7000
PstI
EcoRI
Xbal
2000
Xbal
Bglll
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they were deemed to be pure. After restriction enzyme 
analysis stocks were grown of three isolates - A54, A510 and 
A515.
It should be noted that these three isolates originated from 
the same co-transfection plate and therefore cannot be 
regarded as independent.
5.1.3. Restriction Enzyme Analysis of UL13-iacZ Virus DNA
The genome structure of the UL13-IacZ virus was determined by 
digestion of 32P-labelled DNA with Xbal and Bglll.
The UL13 gene lies within the Xbal c fragment of the wt 
genome (Figure 5.3(a)). Insertion of the lacZ gene 
introduces two additional Xbal sites into the genome (Figure 
5.3(b)). Thus, the Xbal c fragment (34 kbp) is replaced by 
three novel fragments: one of 17.4 kbp (N1), which runs below 
the f fragment (24.7 kbp); one of 16.5 kbp (N''1), which runs 
above the g fragment (10.6 kbp); and one of 4.1 kbp (N'') 
representing the lacZ insert, which runs below g . These 
changes in the Xbal restriction profile of the A54, A510 and 
A515 isolates are shown in Figure 5.4.
The position of the Bglll sites in the wt and the UL13-IacZ 
genomes is shown in Figure 5.5. The insertion of the lacZ 
gene introduces a novel Bglll site resulting in the loss of 
the o fragment (5.3 kbp) and the generation of two novel
Figure 5.3 Location of Xbal sites surrounding the UL13
gene in the wt and UL13-IacZ virus.
The genomes of HSV-1 wt (a) and the UL13-lacZ virus (b) are 
shown, with the unique regions represented by solid lines 
and the repeat elements as open boxes. The dotted line 
represents the boundary between the L and the S segments.
The vertical lines mark the position of Xbal restriction 
sites and the letters represent the names of individual 
restriction fragments.
N', N ' 1 and N ' '' indicate the location of novel fragments 
in the UL13-lacZ genome.

Figure 5.4 Xbal restriction profile of wt virus and the
UL13-lacZ isolates.
32P-labelled viral DNA was cut with Xbal and the fragments 
separated on a 0.6% agarose gel. The gel was dried and 
exposed to X-Omat XS-1 film. Lane 1; wt virus, lanes 2, 3 
and 4; A54, A510 and A515, respectively. The names of the 
wt restriction fragments are to the left of the wt lane. 
Empty arrowheads ([>) indicate wt fragments which have been 
lost while filled arrowheads (►) indicate the presence of 
novel fragments.
1 2  3 4
<
Figure 5.5 Location of Bglll sites surrounding the UL13
gene in the wt and UL13-iacZ virus.
The genomes of HSV-1 wt (a) and the UL13-lacZ virus (b) are 
shown, with the unique regions represented by solid lines 
and the repeat elements as open boxes. The dotted line 
represents the boundary between the L and the S segments.
The vertical lines mark the position of Bglll restriction 
sites and the letters represent the names of individual 
restriction fragments.
N 1 and N ' 1 indicate the location of novel fragments in the 
UL13-lacZ genome.

Figure 5.6 Bglll restriction profile of wt virus and
the UL13-lacZ isolates.
32P-labelled viral DNA was cut with Bglll and the fragments 
separated on a 0.8% agarose gel. The gel was dried and 
exposed to X-Omat XS-1 film. Lane 1; wt virus, lanes 2, 3 
and 4; A515, A510 and A54, respectively. The names of the 
wt restriction fragments are to the left of the wt lane. 
Empty arrowheads ([>) indicate wt fragments which have been 
lost while filled arrowheads (►) indicate the presence of 
novel fragments.
1 2  3 4
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fragments, one of 6.7 kbp (N11), which runs just above m (6.4 
kbp) and one of 2.7 kbp (N *) which runs below the p fragment 
(4.6 kbp). The loss of the o fragment and the appearance of 
the bands above m and below p are shown in Figure 5.6. (The 
variation in the size of the 1 fragment is due to the fact 
that it represents the termini of the short region of the 
genome (see section 4.1.3.).
These results confirmed that the lacZ gene had been inserted 
at the correct position in the UL13 ORF.
5.2. GROWTH PROPERTIES OF THE UL13-LACZ VIRUS
The fact that a UL13-lacZ virus had been purified and stocks 
grown indicated that the UL13 product, like the US3 gene 
product, is not required for virus growth in tissue culture. 
Differences in the growth of the UL13-lacZ virus, compared to 
wt, were investigated:
5.2.1. Plaque morphology
The UL13-lacZ isolates produced plaques which were similar to 
those of the US3-lacZ isolates, that is, they were slightly 
smaller than wt plaques and their borders were more sharply 
defined (Figure 5.7).
Figure 5.7 Plaque morphology of the UL13-iacZ virus.
Morphology of (a) wt and (b) UL13-lacZ A54 isolate plaques 
on BHK cells. The viruses were titrated in parallel and 
after two days were stained with Giemsa stain and 
photographed.
The bar represents approximately 2mm.
.i— i
5.2.2. Growth curve at a high moi
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BHK cells were infected with HSV-1 wt or with the three UL13- 
lacZ isolates at a moi of 10 and harvested over a period of 
30 hours. The growth curves are shown in Figure 5.8.
The three isolates grew to titres which were 2.2-fold (A515), 
3.7-fold (A510) or 6.2-fold (A54) less than that of wt, 
indicating that the disruption of the UL13 gene has little 
effect on virus growth. This experiment was repeated in 
order to determine if the differences in the growth of the 
three isolates are reproducible. The final yields of the 
isolates were found to be 1.2-fold (A515), 15.9-fold (A510) 
and 3.0-fold (A54) less than that of wt. (The difference for 
A510 in this experiment is unusually high and cannot be 
explained.) Thus, it is apparent from these results that the 
A515 isolate consistently grows to higher titres than the 
other two isolates. One possible explanation for this 
increased growth is that the A515 isolate stock is 
contaminated with wt virus. The stock was therefore used to 
set up a low multiplicity infection which was titrated, 
overlaid with EMCs/X-Gal and examined for the presence of wt 
plaques. Restriction enzyme profiles of s^P-labelled A515 
DNA were also examined closely for the presence of wt 
fragments. However, no evidence of wt contamination could be 
found. Another possible explanation for the differences in 
the growth of the three isolates is that the A54 and A510 
isolates possess an additional mutation which is responsible
Figure 5.8 Growth curve at a high moi.
BHK cells were infected with wt virus or with one of the 
three \JL13-lacZ isolates (A54, A510 or A515) at a moi of 
10. The cells were incubated at 37°C and harvested over 
period of 30h. The samples were subjected to ultrasonic 
disription and titrated.
Virus yield represents the titre x sample volume.
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for their reduced yields. Such mutations, if present, would 
be expected to be point mutations or small 
insertions/deletions, as the restriction enzyme profiles 
provide no evidence of gross structural differences between 
the genomes of the three isolates (Figures 5.4 and 5.6).
5.2.3. Growth curve at a low moi
BHK cells were infected at a moi of 0.001 and harvested over 
a period of 72h. The virus yields are shown in Figure 5.9.
The three isolates gave final yields which were 3.6-fold 
(A54), 2.8-fold (A510) or 4.0-fold (A515) less than that of 
wt. Similar results were obtained when the experiment was 
repeated (3.0-fold for A54, 2.5-fold for A510 and 2.5-fold 
for A515). These experiments therefore confirm that 
disruption of the UL13 gene does not result in a significant 
reduction in virus growth compared to wt.
It is interesting to note that, unlike the experiment with 
the US3-lacZ virus (section 4.2.3.) the ratios between the wt 
and UL13-lacZ isolate yields in this experiment are very 
similar to those observed following high multiplicity 
infection (section 5.2.2.), indicating that the slight 
reduction in growth which follows one round of UL13-lacZ 
viral DNA replication is insufficient to affect the quality 
of virus entering further rounds.
Figure 5.9 Growth curve at a low moi.
BHK cells were infected with wt virus or with one of the 
three UL13-lacZ isolates (A54, A510 or A515) at a moi of 
0.001. The cells were incubated at 37°C and harvested over 
a period of 72h. The samples were subjected to ultrasonic 
disruption and titrated.
Virus yield represents the titre (pfu/ml) x sample volume.
Lo
g 
10 
Yi
el
d
10
8
6
4
w.t.
A.5.4,
2 A.5.10,
A.5.15
0
0 4020 60 80
Hours (p.i.)
188
It is also apparent from these results that all three 
isolates grew to similar yields, that is, the small 
differences in the growth of the isolates, observed during 
the high multiplicity infection (section 5.2.2.) are 
eliminated following several rounds of replication. The 
reason for this is unclear.
5.2.4. Growth of UL13-lacZ virus at different temperatures
The temperature sensitivity of the UL13-IacZ virus was 
examined by infecting BHK cells with wt or the three UL13- 
la.cZ isolates at a multiplicity of 10 and incubating 
overnight at 31°C, 37°C, 38.5°C or 39.5°C. The virus yields 
obtained and the ratios of the wt yields to the isolate 
yields are shown in Table 5.1.
The growth of the UL13-IacZ isolates was only slightly 
reduced compared to wt, over all the temperatures, and 
followed a very similar pattern to that of wt, that is, 
maximal yields were reached at 37°C and 31°C with yields 
decreasing as the temperature was raised. Thus, the UL13- 
lacZ virus is not temperature-sensitive.
Once again, it was noted that the A54 and A510 yields were 
consistently lower than the A515 yields (see 5.2.2.).
Table 5.1 Growth of UL13-lacZ virus at different
temperatures
BHK cells were infected at a moi of 10 with wt or one of 
the three UL13-IacZ isolates (A54, A510 and A515) and 
incubated overnight at 31°C, 37°C, 38.5°C or 39.5°C. The 
infected cells were harvested and titrated on BHK cells at 
37°C.
Virus yield represents the titre (pfu/ml) multiplied by the 
sample volume.
The growth of the UL13-IacZ isolates, at each temperature, 
was compared with that of wt by calculating the ratio of wt 
yield:isolate yield.
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5.2.5. Growth of UL13-lacZ virus on different cell types
BHK, HFL or Vero cells were infected with wt virus or one of 
the UL13-lacZ isolates at a moi of 10 and incubated at 37°C 
overnight. The resulting yields and the ratios of wt to 
isolate yields are shown in Table 5.2.
On BHK cells the yields of the UL13-IacZ isolates were, on 
average, 4.4-fold (A54), 3.0-fold (A510) and 1.7-fold (A515) 
less than that of wt. These ratios are all within the range 
expected from previous results (see 5.2.2.) and confirm that, 
on BHK cells, the growth of the UL13-iacZ isolates is only 
slightly reduced compared to wt. On HFL cells, the yields of 
the three isolates were slightly reduced, compared to those 
obtained on BHK cells, while the wt yields remained 
unchanged. Thus, the corresponding wt:isolate ratios were 
slightly higher than for BHK cells (6.5 for A54, 5.7 for A510 
and 3.0 for A515). On Vero cells, the isolate yields were 
considerably reduced compared to wt resulting in higher 
ratios of 8.8 for A54, 13.4 for A510 and 7.5 for A515.
Thus the UL13-JacZ virus displays a slight preference for BHK 
cells over HFL and Vero cells.
It should be noted that, once again, the A515 isolate grew to 
higher titres than the A54 or A510 isolates, irrespective of 
the cell type used.
Table 5.2 Growth of UL13-lacZ virus on different cell
types
BHK, HFL and Vero cells were infected at a moi of 10 with 
wt or one of the three UL13-lacZ isolates (A54, A510 and 
A515) and incubated overnight at 37°C. The infected cells 
were harvested and titrated on BHK cells.
Virus yield represents the titre (pfu/ml) multiplied by the 
sample volume.
The growth of the UL13-lacZ isolates on each cell type was 
compared with that of wt by calculating the ratio of wt 
yield:isolate yield.
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5.2.6. Growth of UL13-iacZ virus on "resting" cells
The UL13-lacZ isolates were grown on "resting" cells in order 
to determine if the viability of the UL13-lacZ virus is 
dependent on the presence of a factor found in exponentially 
growing BHK cells which complements the mutation in the UL13 
gene.
Both "resting" and exponentially growing cells were infected 
with HSV-1 wt or the three UL13- lacZ isolates, in duplicate, 
at a moi of 10, incubated at 37°C overnight, harvested and 
titrated. The results are shown in Table 5.3. [This 
experiment was carried out at the same time as the US3-IacZ 
virus experiments (section 4.2.7.)].
As mentioned previously (section 4.2.7.) the wt yields on the 
exponentially growing BHK cells were lower than expected from 
earlier experiments, resulting in slightly lower wt:isolate 
ratios. On "resting" cells the isolate yields were similar 
to those observed on the exponentially growing cells except 
for two plates which gave considerably reduced yields (9.2 x 
105 pfu/ml for A510 and 6.0 x 105 pfu/ml for A515). As in 
the US3-lacZ experiments, it was assumed that the cells on 
these two plates had died and the yields were not used for 
calculating the ratios. Thus, despite the uncharacteristic 
growth of wt on exponentially growing cells, it is clear that 
the growth of the UL13-iacZ virus is not significantly 
impaired on "resting" cells, indicating that the function of
Table 5.3 Growth of UL13-IacZ virus on "resting" cells
Exponentially growing and "resting" BHK cells were infected 
at a moi of 10 with wt or one of the three UL13-lacZ 
isolates (A54, A510 and A515) and incubated overnight at 
37°C. The infected cells were harvested and titrated.
Virus yields represent the titre multiplied by the sample 
volume.
The growth of the UL13-lacZ isolates was compared with that 
of wt by calculating the ratio of wt yield:isolate yield.
* indicates unusually low yields which were ignored when 
the yield ratios were calculated.
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the UL13 gene product is not complemented by a factor present 
only in exponentially growing BHK cells.
These results also suggest that the UL13-lacZ virus will be 
viable in vivo, as "resting" cells are thought to resemble 
the cells naturally infected with HSV-1 more closely than 
exponentially growing cells (see section 4.2.7.).
[Once again, it was noted that the A515 isolate grew to 
higher titres than the A54 or A510 isolates.]
5.3. NEUROVIRULENCE OF THE UL13-lacZ INSERTION MUTANT
The neurovirulence of the A515 isolate of the UL13-IacZ 
insertion mutant was compared to that of the wt virus, as 
described in section 4.9. (This work was kindly carried out 
by Dr Lesley Robertson.) The results, shown in Table 5.4, 
indicate that the A515 virus is viable in vivo and, with an 
LD50 of 5 x 102 pfu/animal, is only slightly less 
neurovirulent than wt (LD50 ^10 pfu/animal). To verify that 
animal death was due to the A515 virus, the viral DNA present 
within the brains of A515 infected mice which had died was 
analysed, as before, (section 4.9., work carried out by Dr 
Christine MacLean). The restriction profile was 
characteristic of the A515 stock virus and no wt virus was 
detected.
Thus, the absence of the UL13 gene product does not
Table 5.4 Neurovirulence of the UL13-lacZ insertion
mutant
Three-week old BALB/c mice were infected intracranially 
with either wt or the A515 isolate of the UL13-lacZ 
insertion mutant and the number of deaths (out of a total 
of 4) scored for each virus dose. The LD50 of each virus 
was determined by plotting the % dead animals against the 
virus dose (graphs not shown).
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significantly reduce virus growth
A
in tissue culture.
5.4. PARTICLE COUNTS
Particle counts were carried out on purified virion 
preparations, which are cleaner than SV stocks and therefore 
give more reliable results.
Both wt and UL13-lacZ A515 virions were prepared (as 
described in section 3.1.5.) and the number of particles 
present in a sample of each preparation counted. Virion 
samples were also titrated, in parallel, and the particleipfu 
ratios calculated.
The results, shown in Table 5.5, indicate that there is no 
significant difference between the wt and A515 ratios. This 
result is not unexpected as the growth of the A515 isolate is 
only slightly less than that of wt.
5.5.1. Analysis of r3SS]-methionine-labelled infected cell 
extracts
5.5. ANALYSIS OF UL13-lacZ VIRUS-INDUCED POLYPEPTIDES
The polypeptides induced by wt and the UL13-IacZ virus were 
labelled with [35S]-methionine, separated on a 5-12.5% 
gradient polyacrylamide gel and compared. Two differences
Table 5.5 Particle:pfu ratio of UL13-lacZ virus
The number of particles/ml present in two wt and A515 
virion preparations were divided by the titres to give the 
particle:pfu ratios.
Particle counts were carried out by Mr J Aitken.
Virus Virion
Prep.
Particles/ml Titre
(pfu/ml)
Particle:pfu
Ratio
wt 1 2.6x10*1 7.9xl09 32.9 : 1
2 1.6xl010 1.4xl010 1.1 : 1
A515 1 1.7x10® 1.8x10® 0.9: 1
2 1.4x10*® 2.9xl08 48.3 : 1
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were expected in the UL13-IacZ virus polypeptide profiles. 
Firstly, the 57K protein which corresponds to the UL13 gene 
product (Cunningham et al., 1992) should not be produced by 
the UL13-IacZ virus, and secondly, there should be a novel 
protein of approximately 120K representing the 
P -galactosidase protein. In addition, a novel protein of 
approximately 25K, representing the C-terminal 288 amino 
acids of the UL13 protein, may be present. However, the 
expression of this protein is speculative, depending on a 
suitably placed promoter.
Figure 5.10 shows the wt A54, A510 and A515 induced proteins 
labelled during a 4h-7h pulse (lanes 1-5), a 7h-10h pulse 
(lanes 6-10) and an overnight label (lanes 11-15). None of 
the predicted changes in the UL13-IacZ virus were observed in 
any of the three isolates, during any of the labels. It is 
possible that the proteins of interest have been masked by 
co-migrating proteins or are present in only small 
quantities.
One difference that was noted in the UL13-IacZ profiles was a 
slight increase in the mobility of Vmw65, the UL48 gene 
product (indicated in Figure 5.10). This may be caused by a 
change in the post-translational modification of the protein, 
for example, phosphorylation, glycosylation or cleavage. 
However, it is possible that this apparent decrease in 
molecular weight is an artifact of this experiment as 
silver-stained UL13-IacZ virion preparations do not show a
Figure 5.10 [35S]-methionine-labelled polypeptides
induced by wt virus and the UL13-lacZ 
isolates.
BHK cells were either mock-infected (lanes 1, 6 and 11) or 
infected with wt (lanes 2, 7 and 12), A54 (lanes 3, 8 and 
13), A510 (lanes 4, 9 and 14) or A515 (lanes 5, 10 and 15) 
and labelled with [35S]-methionine at 4-7h p.i. (lanes 1- 
5), 7-10h p.i. (lanes 6-10) or overnight (lanes 11-15).
The cells were harvested and the proteins separated on a 5- 
12.5% gradient gel.
Known MWs are indicated to the right of lane 15.
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corresponding shift in the mobility of Vmw65 (see Figure 
5.11) .
5.5.2. Analysis of [3SS1-methionine Labelled Virions.
The UL13 gene product is known to be a constituent of the 
virion (Cunningham et al., 1992). The polypeptide profiles 
of UL13-lacZ A515 virions and wt virions were therefore 
compared. (The A515 isolate was chosen as it has a slight 
growth advantage over the other two isolates and should 
therefore produce slightly greater numbers of virions.)
To visualise the virion proteins, the infected cells were 
labelled, in vivo with [35S]-methionine. The labelled 
virions were then purified on a Ficoll 400 gradient and their 
proteins separated on an SDS-9% polyacrylamide gel. However, 
the signals from the labelled proteins were very weak (even 
after long exposures) suggesting that either the labelling 
was inefficient or that the virion yield was poor. Thus, the 
expected loss of the UL13 protein from the A515 virions could 
not be visualised.
5.5.3. Silver-stainincr of UL13-lacZ Virion Proteins
Another approach used to investigate the expression of UL13 
in the UL13-lacZ virus was to silver-stain virion 
preparations.
Both virions and light (L) particles of wt and the UL13-lacZ 
A515 isolate were purified. These preparations were 
fractionated on an SDS 9% polyacrylamide gel which was then 
silver-stained (see 3.5.2.b.). A 57K protein, which 
corresponds to the observed size of the UL13 gene product 
(Cunningham et al., 1992), was present in both wt virions and 
L particles, but was absent from the A515 preparations (see 
Figure 5.11). These results therefore confirm that the UL13 
gene product is not synthesized in the UL13-lacZ virus and 
also provides evidence that the UL13 protein is present in 
the virion in appreciable quantities. In addition, the fact 
that the UL13 protein is present in both virions and L 
particles suggests that the protein is a constituent of the 
tegument or envelope, as L particles do not contain copsids. 
In further experiments, carried out by Dr H. W. McL. Moss, 
the membranes were stripped from wt virions and L particles 
and the proteins fractionated on an SDS-polyacrylamide gel 
which was then silver-stained. The 57K UL13 protein was 
still present in these preparations indicating that UL13 must 
be a tegument protein (data not shown). [The electrophoresis 
and the silver staining of the gel shown were carried out by 
Dr H. W. McL. Moss.]
5.6. In vitro PHOSPHORYLATION OF UL13-1acZ-INFECTED CELL 
EXTRACTS AND VIRIONS
The experiments described in this section were carried out in 
conjunction with Dr H. W. McL. Moss.
Figure 5.11 Silver-stained preparations of wt and UL13-
lacZ A515 virions and L-particles.
Virions (lanes 1 and 2) and L-particles (lanes 3 and 4) 
were purified from wt- (lanes 1 and 3), or A515- (lanes 2 
and 4) infected cells and separated on an SDS 9%- 
polyacrylamide gel. The gel was then silver-stained, as 
described in section 3.5.2. (b), and a copy of the gel was 
transferred from duplicating film (Kodak, X-Omat 
Duplicating Film).
Known virion proteins are indicated to the left of lane 1 
and the 57K UL13 gene product is indicated, with an arrow, 
to the right of lane 4.
The staining of these preparations was carried out by Dr H. 
W. McL. Moss.
155 -
g B -
82/81 -  
6 5 -
53 -
46 -
3 8 -
34 -
196
5.6.1. In vitro Phosphorylation of Nuclear Extracts of
Infected Cells.
Nuclear extracts were used for these experiments as the UL13 
protein had previously been shown to localise in the nuclei 
of infected cells (Cunningham et al,, 1992).
BHK cells were infected with wt or one of three UL13-IacZ 
isolates and incubated at 37°C for 5h. Nuclear extracts were 
prepared and aliquots were incubated with [#-32p]-ATP in the 
presence of different concentrations of salt (ranging from 0 
to 1.5M). The proteins were then separated on an SDS 9% 
polyacrylamide gel and the phosphorylation profiles of the 
two viruses compared to determine if the UL13 gene plays a 
role in virus-induced protein phosphorylation.
Figure 5.12 shows the phosphorylation profiles of wt, UL13- 
lacZ A54, and MI extracts. The wt extracts contain many 
phosphoproteins among which is the prominently labelled 57K 
UL13 phosphoprotein. The intensity of this band increases as 
the salt concentration increases, up to the 1.5M maximum, 
which is consistent with the previously observed optimal salt 
concentration for UL13 phosphorylation (Cunningham et al., 
1992) .
Examination of the UL13-IacZ A54 phosphorylation profile 
reveals several differences compared to wt. The most 
noticeable difference is the complete absence of the 57K UL13
Figure 5.12 In vitro phosphorylation of nuclear extracts 
from wt and UL13-IacZ-infected cells, at a 
range of salt concentrations.
BHK cells were mock-infected or infected with wt or the A54
isolate for 5h at 37<>C. Nuclear extracts were prepared
which were then incubated with [ # - 3*P]-ATP in the presence
of a range of salt concentrations. The phosphoproteiiis
were separated on a 9% gel. The phosphoproteins which were 
hyperphosphorylated| 
absent^or underphosphorylated in the UL13- lacZ extracts are
indicated, with arrows, to the left of the wt tracks.
This autoradiograph was prepared by Dr H. W. McL. Moss.
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phosphoprotein, at all salt concentrations. There is also a 
reduction in the phosphorylation of several other proteins, 
especially at the higher salt concentrations. The apparent 
molecular weights of these proteins have been estimated to be 
160K, 60K, 45K and 38K. The 38K phosphoprotein has been 
mapped (by Dr H. W. McL. Moss), using intertypic 
recombinants, to gene UL49 (Coulter et al., 1993) and is 
equivalent to the previously observed virion/tegument protein 
VP22 (Elliott &. Meredith, 1992). The 160K protein is 
presumed to be viral in origin, as there is no corresponding 
band in MI extracts, and may represent Vmwl75 or a breakdown 
product of the 273K UL36 phosphoprotein. The origins of the 
other two substrates are unknown, although a protein of MW 
60K is present in MI extracts suggesting that the 60K 
substrate could be a cellular protein.
The most straightforward explanation for the observed 
reduction in phosphorylation of these proteins is that they 
are acting as substrates for a protein kinase which is 
induced by the UL13 gene, directly or indirectly. As the 
UL13 gene has been predicted to encode a serine/threonine 
kinase it is considered likely that this protein kinase 
activity is encoded by the UL13 gene itself.
It is assumed that the observed phosphorylation of the 160K 
and the 38K proteins in the lower salt concentration A54 
extracts is due primarily to the action of cellular kinases 
which are optimally active at these low salt concentrations,
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although there does appear to be a reduction in the degree of 
labelling compared to wt suggesting that the UL13 protein 
kinase also contributes to the phosphorylation of these 
proteins at low salt concentrations.
Another noticeable difference between the wt and A54 
phosphoprotein profiles is the apparent increase in the 
phosphorylation of two proteins in the A54 extracts: a 45K 
protein in the 0-0.1 M NaCl extracts and a 70K protein in all 
A54 extracts. The 45K protein may be equivalent to the 45K 
protein mentioned above, which exhibits a reduction in 
phosphorylation in A54 extracts with higher salt 
concentrations or it may represent a novel phosphoprotein.
The identity of the 70K protein has not yet been determined. 
The reason for the increased labelling of these proteins is 
not known: either the proteins are more extensively 
phosphorylated or there are increased amounts of the proteins 
present.
5.6.2. In vitro Phosphorylation of Virion Preparations
As the UL13 protein is known to be a constituent of the 
virion (Cunningham et al., 1992; section 5.5.3.), the wt and 
UL13-iacZ A515 virion proteins were incubated with [ Jf- 
32P]-ATP and subjected to SDS-PAGE. The resulting 
phosphoprotein profiles were then compared and differences 
noted (see Figure 5.13).
Figure 5.13 In vitro phosphorylation of wt and UL13-lacZ 
virions.
Wild-type and UL13-lacZ A515 virions were purified, treated 
with NP40 and incubated with [ # - 32P]-ATP, in the presence 
of a range of salt concentrations. The MWs of the marker 
proteins (M) are shown to the left of the wt tracks. The 
phosphoproteins which were absent or underphosphorylated in 
the UL13-IacZ virions are indicated, by arrows, to the 
right of the A515 tracks.
This autoradiograph was prepared by Dr H. W. McL. Moss.
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As expected, the prominent 57K UL13 protein, present in the 
wt virions was absent from the UL13-iacZ A515 virions and 
there was also a marked decrease in the phosphorylation of a 
160K protein, a 106K protein, a 45K protein and a 38K 
protein, especially at the higher salt concentrations.
The 38K protein, as previously mentioned (section 5.6.1.), 
has been shown to be the product of the UL49 gene and it is 
assumed that the 160K and 45K phosphoproteins are equivalent 
to the underphosphorylated proteins of similar size observed 
in the nuclear extracts (section 5.6.1.). The origin of the 
novel 106K phosphoprotein is unknown. The 60K phospho­
protein, which was labelled in the nuclear extracts (section
5.6.1.), does not appear to be present in these purified 
virion preparations supporting the suggestion that this is a 
cellular protein.
The 45K and 70K proteins which are hyperphosphorylated in the 
A54 nuclear extracts (see section 5.6.1.) were absent from 
the A515 virion preparation. This indicates that these 
phosphoproteins are not constituents of the virion and also 
suggests that there are two distinct 45K phosphorylated 
species in nuclear extracts.
These results provide further evidence that the UL13 gene 
encodes a virion protein kinase.
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5.6.3. Investigation of the Phosphorylation of the UL11 
Gene Product
Work carried out in this laboratory by Dr C. A. MacLean has 
identified the product of the UL11 gene of HSV-1 as a 13-16K 
myristylated phosphoprotein which is located in the virion 
tegument (MacLean et al., 1989; 1992). As the UL13 gene 
product is a constitutent of the virion and has been shown to 
phosphorylate a 38K virion protein (VP22, the product of gene 
UL49) it was thought possible that the UL11 protein may 
represent another substrate of the UL13 protein kinase 
activity. [The UL11 protein would not have been detected in 
the previous in vitro phosphorylation experiments (sections
5.6.1. and 5.6.2.) due to its low molecular weight.] The 
phosphorylation state of the UL11 protein in UL13-lacZ 
virions was therefore determined by immunoprecipitating the 
protein from virions which had been labelled, in vitro, with 
[%-32P]-ATP. (The anti-ULll sera was a gift from Dr C. A. 
MacLean.) The phosphorylation state of the UL11 protein in 
US3-lacZ virions was also determined.
Figure 5.14 shows that a prominently labelled phosphoprotein 
is immunoprecipitated from all three virion preparations (wt 
virions, lane 1; US3-IacZ A57 virions, lane 3; and UL13-JacZ 
A515 virions, lane 5). The fact that this protein is absent 
from samples which contain the peptide against which the 
antisera had been raised confirms that this protein is the 
product of the UL11 gene. Thus, it is apparent that neither
Figure 5.14 Immunoprecipitation of the phosphorylated
UL11 virion protein from wt, UL13-lacZ, and 
US3-lacZ virions.
Wild-type virions (lanes 1 and 2), US3-lacZ A57 virions 
(lanes 3 and 4), and UL13-lacZ A515 virions (lanes 5 and 6) 
were treated with NP40 and incubated with [ y - 32P]-ATP.
The phosphorylated virions were then incubated with an 
anti-peptide antiserum raised against UL11 in the absence 
of peptide (lanes 1, 3 and 5) or in the presence of peptide 
(lanes 2, 4 and 6) and loaded onto a 7.5-15% gradient gel. 
The UL11 gene product is indicated with an arrow.
fULTI
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the UL13 nor the US3 protein kinase is solely responsible for 
the phosphorylation of the UL11 virion protein. [It is not 
possible to determine if the two HSV-1 protein kinases 
contribute to the phosphorylation of the UL11 protein as the 
amount of protein loaded onto each track was not 
standardised.]
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CHAPTER 6: CONSTRUCTION AND INITIAL CHARACTERISATION OF A 
UL13-US3 DOUBLE INSERTION MUTANT
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6. UL13-US3 DOUBLE INSERTION MUTANT
The main purpose behind the construction of a UL13-US3 double 
insertion mutant was to determine if there is any degree of 
cooperativity between the two HSV-1 protein kinases. If 
cooperativity does exist then a considerable decrease in 
virus yields would be expected from a virus in which both 
protein kinase genes had been disrupted. This was 
investigated as described below.
6.1. CO-INFECTION AND PLAQUE PURIFICATION OF THE DOUBLE 
MUTANT
An HSV-1 mutant with a lacZ insertion in both the US3 and the 
UL13 genes was generated by a double recombination between 
the DNA of the two single lacZ insertion mutants. This was 
achieved by co-infecting BHK cells, in duplicate, with 5 
pfu/cell of both the US3-lacZ virus (A57 isolate) and the 
UL13-JacZ virus (A515 isolate). The cells were incubated at 
37°C overnight, harvested, subjected to ultrasonic disruption 
and titrated. The expected progeny from this co-infection 
are the two single lacZ insertion mutants ("blue" plaques), 
the double lacZ insertion mutant ("blue" plaques) and also wt 
virus ("white" plaques). The frequency of "white" plaques 
present should give an indication of the likely frequency of 
double mutant plaques. In this experiment, the percentage of 
"white" plaques was calculated to be 15%. Therefore out of 
the 62 plaques which were picked, approximately 9 might be
expected to possess the double mutant genotype, assuming this 
was viable. The DNAs of the 62 plaques were analysed by 
digestion with BamHI (see next section) and 4 plaques were 
found to produce the restriction profile expected for the 
double mutant. These plaques were picked from the same plate 
and are probably related. The four plaques were carried 
through four successive rounds of plaque purification and 
stocks were grown of two isolates, A42 and A44.
6.2. RESTRICTION ENZYME ANALYSIS OF THE DOUBLE INSERTION 
MUTANT
The genome structure of the double mutant was analysed by 
digestion of 3 2p-iabelled DNA with BamHI or with Bindlll.
The location of BamHI restriction sites in the wt virus, the 
UL13-IacZ virus and the US3-IacZ virus genomes are shown in 
Figure 6.1. (a), (b) and (c). The predicted BamHI sites in 
the double mutant genome are shown in Figure 6.1 (d). The 
UL13 and US3 genes of HSV-1 lie within the BamHI a and n 
fragments, respectively. The lacZ insert possesses an 
additional Ba/nHI site. Thus, in the double lacZ insertion 
mutant the a and n fragments are expected to be replaced by 
four novel fragments (Figure 6.1. (d)). The two fragments 
which replace the a (12.5 kbp) fragment are a 10.2 kbp 
fragment (N2 ) which runs just above the b fragment (10.1 kbp) 
on an agarose gel, and a 6.4 kbp fragment (Ni) which runs 
slightly below the j fragment (6.5 kbp). The two fragments
Figure 6.1 Location of BamHI restriction sites in the
wt, the UL13-lacZ, the US3-IacZ and the 
UL13-US3-IacZ genomes.
The genomes of HSV-1 wt (a), the UL13-lacZ virus (b) , the 
US3-lacZ virus (c) and the UL13-US3 double mutant (d) are 
shown. The unique regions are represented by solid lines 
and the repeat elements as open boxes. The dotted line 
represents the boundary between the L and the S segments.
The vertical lines mark the position of BamHI restriction 
sites and the letters represent the names of individual 
restriction fragments (Davison, 1981).
Ni and N 2 indicate the location of novel fragments in the 
UL13-IacZ genome and also at the UL13 locus of the double 
mutant.
N 3 and N 4 indicate the location of novel fragments in the 
US3-lacZ genome and also at the US3 locus of the double 
mutant.
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replacing the n (4.9 kbp) fragment are an 8.4 kbp fragment 
(N3 ) which runs between the e (8.9 kbp) and f (8.1 kbp) 
fragments and a 0 . 6 kbp fragment (N4 ) which runs below 1 
(0.76 kbp).
Figure 6.2 shows the BamRI restriction profile for the wt 
virus and the A42 and A44 isolates. The profile for the A42 
isolate is as expected for the double mutant showing all the 
changes mentioned above except for the presence of the 0.6 
kbp fragment which is assumed to have run off the bottom of 
the gel. The A44 isolate, however, while gaining the 
expected novel fragments, also contains the a and the n wt 
fragments.
These results were checked by digesting the DNA with Hindlll. 
The location of the Hindlll sites in the wt virus, the UL13- 
lacZ virus, the US3-lacZ virus and the double mutant are 
shown in Figure 6.3.
The UL13 gene lies within the Hindlll j fragment and the US3 
gene lies within the Hindlll n fragment. The lacZ insert 
contains two HindiII sites. Therefore, in the double mutant 
(see Figure 6.3 (d)) the j fragment (11.8 kbp) will be 
replaced by two fragments; one of 12.1 kbp (N2 ) which will 
run below the h fragment (12.4 kbp) and one of 3.8 kbp (Ni), 
which will run between the o fragment (2.9 kbp) and the n 
fragment (4.9 kbp). A very small fragment of approximately 
20 bp will also be produced but is not seen on the gel. The
Figure 6.2 Ban&l restriction profile of wt virus and
the UL13-US3 double insertion mutant.
32p-iabelled viral DNA was cut with BamHI and the fragments 
separated on a 0.8% agarose gel. The gel was dried and 
exposed to X-Omat XS-1 film. Lane 1; wt virus, lanes 2 and 
3; A42 and A44 isolates, respectively. The names of the wt 
restriction fragments are to the left of the wt lane.
Empty arrowheads ([>) indicate wt fragments which have been 
lost while filled arrowheads (►) indicate the presence of 
novel fragments.
1 2 3
a —
6= 
de —
9 ^-—  h —
J —  
k —
m n
o —  
P —
q —
Figure 6.3 Location of Hindlll restriction sites in the
wt, the UL13-lacZ, the US3-JacZ and the 
UL13-US3-lacZ genomes.
The genomes of HSV-1 wt (a), the UL13-JacZ virus (b), the 
US3-JacZ virus (c) and the UL13-US3 double mutant (d) are 
shown. The unique regions are represented by solid lines 
and the repeat elements as open boxes. The dotted line 
represents the boundary between the L and the S segments.
The vertical lines mark the position of Hindlll restriction 
sites and the letters represent the names of individual 
restriction fragments (Wilkie, 1976; Davison, 1981).
Ni and N 2 indicate the location of novel fragments in the 
UL13-IacZ genome and also at the UL13 locus of the double 
mutant.
N 3 , N 4 and Ns indicate the location of novel fragments in 
the US3-lacZ genome and also at the US3 locus of the double 
mutant.
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US3-lacZ insertion will result in the loss of the n fragment 
(4.9 kbp) and the generation of three novel fragments; one 
which will co-migrate with the 3.8 kbp fragment generated by 
the UL13-lacZ insertion (N4 ) and two 2.6 kbp fragments (N3 
and N 5 ) which will run below the o fragment as a 
two-molar band.
Figure 6.4 shows the Hindlll restriction profiles for the wt, 
A42 and A44 viruses. The A42 profile contains the changes 
predicted above but, once again, the A44 profile contains the 
predicted novel fragments while retaining the wt fragments. 
The obvious explanation for these results is that the A44 
virus preparation is contaminated with wt virus, despite the 
four rounds of purification. While this is possible, no wt 
plaques were observed when the stocks were titrated and the 
low titre of the stock (see later) would also suggest that wt 
virus is not present. In view of these results the A44 
isolate can not be classed as a double mutant.
6.3. GROWTH PROPERTIES OF THE DOUBLE MUTANT
6.3.1. Plaque Morphology
The plaques formed by the A42 (and A44) isolates were much 
smaller than those produced by wt or by the two single lacZ 
insertion mutants, with maximum diameters equivalent to 20- 
30% of the maximum diameter of wt plaques.
Figure 6.4 Hin&III restriction profile of wt virus and
the UL13-US3 double insertion mutant.
32P-labelled viral DNA was cut with Hindlll and the 
fragments separated on a 0.8% agarose gel. The gel was 
dried and exposed to X-Omat XS-1 film. Lane 1; wt virus, 
lanes 2 and 3; A42 and A44 isolates, respectively. The 
names of the wt restriction fragments are to the left of 
the wt lane*. Empty arrowheads (t>) indicate wt fragments 
which have been lost while filled arrowheads (►) indicate 
the presence of novel fragments.
* Bands not named represent fragments which have been 
only partially digested.
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6.3.2. Titres of Virus Stocks
The titre for the A42 stock was 2.8 x 107 pfu/ml which was 
considerably lower than that of the wt stock (1.5 x 10*0 
pfu/ml). (The titre for the A44 isolate was even lower, at 
4.0 x 104 pfu/ml.)
6.3.3 Particle Counts
The number of particles present in stocks of the A42 isolate 
and wt were counted and divided by the titres to give the 
particle:pfu ratios. The results, shown in Table 6.1, show 
that the A42 virus exhibits a much larger particle:pfu ratio 
(3643:1) than that of the wt stock (16:1) indicating that the 
A42 virus stock contains a greater number of non-infectious 
particles.
6.3.4. Growth Curve at a Low moi
BHK cells were infected with wt virus or A42 isolate at a moi 
of 0.001 and harvested over a period of 72 hours. The growth 
curves are shown in Figure 6.5.
The growth of the double mutant is reduced approximately 800- 
fold compared to wt. This reduction is considerably greater 
than would be predicted from a simple combination of the 
growth properties of the two single mutants, but is 
consistent with the very high particle:pfu ratio of the A42
Table 6.1 Particle:pfu ratio of UL13-US3 double mutant
The number of particles/ml present in stocks of the wt and 
A42 viruses were divided by the titres to give the 
particle:pfu ratios.
Particle counts were carried out by Mr J Aitken.
Virus Particles/ml Titre Particle :pfu
(pfu/ml) Ratio
wt 2.3xlOn 1.5xl010 16.0: 1
A42 l.OxlO11 2.8xl07 3643 : 1
Figure 6.5 Growth curve at a low moi.
BHK cells were infected with wt virus or with the A42 
UL13-US3-lacZ isolate at a moi of 0.001 and harvested over 
a period of 72h. The samples were subjected to ultrasonic 
disruption and the virus yields calculated (titre x sample 
volume).
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stock.
These results may be interpreted in two ways: either there is 
a considerable degree of cooperativity between the two viral 
protein kinases in wt HSV-1, or another deleterious mutation 
has been inadvertently introduced into the genome. The 
construction of a revertant virus could resolve this.
(It should be noted that, during the low moi growth curve, 
the A44 isolate reached yields similar to those of the A42 
isolate (data not shown)).
CHAPTER 7: DISCUSSION
7. DISCUSSION
The aim of the research presented in this thesis was to 
investigate the role of two HSV-1 genes, US3 and UL13, during 
the HSV-1 lytic cycle. At the start of this research, both 
US3 and UL13 had been predicted to encode protein kinases due 
to the presence of characteristic amino acid sequence motifs 
(McGeoch & Davison, 1986; Smith & Smith, 1989; Chee et al., 
1989). The US3 gene had been shown indeed to encode a novel 
protein kinase, present in the cytoplasm of HSV-1 infected 
cells. This protein kinase had been purified and its 
enzymatic properties characterised (Purves et al., 1986a). 
However, the substrates of the kinase and its functions were 
unknown. In contrast to US3, protein kinase activity had not 
been assigned to the UL13 gene product although the protein 
had been shown to correlate with a novel protein kinase 
activity present in the nuclei of HSV-1 infected cells 
(Cunningham et al., 1992). Thus, the specific aims of this 
project were (1) to identify the substrates of the US3 
protein kinase, (2) to determine if the UL13 gene product 
possesses protein kinase activity, and if so, (3) to identify 
its substrates.
The tools used in this research were three HSV-1 mutants 
which were constructed by inserting the lacZ gene of 
Escherichia coli into the US3 gene, the UL13 gene, or both 
the US3 and UL13 genes. The US3-lacZ and UL13-lacZ viruses 
were characterised with respect to their growth properties
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and polypeptide synthesis and the protein kinase activity of 
the viruses was investigated by in vitro phosphorylation 
experiments. The UL13/US3 double lacZ insertion mutant 
underwent only limited characterisation due to a lack of 
time.
The conclusions reached about the substrates and the 
functions of the US3 and UL13 gene products are discussed 
below.
7.1. US3-lacZ INSERTION MUTANT
The US3-lacZ mutant was constructed by cotransfection of 
plasmid DNA containing the disrupted US3 gene with wt HSV-1 
DNA. The plaques formed by the recombinant virus, which 
turned blue in the presence of X-Gal, were picked and carried 
through 5 to 6 rounds of plaque purification. Three US3-lacZ 
isolates were chosen for further investigation and stocks 
grown. These stocks were deemed to be pure on the basis of
(i) a lack of wt fragments following restriction enzyme 
digestion of the viral DNA and (ii) the absence of wt plaques 
following titration of the US3-lacZ virus stocks. However, 
following the in vivo neurovirulence experiments, the three 
US3-IacZ isolates were found to be contaminated with a low 
level of wt virus. Thus, all of the US3-lacZ experiments 
described in this thesis were, presumably, carried out with 
low levels of wt virus present, and the results are therefore 
not truly representative of a US3-negative virus.
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The viability of the recombinant US3-lacZ virus indicated 
that the US3 gene is not essential for virus growth in tissue 
culture. (The low level of wt contamination cannot, alone, 
account for the observed virus titres.) This result is 
consistent with that of Longnecker & Roizman (1987) who 
reported the construction of a US3 deletion mutant. However 
the US3-lacZ mutant differs from the deletion mutant in its 
growth properties. Longnecker & Roizman (1987) reported that 
the US3- deletion mutant grew to similar titres as wt, 
however the US3-lacZ virus (despite the presence of wt virus) 
exhibits a significant reduction in growth compared to wt. 
This difference in the growth of the two mutants may be due 
to the different host cells used - Vero cells for the US3- 
deletion mutant and BHK cells for the US3-lacZ mutant. Thus, 
the US3-lacZ virus was grown on different cell types to 
determine if a US3-negative virus exhibits a host range 
phenotype. The US3-lacZ virus grew on all the cell types 
tested, although titres did vary depending on the cell type. 
On cells which gave lower US3-lacZ titres (3T6, BSC-1 and one 
batch of Vero cells) the wt yields were also reduced and the 
difference between the two viruses was negligible, while on 
cells which supported good virus growth (BHK, HFL, Flow 2002 
and one batch of Vero cells) a significant reduction in US3- 
lacZ virus titres, compared to wt, was observed. Thus, in 
contrast to the US3-deletion mutant of Longnecker & Roizman 
(1987), a reduction in the growth of the US3-lacZ virus, 
compared to wt, on Vero cells is observed.
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Further characterisation of the growth properties of the US3- 
lacZ virus revealed that the virus , is slightly temperature 
sensitive, being more tolerant than wt of lower temperatures 
(31°C) but more sensitive to higher temperatures of 38.5°C 
and 39.5°C. The mutant was found to grow well on "resting" 
cells indicating that virus growth is not dependent upon a 
factor present in actively dividing cells. The in vivo 
growth experiments revealed that the US3-IacZ virus exhibits 
a reduced neurovirulence, following intracerebral infection, 
with an LD50 of 1 x 104 pfu/animal compared to the wt LD50 of
l-JT
<10 pfu/animal. This LD50 value is lower than that reported 
by Meignier et al. (1988) for the US3-deletion mutant 
following corneal infection (1.8 x 106 pfu/animal) but is 
greater than that reported recently by Nishiyama et al.
(1992) for an HSV-2 US3-IacZ mutant which was only 10-fold 
less virulent than wt following corneal or intracerebral 
infection. Following analysis of the virus present in the 
brains of the mice inoculated with the US3-IacZ virus 
significant quantities of wt virus was discovered, which led 
to the discovery of a low level of wt contamination within 
the US3-IacZ virus stocks. It is therefore anticipated that 
the neurovirulence of a purified US3-IacZ virus will be 
reduced further. Latency experiments were not performed with 
this mutant. However, both Meignier et al. (1988) and 
Nishiyama et al. (1992) have reported that HSV-1 and HSV-2 
US3-negative viruses are able to establish and maintain 
latency.
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Alterations in the polypeptide synthesis of the US3-lacZ 
virus were investigated by [35S]-methionine-labelling of US3- 
lacZ and wt infected cells, followed by SDS-PAGE. The 
polypeptide profiles of the two viruses were then compared. 
The absence of, or (allowing for the low level of wt 
contamination) a reduction|in the amount of a 68K protein was 
expected in the US3-lacZ polypeptide profile, as the MW of 
the US3 gene product has previously been observed to be 68K 
(Purves et al., 1986a; Frame et al., 1987). However, no 
differences were observed between the US3-lacZ and wt 
profiles. This is probably due to comigration of the US3 
protein with other proteins. The US3-lacZ virion proteins 
were also analysed as Zhang et al. (1990) had reported that 
the US3 protein is a component of virions. Both US3-lacZ and 
wt virions were purified and the proteins separated by SDS- 
PAGE and visualised by silver-staining. However, once again, 
no difference between the wt and US3-lacZ profiles was 
observed. Immunoprecipitation and immunoblotting experiments 
were also carried out on extracts of US3-lacZ or wt infected 
cells using antisera raised against the C-terminus of the US3 
protein. These antisera had previously been shown to react 
with a 68K protein in purified preparations of the US3 
protein (Frame et al., 1987). However, in these experiments, 
the antisera failed to recognise the wt US3 protein. This is 
probably due to the fact that in these experiments the wt US3 
protein was present as a minor protein in infected cell 
extracts rather than as a purified preparation, as in the
experiments of Frame et al., (1987). In addition, the
affinity of the antisera may have reduced with age.
It is also possible that the lack of detection of US3 is due to a
poor HSV-1 infection.
DNA synthesis by the US3-IacZ virus was examined as any 
reduction in the amount of DNA synthesised or packaged by the 
virus would result in a decrease in the number of infectious 
particles which could account for the observed reduction in 
the growth of the US3-lacZ virus. Thus, the total amount of 
DNA synthesised by US3-lacZ and wt were measured, together 
with the amount of DNA encapsidated and the amount of DNA 
released into the medium. The wt and US3-IacZ measurements 
were then compared statistically using the Students t-test.
The total DNA levels for the two viruses were not 
significantly different indicating that there is no gross 
reduction in the synthesis of US3-IacZ DNA compared to wt.
The results for the encapsidated and released DNA proved to 
be contradictory to those of the total and released DNA, with 
an approximate 2-fold reduction in the amount of US3-IacZ 
encapsidated DNA classed as statistically significant while 
similar reductions in the amount of total DNA or released DNA 
(which must also be encapsidated) were not. Disregarding the 
inconsistencies in the statistical analysis (probably caused 
by insufficient data), it was concluded that the small 
reduction in DNA levels detected for the US3-lacZ virus could 
not account for the observed reduction in virus growth. This 
conclusion is supported by the particle:pfu ratio of the US3- 
lacZ virus which is significantly greater than that of wt 
implying that the reduction in US3-IacZ growth is not due to
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a decrease in the number of DNA-containing virus particles 
but to an increase in the proportion of non-infectious 
particles. Consistent with this rise in non-infectious 
particles is the observation that, during the lag phases of 
both the high and low multiplicity growth curves, the US3- 
lacZ virus titres do not decrease as much as those of wt, 
suggesting that the US3-IacZ virions are impaired for cell 
entry. The lag phase was therefore investigated further, 
taking samples at 30 minute intervals for the first 5 hours 
p.i., however, in this experiment a significant difference 
was not observed between the titres of the two viruses.
Thus, a conclusion cannot be reached about the ability of the 
US3-lacZ virions to enter the host cells.
In order to identify potential substrates of the US3 protein 
kinase extracts of US3-lacZ and wt infected cells were 
labelled in vitro with Jf-33P-ATP and the phosphoproteins 
separated by SDS-PAGE. In the cytoplasmic extracts of cells 
infected with wt for a period of 5 hours at 37°C, a 68K 
phosphoprotein was observed which was found to be absent from 
the equivalent extracts of US3-IacZ infected cells. It was 
concluded that this phosphoprotein probably represents the 
US3 protein kinase. It should be noted that the 68K US3 
protein kinase was not present in nuclear extracts of wt- 
infected cells, which is consistent with the findings of 
Purves et al. (1986a). In addition, the US3 protein was also 
absent from cytoplasmic extracts of cells which had been 
infected with wt for 16h at 31°C, suggesting that either the
Ill
protein has been degraded by this stage in the infection or 
is no longer phosphorylated. This observation, combined with 
the fact that the US3 mRNAs are known to be present early in 
infection, suggests that the US3 protein kinase is active 
during the initial stages of infection and may therefore be 
involved in altering the environment of the host cell in 
order to facilitate viral infection. As US3 is present only 
in alphaherpesviruses such a function could help determine 
the host range of the virus.
The absence of the 68K US3 protein kinase was not the only 
difference observed in the US3-lacZ phosphorylation profile, 
there was also a reduction in the phosphorylation of several 
other proteins with estimated MWs of 200K, 80K and 30K. The 
identity of these potential substrates has not yet been 
established, although it is considered likely that the 30K 
protein represents the 30K UL34 gene product which has 
recently been reported to be a substrate of the US3 protein 
kinase (Purves et a l ., 1991, 1992). The UL34 protein is a 
virion protein which is essential for virus replication in 
tissue culture, although its phosphorylation by US3 is not 
essential (Purves et al., 1991). During infection with a US3 
deletion mutant the UL34 phosphoprotein, which localises to 
the plasma membrane, was reported to be replaced with four 
faster migrating phosphoproteins (MW 25-35K) which are not 
structurally related to the UL34 protein. Purves et al.
(1992) postulate that the US3 protein kinase is responsible 
for maintaining these proteins in their unphosphorylated
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states, perhaps by regulating the activity of cellular 
kinases associated with cellular membranes.
Identification of the other potential US3 protein kinase 
substrates, observed during the in vitro labelling 
experiments, will be of importance in elucidating the precise 
role of the US3 protein kinase during HSV-1 infection.
7.2. UL13- lacZ INSERTION MUTANT
In contrast to US3, the HSV-1 UL13 gene has homologues in all 
three herpesvirus subfamilies (Smith & Smith, 1989; Chee et 
al., 1989) suggesting that it was acquired early in 
herpesvirus evolution, and may play a generally important 
role in the life cycle of the virus. Thus, at the start of 
this research, it was considered possible that a 
UL13-negative mutant would not be viable in tissue culture. 
Access therefore had been arranged to two UL13 expressing 
cell lines (constructed by S. Weller and J. Lang) but, as it 
turned out, these were not needed. The UL13~IacZ insertion 
mutant was constructed by homologous recombination between 
plasmid DNA, containing the E. coli lacZ gene inserted into 
the UL13 ORF, and wt HSV-1 DNA. Recombinant "blue" plaques 
were picked and purified indicating that the UL13 gene is not 
essential for virus growth in tissue culture.
The growth properties of the UL13-IacZ mutant were 
investigated. Growth curves carried out at both high and low
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multiplicities revealed that the virus grows to titres 
similar to wt but produces smaller plaques. This result 
differs from that recently reported for an HSV-1 UL13- 
deletion mutant which was found to be impaired in both growth 
and plaque formation (Purves & Roizman, 1992). However, 
growth experiments on a PRV mutant which contains an 
oligonucleotide insertion in the PRV UL13 homologue revealed 
no significant differences in either plaque size or titre 
compared to wt PRV (de Wind et al., 1992). The UL13-IacZ 
virus does not display a marked ts phenotype and was able to 
replicate on all cell types tested although titres were 
slightly reduced on Vero cells. The virus also grew well on 
"resting" cells. In an experiment to test the pathogenicity 
of the UL13-lacZ virus in mice by intracerebral inoculation, 
the LD50 was found to be only slightly increased compared to 
wt. Thus, it is concluded that the UL13-IacZ virus is not 
significantly impaired for growth either in vitro or in vivo.
The UL13 gene product has been recognised as a 55-57 KDa 
phosphoprotein, present in HSV-1 virions (Cunningham et al., 
1992; Overton et al., 1992). The virion proteins of the 
UL13-IacZ virus were therefore examined by comparing the 
silver stained polypeptide profiles of UL13-iacZ and wt 
purified virions. A protein of approximately 57K, which 
corresponds to the observed MW of the UL13 gene product, was 
found to be absent from the UL13-iacZ virions and is 
therefore presumed to represent the UL13 gene product. The 
ability to detect the unlabelled UL13 protein indicates that
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the protein is a relatively abundant component of HSV-1 
virions.
Cunningham et al. (1992) reported that the UL13 gene product 
is phosphorylated by a novel protein kinase activity present 
in the nuclei of infected cells and suggested that the 
activity was actually encoded by UL13 with the observed 
phosphorylation representing an autophosphorylation reaction. 
To investigate this, nuclear extracts of infected cells and 
purified virion preparations were incubated with y ~ 33P-ATP 
in vitro and the phosphoproteins separated by SDS-PAGE. As 
expected, the strongly phosphorylated 57K UL13 protein was 
absent from the UL13-lacZ phosphoprotein profile. In 
addition, there was a reduction in the phosphorylation of 
several other proteins, with estimated MWs of 160K, 106K,
60K, 45K and 38K, indicating that the UL13 gene product does 
indeed possess protein kinase activity. This conclusion is 
supported by the recent reports that the VZV and PRV 
homologues of UL13 also display protein kinase activity (Ng & 
Grose, 1992; DeWind et al., 1992). One of the potential 
substrates of the UL13 protein kinase, the 38K protein, has 
been mapped, using intertypic recombinants, to gene UL49, the 
product of which has recently been reported to be a tegument 
protein, previously identified as VP22 (Elliott & Meredith, 
1992). The identity of the other underphosphorylated 
proteins have not yet been determined.
Another difference observed between the wt and US3-iacZ
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phosphoprotein profiles was the apparent hyperphosphorylation 
of two proteins, with estimated MWs of 45K and 70K, in the 
A54 nuclear extracts. These two proteins have not yet been 
identified, although they do not appear to be virion proteins 
(see section 5.6.2.) and it is considered likely that the 45K 
phosphoprotein is distinct from the phosphoprotein of the 
same MW which exhibits reduced phosphorylation in both UL13- 
lacZ nuclear extracts and virions. The reason for the 
increased labelling of these proteins is not known: either 
the proteins are more extensively phosphorylated or there are 
increased amounts of the proteins present. It is interesting 
to note that Purves & Roizman (1992) have recently reported 
the presence of a prominently labelled 70K protein in 
extracts of cells infected with a UL13-negative virus. This 
protein was identified as one of the five post- 
translationally modified forms of Vmw68 (ICP22) (MWs 70-82K), 
the products of gene US1 (<X22). Further analysis revealed 
that the increased labelling of the 70K protein was due, not 
to an increase in the phosphorylation state of the protein 
but, to an increase in the amount of protein present. Purves 
& Roizman (1992) therefore concluded that UL13 is responsible 
for the post-translational processing of Vmw68 to the 
apparent higher MW species. Vmw68 has been reported to be 
involved in extending the host range of HSV-1 in tissue 
culture and also appears to regulate late protein synthesis 
(Sears et al., 1985). Thus, Purves & Roizman (1992) propose 
that UL13 modifies Vmw68 late in infection thereby altering 
the protein's function and perhaps regulating protein
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synthesis. A late function for UL13 would not be unexpected 
as the gene has previously been assigned to the (iV temporal 
class (Costa et al., 1983) or, more recently, to the 
temporal class (Overton et al., 1992). However, the presence 
of UL13 in the virion also suggests that the protein kinase 
might play a role early in infection or may be active in the 
virion itself.
Recent work on the HCMV UL13 homologue UL97 has revealed that 
the product of this gene is responsible for the 
phosphorylation of the antiviral analogue ganciclovir 
(Littler et al., 1992; Sullivan et al., 1992). The activity 
of ganciclovir is dependent upon the formation of the 
triphosphate, which is a strong inhibitor of the viral DNA 
polymerase. In many herpesviruses, this initial 
phosphorylation of ganciclovir is catalysed by viral 
thymidine kinase, however, in HCMV, which does not appear to 
encode a thymidine kinase, it is the UL97 gene product which 
is responsible for the phosphorylation. It is not known if 
this function of UL97 has evolved to compensate for the 
absence of an HCMV-encoded thymidine kinase or if 
phosphorylation occurs due to a chance similarity between 
ganciclovir and one of its natural substrates. Whichever is 
the case, this function has important implications for 
antiviral drug design. It is not known if the HSV-1 UL13 
protein kinase possesses a similar activi ty.
7.3. UL13-US3 DOUBLE INSERTION MUTANT
A UL13-US3 double insertion mutant was constructed by
crossing the US3-lacZ DNA with the DNA of the UL13-lacZ virus
during a co-infection of BHK cells. The plaques formed by
the recombinant virus were very small, approximately 20-30%
of the diameter of wt plaques, and the growth of the virus
following a low multiplicity infection was found to be
approximately 800-fold less than that of wt. This reduction
in growth is considerably more than would be exDected from a
land the US3-lacZ virus (contaminated with wt\ 
simple combination of the growth properties of the |UL13-Iacz virus^
There are several possible explanations for this. 
Firstly, the two protein kinases may have common substrates 
and can therefore substitute for each other in the single 
insertion mutants. However, this is not thought likely to be 
the case as the two protein kinases have very different 
substrate specificities (Purves et al., 1986b; Cunningham et 
al. , 1992) and the in vitro phosphorylation experiments 
carried out during the course of this research have not 
identified common substrates. Secondly, there is the 
possibility that the large reduction in growth is caused by 
an additional mutation inadvertantly introduced into the 
genome of the double mutant during its construction. This 
possibility could be eliminated by the construction of a 
revertant. Another possible explanation for the large 
reduction in growth is that the two HSV-1 protein kinases 
play similar roles in the virus life cycle.
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De Wind et al. (1992) have reported that a PRV mutant 
containing oligonucleoside insertions in the PRV UL13 and US3 
homologues is greatly reduced in both growth and plaque size. 
The construction of a UL13/US3 double deletion mutant has 
also been reported by Purves & Roizman (1992) - the virus is 
viable in tissue culture but no other details of its growth 
properties have been reported.
Further characterisation of this mutant has not been possible 
due to a lack of time.
7.4. CONCLUSIONS AND FUTURE WORK
The work presented in this thesis has confirmed that the US3 
protein kinase is non-essential for virus growth in tissue 
culture, although its absence does cause a significant 
reduction in virus titres. Three potential substrates of the 
kinase have been detected, one of which probably corresponds 
to the UL34 gene product, identified as a substrate of the 
US3 protein kinase by Purves et al. (1992). This work has 
also shown that the UL13 gene is non-essential for virus 
growth, despite its conservation throughout the three 
herpesvirus families, and that the product of this gene is a 
relatively abundant component of the HSV-1 virion. It has 
been demonstrated that the UL13 protein possesses protein 
kinase activity and five potential substrates have been 
detected. One of these substrates has been identified as the 
38K UL49 protein which is a tegument protein, designated
225
VP22. Finally, preliminary experiments with the UL13/US3 
double insertion mutant have suggested that there is a degree 
of cooperativity between the two HSV-1 protein kinases.
Despite this work and the results published recently on US3 
and UL13, little is still known about the role of these 
protein kinases during HSV-1 infection. Further 
investigation of the potential substrates of the two kinases 
is therefore of importance. Identification of potential 
viral substrates may be possible by gene mapping, using 
intertypic recombinants, as with the 38K UL49 gene product. 
Alternatively, identification may be achieved through 
recognition of the protein by antisera previously raised 
against specific HSV-1 proteins. Once identified, the 
functions of the substrates should give vital clues as to the 
roles played by the kinases. In cases where the function of 
the substrate is not known, as with the UL49 gene product, 
HSV-1 mutants with lesions in the appropriate gene can be 
constructed and their phenotypes closely examined in order to 
determine gene function.
Investigating the location of the protein kinases and their 
substrates throughout the course of infection should also 
provide valuable information about their functions. This may 
be achieved through the use of specific antibodies, which are 
then recognised by a second antibody labelled in such a way 
as to be visible by microscopy (immunofluorescence).
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Other experiments to be carried out include (1) the 
construction of deletion mutants, to eliminate foreign DNA,
(2) the generation of revertants for the three lacZ insertion 
mutants, to ensure that the phenotypes of the viruses are due 
to the introduced mutations and, (3) further characterisation 
of the UL13/US3 double insertion mutant, including extensive 
analysis of the growth properties of the muant and in vitro 
phosphorylation experiments.
Characterisation of the three HSV-1 mutants constructed 
during this research has yielded information regarding the 
functions of the US3 and UL13 gene products.
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